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The first step of embryonic differentiation involves a transition from a naïve to a 
primed pluripotency state that occurs between the pre- and post-implantation 
stages of development. Mouse embryonic stem cells (ESCs) and epiblast stem cells 
(EpiSCs) are used as in vitro models of each of these pluripotent states. Although 
significant insight has been gained into the regulation of the self-renewal and 
differentiation capacity of pluripotent cells, little is known regarding how their 
survival is controlled. It has been demonstrated that cells in the primed 
pluripotent state are hypersensitive to cell death stimuli. Here we show the 
importance of miRNAs ensuring cell survival of EpiSCs and post-implantation 
embryos preventing apoptosis by inhibiting the expression of the pro-apoptotic 
protein BIM. In this way, miRNAs maintain primed pluripotent cells in a state that 
is also primed for death. We next compared if ESCs and EpiSCs have different 
apoptotic requirements. We observed that while EpiSCs are very sensitive to 
apoptotic stimuli and require the expression of the anti-apoptotic factors Bcl2, Bcl-
xL, Bcl-w and Mcl1 for their survival, ESCs are relatively resistant to apoptosis and 
mainly rely on Mcl1 to block apoptosis. To unravel the possible reasons for these 
different apoptotic requirements we studied mitochondrial morphology and 
dynamics and found that as cells exit the naïve pluripotent state they change from 
having fragmented to having fused mitochondria. Furthermore, we demonstrated 
that inhibiting mitochondrial fusion by inhibiting DRP1 or inhibiting mitochondrial 
activity by blocking the activity of the ATP-synthase, increased the sensitivity of 
ESCs to cell death. Therefore, these results highlight how miRNA expression, 
pluripotency status, metabolism and mitochondrial dynamics determine the 
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1.1 Early Mouse Embryonic Development 
 
Mouse embryonic development is a complex process orchestrated by progressive 
activation of signalling pathways that will drive specific cell lineage commitment 
accompanied by changes in epigenetics, gene expression, metabolism and cell 
death.  
 
1.1.1 Pre-implantation embryonic development 
Embryonic development starts at fertilization. This process occurs in the oviduct 
when two haploid cells, the oocyte and the sperm, fuse together generating a 1-cell 
embryo or zygote. Sperm entry triggers several waves of calcium oscillations that 
will drive exit from meiosis. This is followed by the first mitotic division, which will 
generate two diploid cells. Maternal transcripts and proteins begin their 
degradation after fertilization while transcriptional activation of the zygote 
genome starts. This process is known as maternal to zygotic transition (MZT).  By 
the end of the 2-cells stage, maternal transcripts reach a minimum and the 
transcriptional machinery relies on the zygotic genome (Clift, 2013). The MZT is 
accompanied by epigenetic changes including changes in DNA methylation and 
histone modifications that will allow acquisition of a totipotent identity (Zhou, 
2015).During the following days of embryonic development these cells will go 
through several further rounds of mitotic divisions (cleavage of the zygote) 
generating new cells or blastomeres while the conceptus moves towards the 
uterus (Clift, 2013).  
 
At the 8-cell stage the process of compaction occurs. Cells will transit from a loose 
to a tight organization accompanied by the acquisition of intracellular polarity as a 
consequence of increased expression of the cell-cell adhesion protein E-cadherin. 
Each cell will have an apical domain (facing the external environment) and a baso-
lateral domain (facing the internal environment).  Further divisions from the 8-cell 
stage will generate either two polar outer cells (symmetric division) or one polar 
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outer cell and one apolar inner cell (asymmetric division) (Cockburn 2010; 
Stephenson 2012). 
At this early stage the first lineage decision takes place in the embryo, the 
segregation of the inner cell mass (ICM) and the trophectoderm (TE). The TE will 
give rise to extra-embryonic structures that have essential roles for the correct 
implantation of the embryo, placenta development and patterning (Cockburn, 
2010) The ICM will remain pluripotent at this stage. However, when cells get 
polarized the expression pattern of some transcription factors become restricted 
to the nucleus of trophectoderm cells such as Cdx2. Cdx2 mutant embryos fail to 
implant because they are not able to silence the expression of Pou5f1 and Nanog in 
the trophectoderm. This causes cell death of trophectoderm cells then of the 
embryo (Strumpf, 2005).  
 
The mechanism behind this restriction is not yet fully understood but the most 
accepted model is based on the Hippo pathway. High levels of cell-cell interactions 
and junction-associated proteins will activate this pathway in the ICM at around 
3.5dpc (Hirate, 2013) leading to the phosphorylation of YAP preventing its 
translocation to the nucleus helping the ICM to remain pluripotent (Cockburn, 
2013). Conversely, in the TE cells, that have less inter-cellular interactions, the 
Hippo pathway is inactive. Thus, YAP is able translocate into the nucleus allowing 
the transcription of Tead4. This will enhance the expression of TE specific markers 
such as Cdx2 that will inhibit pluripotency-associated factors such as Pou5f1 or 
Nanog (Carey, 2014). A recent publication has described that Notch signalling 
pathway is active in the trophectoderm and collaborates with the Hippo pathway 
for the segregation of these two lineages by activating a trophectoderm enhancer 
that promotes the transcription of Cdx2 (Rayon, 2014). Conversely, analysis of 
transcription factors that are restricted to the ICM such as Pou5f1 mutant embryos 
are not able to maintain the ICM and they differentiate towards trophectoderm 
lineage (Nichols, 1998). 
 
At 4.5dpc two different lineages are morphologically distinguishable in the ICM, 1) 
the primitive endoderm (PrE), a monolayer of cells located at the distal surface of 
the ICM, and 2) the epiblast that is in between this layer and the trophectoderm. 
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The primitive endoderm will develop into the anterior endoderm and parietal 
endoderm whereas the epiblast will form the foetus (Grapin-Botton, 2008). At the 
morula stage, Nanog and Gata6, the transcription factors required for this 
segregation, are expressed in an overlapping manner (Plusa, 2008). However, at 
3.5dpc the expression pattern of these factors is mutually exclusive and occurs in a 
random “salt and pepper” fashion (Chazaud, 2006). The segregation of these two 
lineages appears to be dependent on different responsiveness of these cells to FGF 
signals. Nanog positive cells will repress Gata6 expression and will secrete FGF4. 
Gata6 positive cells, that higher levels of Pdfgra (Plusa, 2008) and Fgfr2 (Ohnishi, 
2014), will respond to the FGF signals repressing Nanog and activating the 
transcription of PrE specific genes such us Sox17   (Schrode, 2014).  Gata6 null 
embryos are not able to develop a primitive endoderm or to respond to FGF 
signals. Embryos that lack GRB2, FGF4 or FGFR2, upstream components of the 
MAPK signalling pathway, do not express Gata6 and therefore also do not form a 
PE (reviewed in Arnold and Robertson, 2009). Conversely, Nanog knockout 
embryos are not able to develop the ICM and cells form primitive endoderm 
derivatives (Mitsui, 2003). Interestingly, those cells that are committed to become 
primitive endoderm but that do not reach their correct destination at the surface 
of the ICM undergo apoptosis (Plusa, 2008).  
 
 
1.1.2 Post-implantation embryonic development 
By the end of pre-implantation development there are two domains that can be 
easily identified in the blastocyst. The primitive endoderm, the epiblast and the 
polar trophectoderm (area of the TE adjacent to the epiblast) form the first domain. 
The blastocoel (cavity) enclosed by the rest of the trophectoderm, termed mural 
trophectoderm, form the second. These two domains establish the embryonic-
abembryonic axes (reviewed in Rossant, 2009) (Figure1.1).  
 
At around 4.5-5.0dpc the embryo implants. This is a complex process that requires 
coordination and receptivity of both the blastocyst and the uterus. This receptivity 
depends on several signalling molecules such as cytokines, growth factors, 
transcription factors, lipid mediators and morphogens. It requires intercellular 
 17 
interaction, cell invasion, angiogenesis and regulated cell growth (Wang and Dey, 
2006). 
 
The polar trophectoderm attaches to the uterine wall and starts to proliferate 
giving rise to the ectoplacental cone (EPC) and to the extra-embryonic ectoderm 
(ExE) in response to FGF4. The epiblast, signalling source of this factor (Tanaka, 
1998), is displaced across the blastocoel by the growth of this extra-embryonic 
tissues.  While epiblast cells divide, they acquire a columnar epithelial identity and 
cavitate giving rise to egg cylinder structure and to the amniotic cavity (Ferrer-
Varquer, 2010). The proximal-distal axis is established, with the ExE situated 
proximally and the tip of the epiblast distally. However, in order to form the 
anterior-posterior axes further specialization of other extra-embryonic structures 
must take place. The PrE will give rise to the visceral endoderm  and to the parietal 
endoderm (Figure 1.1). Parietal endoderm cells migrate along the mural 
trophectoderm and together they will form the Reichert’s membrane (Grapin-
Botton, 2008). This membrane will allow nutrient transfer to the embryo 
preventing invasion of maternal cells (Salamat, 1995). The extra-embryonic region 
of the visceral endoderm will contribute to the formation of the yolk sac in 
combination with extra-embryonic mesoderm (Paca, 2012). The visceral 
endoderm surrounding the epiblast (embryonic visceral endoderm, VE) has an 
important role for embryo patterning. The anterior visceral endoderm (AVE) is 
originated from a subset of cells that migrate from the VE located at distal tip of the 
egg cylinder. The AVE is a signalling centre that has an essential role determining 
the anterior-posterior axis of the embryo and also in the correct positioning of the 
primitive streak, a region in the proximal posterior epiblast that will mark the 
onset of gastrulation (Stower, 2014). Interestingly, Kwon and colleagues have 
shown that the embryonic visceral endoderm also contributes to the formation of 
the embryonic gut (Kwon, 2008). The ExE is essential for the correct induction of 
the AVE. It will 1) cleave nodal precursor in the epiblast establishing a positive 
feedback loop back to potentiate nodal expression in the epiblast; 2) activate 
BMP4 which will activate Wnt in the proximal posterior epiblast and 3) establish a 
proximal–distal gradient of Nodal signalling marked by the asymmetric expression 
of Cripto (Arnold and Robertson, 2009; Beck, 2002). The AVE expresses Nodal and 
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Wnt antagonists such as Lefty1, Cer1 and Dkk1 (reviewed in Stower 2014).  The 
expression of these factors is required for the correct positioning expression of 
primitive streak. It also expresses the homeobox gene Hex, which is essential for 
correct definitive endoderm development (Martinez-Barberá, 2000).  Removal of 
the ExE leads to the ectopic expression of AVE specific markers impairing correct 
embryonic development. Unknown signals from the ExE inhibit the activation of 
DVE in the proximal posterior VE restricting DVE to the distal tip (Rodriguez, 
2005). 
 
It is important to mention that Nodal and BMPs, members of the TFG-b 
superfamily are required to maintain the pluripotency of the epiblast at this stage. 
In their absence, neuroectodermal differentiation is favoured (Di-Gregorio, 2007; 
Camus, 2006).  
 
1.1.3 Gastrulation and germ layer formation  
The organization of the AP axis and the different patterns of gene and protein 
expression established within the embryo prepare the epiblast for gastrulation, a 
process in which the three germ layers (ectoderm, mesoderm and endoderm) will 
be specified (Arkell, 2013).  Ectoderm derived cells will form the neural crest, 
neural tissues and skin. Mesoderm will give rise to muscle, bone, connective tissue, 
blood and the vascular system. Endoderm derived cells will form the gut an 
associated organs such as the liver, pancreas (Arnold and Robertson, 2009).  
 
The onset of gastrulation is marked by the formation of the primitive streak, 
located in the proximal posterior part of the embryo. High levels of Nodal and Wnt 
on this region, established in conjunction with restrictive gradients sent from the 
AVE, contribute to specify the location of the primitive streak.  Embryos lacking 
Axin2, a negative regulator of the Wnt signalling pathway, lead to ectopic primitive 
streak formation (Zeng, 1997; Arnold and Robertson, 2009).  Loss of Nodal 
inhibitors, Cer1 and Lefty1, lead to an enlarged PS region and to the formation of 







Figure 1.1 Diagrammatic representation of early mouse embryonic development.   
A) First lineage decision during early stages of mouse embryonic development. Activation of the 
Hippo pathway in the inner apolar cells (ICM precursors) prevents translocation of YAP into the 
nucleus and the transcription of Cdx2, opposite to what occurs in the outer polar cells. In addition, 
the pluripotent inner cell mass expresses Oct4. Mutual repression of Oct4 and Cdx2 enhances the 
segregation of the trophectoderm from the inner cell mass (3dpc). During 3.5-4.5dpc the ICM 
segregates into the naïve pluripotent epiblast and the visceral endoderm. Mutual repression of 
Nanog (epiblast) and Gata6 (primitive endoderm) is required to confer the identity of these 
lineages. In addition, primitive endoderm cells respond to FGF secreted form epiblast cells. After 
implantation (5.5dpc) the primed pluripotent epiblast is ready to start differentiating into the germ 
layers (mesoderm, endoderm and ectoderm) whereas the primitive endoderm develops into the 
visceral endoderm and the parietal endoderm. B) Flow diagram showing lineage segregation and 
main genes involved in the process.   
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The primitive streak elongates towards the distal tip of the embryo and epiblast 
cells adjacent to the streak will undergo an epithelial to mesenchymal transition 
(EMT) to specify the mesodermal and endodermal lineages.  EMT is a process in 
which epithelial cells lose some of their physical characteristics while they acquire 
mesenchymal features by changing their adhesion properties, migratory capacity 
and morphology (Ferrer-Varquer, 2010, Viotti, 2014). An essential step that allows 
EMT to occur is the down-regulation of E-cadherin, a cell-cell adhesion protein.  
This occurs very rapidly in the primitive streak. FGF signalling favours the 
transcription of Snail, a zinc finger transcriptional repressor that will bind to E-
cadherin promoter. Transcriptional down-regulation of E-cadherin is regulated by 
FGF signalling. Mutations on Fgf8, Fgfr1 or Snail disrupt EMT by avoiding cells 
migration (Sun, 1999), missregulation of mesodermal patterning (Yamaguchi, 
1994) or failure to down-regulate of E-cadherin and loose epithelial characteristics 
(Carver, 2001) respectively. Zohn and colleagues described an alternative pathway 
in which p38-interacting protein drives the down-regulation of E-cadherin at the 
protein level (Zohn, 2006) (reviewed in Arnold, 2009).  Another important 
transcription factor involved for a successful gastrulation is Eomes, which also 
plays an important role for correct trophoblast differentiation (Russ, 2000; Arnold, 
2008). Functional studies showed that the expression of Eomes is required for 
down-regulating E-cadherin independently of FGF8 (Arnold, 2008).  
 
EMT will allow cell migration of epiblast cells through the PS that will emerge as a 
mesoderm layer or will be incorporated as definitive endoderm into the pre-
existing visceral-endoderm layer. The precise cell identity of the cells exiting the 
PS (i.e the type of mesoderm they will form) will depend on different morphogens 
gradients controlled by the expression of BMP, Nodal, FGF and Wnt members (Tam 
and Loebel, 2007).  
 
The first mesodermal derivatives formed are the extra-embryonic ones, patterned 
in response to BMP4 secreted by the ExE. They will contribute to the development 
of the chorion, visceral yolk sac mesoderm and the blood islands (Winnier, 1995).  
The intermediate and anterior region of the streak will give rise to the lateral plate, 
paraxial and cardiac mesoderm slightly after. The last cells to ingress through the 
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anterior part the PS will form the notochord, the node and the definitive endoderm. 
The remaining cells of the epiblast that do not ingress trough the PS will form the 
ectoderm (reviewed in Arnold and Robertson, 2009).  
 
In contrast to this, the primordial germ cells (PGCs) escape this somatic 
commitment by inhibiting the transcription machinery activated by the different 
morphogens. BMP signalling from the ExE drives the specification of PGCs. It 
induces the expression of BLIMP1, a transcriptional repressor of T and Eomes 
(Magnusdottir, 2013) and PRDM14, another transcriptional regulator) in a group 
of cells located in the most proximal part of the epiblast at around 6.5dpc. 
Together, these proteins turn off the somatic cell programme and reactivate the 
expression of pluripotency-associated markers such as Sox2 or Oct4. These cells 
migrate from the base of the allantois towards the developing hindgut until they 
reach the genital ridges, where they will start oogenesis or spermatogenesis 
(reviewed in Hayashi, 2007).  
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1.2 Naïve and primed states of pluripotency  
Cell potency is defined as the ability of a cell to differentiate into other cell types.  
The term totipotent refers to those cells that have the ability to develop into a new 
organism because they can acquire both, extra-embryonic and embryonic 
identities. The zygote and first cleavage blastomeres are totipotent. On the other 
hand the term pluripotent refers to those cells that can give rise to derivatives of 
the three germ layers: ectoderm, mesoderm and endoderm (Jaenisch, 2008).  
 
1.2.1 Isolation of embryonic stem cells and implications for scientific 
research 
Embryonic stem cells (ESCs) were isolated from the ICM of the pre-implantation 
embryo for the first time in 1981 (Evans, 1981; Martin, 1981) and since then, years 
of research have allowed a better understanding of the mechanism behind their 
self-renewal and their differentiation potential, the two main features of 
pluripotent cells. To assess the developmental potential of ESCs these can be 
injected in host blastocysts. Several studies show that when these is done these 
cells can contribute or colonize embryonic and, although rarely, to extra-
embryonic tissues (Beddington, 1989; Morgani, 2013). Furthermore, when ESCs 
are injected ectopically subcutaneously they are also able to form teratomas, 
tumours that contain tissue derivatives the three germ layers (Solter, 2006).   
 
In vitro propagation of ESCs was a great scientific breakthrough as it implied not 
only an in vitro model to better understand embryonic differentiation and lineage 
commitment but also a unique system to be applied for regenerative medicine, 
tissue repair, drug discovery or disease modelling (Lane, 2014; Singh, 2015).   
 
1.2.2 Mouse embryonic stem cells – Naïve pluripotency  
ESCs were initially grown on a fibroblast feeder layer that provided cell adhesion 
and secretion of undetermined factors that in the presence of serum permitted the 
propagation of the culture (Evans, 1981; Martin, 1981).  However, a revolutionary 
discovery arrived a few years later with the identification of Leukaemia Inhibitory 
Factor (LIF) as a cytokine that inhibits spontaneous differentiation of ESCs (Smith, 
1988).  Binding of LIF to its receptor, gp130, causes the activation of two pathways 
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JNK/STAT3 and Shp2/ERK. STAT3 promotes the transcription of pluripotency-
associated genes that are required to maintain the stem cell population such as 
Klf4 (Hall, 2009), Gbx2 (Tai, 2013), Myc (Cartwright, 2005) or Tfcp2l1 (Ye, 2013; 
Martello, 2013). Conversely, ERK will promote the exit of this naïve pluripotency 
state priming for germ layer differentiation in vitro (Kunath, 2007). Functional in 
vivo analysis showed that ERK is only required for primitive endoderm 
specification (Hamilton, 2014) but not required for neural specification (Di-
Gregorio, 2007). 
 
BMP4, was discovered as the component in the serum that sustained ESCs self-
renewal in combination with LIF. This allowed ESCs propagation in the absence of 
feeder cells or serum (Ying, 2003). BMPs induce the expression of Id  (Inhibitors of 
differentiation) proteins through the SMAD pathway. These proteins will inhibit 
the expression of lineage specific transcription factors (Ying, 2003). Another group 
suggested that an additional role of BMP is to inhibit ERK (Qi, 2004). The 
mechanism behind this hypothesis appears to be regulated by the increased 
activity of the DUSP9, a specific ERK phosphatase (Li, 2012).  These studies 
showed the importance of BMPs to maintain pluripotency in ESCs. The expression 
of pluripotency-associated genes fluctuates within these culture conditions 
(Serum/BMP + LIF) and there is a small fraction of cells that undergo 
differentiation possibly because FGF/ERK signalling is not completely silenced 
(Hackett, 2014) (Figure 1.2). Therefore, this culture condition provides a good in 
vitro model as it captures the heterogeneity observed in the ICM of the pre-
implantation embryo. 
 
Understanding of the main signalling pathways involved in the regulation ESCs 
pluripotency allowed the development of a defined media without serum 
composed of two small molecule inhibitors that suppresses this heterogeneity 
(Ying, 2008).  In serum + LIF conditions, FGF4 is produced in an autocrine fashion 
by undifferentiated ESCs. FGF4 activates the ERK signalling pathway leading to the 
exit of the naïve state of pluripotency. Ying and colleagues showed that the use of 
different FGF receptor inhibitors to block this pathway is sufficient to substitute 
the presence of serum/BMPs reducing the number of differentiated ESCs in culture 
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- even though they observed the formation of neural progenitors occasionally. 
However they also found that inhibition of FGF signalling it is not sufficient to 
propagate the culture indefinitely due to increased levels of cell death. To 
overcome this problem Ying and co-authors used a GSK3 inhibitor to enhance cell 
propagation of ESCs by activating WNT signalling pathway. This inhibitor induces 
non-neuronal differentiation and enhances growth capacity on its own.  However, 
when combined with the FGF receptor inhibitors this efficiently allowed to expand 
ESCs colonies with low levels of expression of differentiation markers. 
Accumulation of β-Catenin, an activator of the WNT signalling pathway, promotes 
the transcription of Esrrb through the interaction with its transcriptional repressor, 
Tcf3 (Martello, 2012). This indicates that GSK3 inhibition is not only limiting 
differentiation but also by keeping the metabolic/biosynthetic capacity of these 
cells allowing their viability (Ying, 2008).  
 
Two transcription factors have been described to be essential to maintain the self-
renewal and pluripotency, properties that characterize ESCs. These transcription 
factors are Pou5f1 (referred as Oct4) and Sox2 (Hackett, 2014). Nanog, has been 
recurrently included as part of the core intrinsic pluripotency network. However, 
even though the expression of this factor is required for maintaining the integrity 
of the epiblast avoiding differentiation into primitive endoderm (Mitsui, 2003; 
Frankenberg, 2011) it is not essential to sustain pluripotency in vitro (Chambers, 
2007). In fact, Oct4 and Sox2 cooperate to direct the transcriptional activation of 
Nanog (Rodda, 2005).  Oct4 is expressed from the oocyte and its expression 
persists in the ICM, post-implantation epiblast and it finally gets restricted to the 
germ cells (Ovitt, 1998). Functional in vivo analyses have shown that this 
transcription factor is required to keep the pluripotency of the ICM and ESCs. Oct4 
null embryos develop to the blastocyst stage however, cells that constitute to the 
ICM of these embryos are restricted to the trophectoderm lineage, indicating that 
Oct4 is required to repress Cdx2 (Nichols, 1998). Oct4 also modulates levels of 
Nanog allowing flexibility for the segregation of the primitive endoderm from the 
epiblast  (Le Bin, 2014). Sox2 is also expressed in the oocyte, in the ICM, in the 
epiblast of the post implantation embryo and the chorion. It remains expressed in 
ectodermal derived tissues upon embryonic development.  Sox2 null embryos die 
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shortly after implantation, do not develop an epiblast but do form extra-embryonic 
tissues (Avilion, 2003).  
  
The culture conditions in which ESCs are maintained enhance the expression of 
these transcription factors to allow the propagation of these cells and their 
pluripotency identity. There are other auxiliary transcription factors that 
contribute to complicated pluripotency network such as Rex1, Klf2, Klf4, Esrrb, 
Prdm14, Sall4 or Tfcp2l1. The absence of each factor individually is dispensable to 
confer a pluripotent identity (reviewed in Hackett, 2014). These factors “counter-
act” pro-differentiation signals such as pERK or TCF3, which are present when 
ESCs are cultured in serum + LIF. Conversely, blocking differentiation inputs (e.g. 
using 2i + LIF) or by reinforcing the expression of these ancillary factors, promotes 
a robust naïve pluripotency or ground state of pluripotency. Conversely, serum + 
LIF provides differentiation inputs causes slight fluctuations in the pluripotency 
network, causing a metastable naive pluripotent state (Nichols, 2009; Hackett, 
2014) (Figure 1.2). 
 
1.2.3 Epiblast stem cells – Primed pluripotency  
During mouse embryonic differentiation, the epiblast of the post-implantation 
embryo still expresses the factors that constitute the core pluripotency network:, 
Oct4 and Sox2. However, it also starts to express differentiation markers such as 
Fgf5, T or Eomes prior to gastrulation (Avilion, 2003; Mesnard, 2011).   
 
Two independent groups isolated what they termed Epiblast stem cells (EpiSCs) in 
2007. These groups dissected epiblast of pre-gastrulation embryos and cultured 
the cells under ESCs culture condition but cells failed to propagate in culture and 
got differentiated. Interestingly, when they cultured epiblast explants under 
human ESCs culture conditions, using Activin/Nodal and FGF, they could maintain 
the cell line for over 40 passages, suggesting that EpiSCs represent novel 
pluripotent stem cell line (Tesar 2007; Brons, 2007).  This is consistent with the 
developmental origin of EpiSCs, as Nodal is the protein that promotes pluripotency 
in the pre-implantation epiblast (Brennan, 2001; Sun, 2014). In addition, by 
inhibiting activin receptors both research groups observed rapid differentiation of 
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EpiSCs. This suggests that the SMAD2/3 signalling pathway is required to keep the 
self-renewal of this cell type. More specifically, Sakaki-Yumoto and colleagues 
showed that SMAD2 is responsible for blocking BMP signalling and enhancing 
Nanog transcription promoting pluripotency in human ESCs and mouse EpiSCs 
(Sakaki-Yumoto, 2013).   However, in order to be able to propagate the culture 
indefinitely FGF signalling is required, just as occurs in human ESCs (Brons, 2007; 
Tesar, 2007; Vallier, 2005). FGFs prevents differentiation towards the neural 
lineage by regulating the expression of Pax6 and also helps to keep the epiblast 
identity by repressing Klf2/4, required to revert the primed estate of pluripotency 
of ESCs to a naïve estate characteristic of ESCs (Guo, 2009; Greber, 2010). 
 
EpiSCs grow in a monolayer forming flat and compact colonies (similar to human 
ESCs), morphologically very different to the ones of ESCs, which normally grow 
forming domed shaped colonies. Beside these morphological differences, ESCs and 
EpiSCs display different signatures of gene expression. The pluripotency markers 
Sox2, Nanog or Oct4 are expressed in both ESCs and EpiSCs. However, there are 
several genes that are differentially expressed in EpiSCs such as Fgf5, Nodal, Cer1 
or Eomes among others (Brons, 2007; Tesar, 2007). These observations suggest 
that there might be an intermediate state of pluripotency that occurs between the 
epiblast of the pre-implantation embryo and gastrulation in which cells are primed 
for differentiation. For this reason, EpiSCs are termed “primed pluripotent stem 
cells” (Nichols, 2009). Interestingly, even though different EpiSCs lines share 
common features (Oct4 expression, tereatoma formation…) they might differ on 
mesendodermal related gene expression, which can affect to differentiation or 
reprogramming assays (Bernemann, 2011). EpiSCs present an epigenetic signature 
that is more similar to that of human ESCs rather than that of ESCs where Oct4 is 
preferentially bound to its proximal enhancer (Tesar, 2007). In addition, EpiSCs 
display a reduced or absent expression of some of the transcription factors that 
contribute to maintain pluripotency in ESCs such as Rex1, Klf4, Prdm14 or Esrrb, 
caused by lower levels of Nanog expression (Hackett, 2014) (Figure 1.2). These 
similarities suggested that human ESCs are in a primed state of pluripotency as 
they are closer to mouse EpiSCs rather than to mouse ESCs. Further support for 
this idea comes from recent work showing that human ESCs can be reverted to a 
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ground state of pluripotency by inhibiting ERK and protein kinase C (Takashima, 
2014) or six different kinases in the presence of LIF (Theunissen, 2014).  
 
In order to fully assess the pluripotency of EpiSCs, both groups used embryoid 
body assays and injected ectopically these cells into immuno-deficient mice and 
observed teratoma formation. Using these assays the authors were able to confirm 
that EpiSCs can form derivatives of the three germ layers, and were therefore 
pluripotent. However in contrast to this, the authors found that EpiSCs couldn’t 
form chimeras efficiently when these cells are injected in the pre-implantation 
blastocyst (Brons, 2007; Tesar, 2007). They attributed as a possible cause for this a 
biological asynchrony between ESCs and EpiSCs. Interestingly, Huang and 
colleagues have shown that EpiSCs are able to form chimeras when they are 
injected into the post-implantation epiblast.  Chimeras can’t be formed if EpiSCs 
are injected before or after this time window. This work showed the functional 




1.2.4 Induced pluripotent stem cells  
Embryonic differentiation occurs by modulation of gene expression. Specific 
transcription factors will either promote differentiation by activating the 
expression of lineage specific gene programmes or will maintain pluripotency by 
preventing the activation of those programmes. Deciphering the transcriptional 
regulators that control pluripotency has allowed the reversion of a differentiated 
somatic cell into a pluripotent-like stem cell. This was firstly described in 2006, 
when Takahashi and Yamanaka reported that retroviral infection with four 
transcription factors (Oct4, Sox2, Klf4 and c-Myc) could reprogram mouse 
embryonic fibroblast into induced-pluripotent stem cells (iPSCs). iPSCs are similar 
to ESCs regarding gene expression, teratoma formation and contribute to 
embryonic development. These iPSCs did not give rise to adult chimeras and differ 
from ESCs at the epigenetic level (Takahashi, 2006). Interestingly, selection for 
Nanog positive iPSCs showed more similarities to ESCs at the genetic and 
epigenetic levels, as the pluripotency network was enhanced. Additionally, they 
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were able to form adult chimeras. However, these chimeras developed tumours 
due to the presence of the oncogene  c-Myc (Okita, 2007).  In 2007, another group 
reported the generation of human iPSCs by lentiviral infection with Oct4, Sox2, Klf4 
and Lin28 (Yu, 2007). Generation of iPSCs without viral vectors avoided viral 
integration into the host genome reducing risk of tumorogenesis (Okita, 2008). 
Generation of iPSCs overcame raised concerns such as immune rejection problems 
for potential therapeutic use of these cells or ethical issues arose by the use of 









Figure 1.2 Regulation of pluripotency in naïve and primed pluripotent stem cells.  
The core pluripotency factors Oct4 and Sox2 are essential to maintain pluripotency in stem cells. 
Other auxiliary factors (Klf4, Tcfp2l1, Prdm14, Klf2, Nanog, Sall, Rex1) enhance the pluripotency 
network by preventing exit from pluripotency induced by FGF/ERK (Metastable naïve pluripotent 
state: ESC Serum + LIF).  Conversely, by blocking induction of differentiation stimulus using ERK 
inhibitors (PD) and by enhancing the expression of these auxiliary factors (CHIRON) the 
pluripotency network is stabilized and enhanced (Ground naïve pluripotent state – 2i+LIF). EpiSCs 
still express the core pluripotency factors. Activin promotes the expression of Nanog, although 
levels of this transcription factor are lower compared to naïve pluripotent cells. Auxiliary factors 
are reduced or absent in EpiSCs. In addition, EpiSCs express transcription factors characteristic of 
the mouse post-implantation epiblast (Fgf5, Eomes). FGF prevents ectodermal differentiation of 
EpiSCs by blocking the expression of Pax6. Figure based on Hackett, 2014; Greber, 2010. 
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1.3 microRNA and Development 
The correct development of the mammalian embryo after fertilization of the egg 
requires exquisitely controlled events of cell division and correct spatial and 
temporal control of gene expression at different levels – transcriptional, post-
transcriptional and epigenetic. MicroRNAs (miRNAs) are endogenous ≅22 
nucleotide single stranded non-coding RNA molecules that play a very important 
role in animal and plant gene regulation processes. MiRNAs pair to the 3´UTR 
region of the complementary messenger RNA (mRNAs) of protein-coding genes to 
direct their post-transcriptional repression (Bartel, 2009). There are other small 
RNAs that contribute to regulation of gene expression such as small interfering 
RNAs (siRNAs) or PIWI-interaction RNAs (piRNAs). siRNAs contribute to the 
regulation of genomic transcripts and transposons and have a protective role 
against viral infections whereas the main role piRNAs is to repress transposable 
elements in germline cells (Ha, 2014).  
 
1.3.1 miRNAs biogenesis 
The first step during miRNAs biogenesis is the transcription of the pri-miRNA, a 
long precursor molecule which length varies from hundreds to thousands of 
nucleotides. Although transcription of miRNAs by RNA polymerase III has been 
described in the chromosome 19 miRNA cluster (C19MC), most of miRNA are 
transcribed by RNA polymerase II (Lee, 2004; Borchert, 2006).  
 
The pri-miRNAs generated by RNA polymerase II are polyadenylated on their 3’ 
end and capped on the 5’ as if they were coding mRNAs (Lee, 2004). The regulation 
of the expression of miRNAs depends not only on how the polymerases are 
regulated (different recognition of promoters and terminator elements) but also 
on the control of transcription factors such as p53 or c-Myc to control cell cycle 
progression (O’Donnel, 2005; He, 2007; Suzuki, 2009) or even epigenetic factors 
such as the methylation of their promoter sequences (Winter, 2009; Chuang, 2007).  
 
The pri-miRNA, which forms a hairpin leading to a double stranded RNA structure 
is processed by the microprocessor complex formed by the nuclear RNAse type III 
Drosha and DGCR8. DGCR8 binds to the pri-miRNA through double-stranded RNA 
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binding domains (dsRBD) and to Drosha through its C-terminal domain.  Drosha 
cleaves this RNA molecule forming smaller dsRNA hairpins that are 70 nucleotides 
long and which are known as pre-miRNAs (Ha, 2014).   
 
Exportin V selects pre-miRNAs with a defined double stranded stem and 3’ 
overhangs length to export them to the cytoplasm in a complex with the nuclear 
protein  RAN-GTP, independently from their sequences or loop structures. This 
selective process allows only the correct pre-miRNAs to go into the following step 
of their maturation (Winter, 2009).  
 
There are some miRNAs that do not require the maturation carried out by this 
microprocessor complex. Specific cases are mirtrons, miRNAs that are localized in 
introns and are released after mRNA splicing.  Sometimes, their size is adequate to 
form the pre-miRNA structure without the activity of Drosha/Pasha complex 
(Ruby, 2007; Berezikov, 2007) and consequently to be a substrate for Exportin V. 
 
Once in the cytoplasm, Dicer, a type III ribonuclesase, cleaves the pre-miRNAs 
hairpin forming a 20-22 nucleotides long dsRNA molecule. Association of Dicer 
with TRBP (Tar RNA binding protein) and PACT (protein activator of protein 
kinsase R) increases the efficiency of the cleavage process stabilizing Dicer (Winter, 
2009). Usually, the strand with the 5′ terminus located at the thermodynamically 
less-stable end of the duplex is selected to function as a mature miRNA, and the 
other strand is degraded. The guide strand forms the RISC complex (RNA induced 
silencing complex) when it binds to Ago 2, a protein from the argonaute family 
(endonucleases). The non-guide strand is degraded (Filipowicz et al. 2008) 
(Figure1.3).   
 
The post-transcriptional repression mediated by miRNAs occurs mostly by the 
pairing of the miRNA to the 3’-UTR region of mRNAs. Several aspects of the pairing 
are important for an effective targeting of the mRNA. There must be a perfect base 
complementarity between the 7 nucleotides located in the 5’ region of the miRNA 
(seed region), meaning that miRNAs sharing the same seed sequence potentially 
target the same mRNAs. For this reason miRNAs can be grouped into families that 
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share the same seed and therefore potentially regulate the same genes (Hausser, 
2014). However, other aspects of the miRNA-target interaction are also important: 
the AU-rich nucleotide composition near the miRNA site, proximity of sites for co-
expressed miRNAs (which leads to cooperative action); there should also be 
complementarity in the 3’ region of the miRNA to increase the number of 
interactions, and thus stabilize both molecules for Ago2 endonuclease activity 
(Grimsom, 2007). Although perfect complementarity of the miRNA and its target 
leads to mRNA degradation, in animals this interaction tends to be imperfect, 
leading instead to destabilization of protein translation. Some mechanisms by 
which miRNAs exert their post-transcriptional repression have been proposed. 
These are:  
 Deadenylation or the mRNA catalyzed by the CCR4-NOT complex, 
associated with RISC (Piao, 2010).  
 Blocking translation elongation by ribosome “drop-off”.  
 Block of the initiation of translation by repressing mRNA cap recognition or 
ribosome 60S subunit joining. 
 Proteolytic cleavage of the nascent protein by a non-identified protease that 
is recruited by RISC (Filipowicz, 2008).  
It is worth to mention that the 3’UTR are not the only region targeted by miRNAs. 
These molecules also act by pairing to gene open reading frames (ORFs) and 
5’UTRs (reviewed by Winter, 2009).  
 
1.3.2 Importance of miRNAs in development 
The discovery of miRNAs led to the question of their role in development. One way 
to approach this problem has been by generating Dicer mutants in different model 
organisms, as this protein is required at the last steps of miRNA biogenesis. These 
studies showed that loss of function for Dicer causes heterochronic defects and 
sterility in Caenoharbditis elegans (Knight, 2001).  Drosophila melanogaster has 
two isoforms for Dicer: dicer-1 blocks processing of miRNA precursors whereas 
dicer-2 is linked to siRNAs processing (Lee, 2004). In Danio rerio, embryos that 
lack miRNAs show an arrest in development with defects in morphogenesis, 









Figure 1.3 Schematic representation of miRNA biogenesis.  
Most miRNAs are initially transcribed by RNA polymerase II forming a precursor molecule termed 
pri-miRNAs. Pri-miRNAs are recognised by the protein complex formed by Dgcr8/Drosha. This 
complex cleaves pri-miRNAs generating a double stranded hairpin intermediated termed pre-
miRNA. Pre-miRNAs have a specific structure with a long 3’-overhang that allows selective 
exportation to the cytoplasm by the RAN-GTPase Exportin V. Once in the cytoplasm pre-miRNAs 
are cleaved by Dicer generating mature double stranded miRNAs. The non-guide strand is degraded. 
The guide strand binds to Ago proteins forming the RNA induced silencing complex (RISC). 
Directed by the guided strand, RISC targets mRNA. There are miRNAs that do not require 
processing by Dgcr8/Drosha as the pre-miRNA structure is acquired after alternative splicing.   
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Several studies have shown the importance of miRNAs during early mouse 
embryonic development following different approaches (Bernstein, 2003; Wang, 
2007; Tang, 2007) miRNAs and components of their biogenesis pathway are 
expressed in pre-implantation embryos and further on in development (Wang, 
2007; Tang, 2007; Yang, 2008; Pernaute, 2014). In mammals there is only one copy 
of Dicer and knockout embryos for this gene cause a lack of miRNAs, 
morphological abnormalities, reduction in size and embryo death at around 7.5dpc 
(Bernstein, 2003; Spruce, 2010). The main defect found in the embryonic tissues of 
the Dicer null embryos is excessive apoptosis. However, these embryos do not 
show defects in proliferation in the epiblast or in the initiation of patterning in this 
tissue. The apoptotic defects were shown to be specific to the epiblast as deletion 
of Dicer specifically in this tissue also showed this defect (Spruce, 2010). Dicer null 
mutant embryos also displayed an abnormal morphology, a failure in the 
elongation of the primitive streak and defective expression patterns of definitive 
endoderm markers suggesting that miRNAs are required for a correct progression 
of patterning during gastrulation.  
 
1.3.3 miRNAs in Stem Cells 
Several studies have shown the importance of miRNAs in ESCs by different 
approaches. Dicer deletion in ESCs leads to a decrease in proliferation and defects 
in differentiation (Kanellopoulou, 2005) similarly to the phenotype observed in 
Dgcr8 mutant ESCs (Wang, 2007). A miRNA expression profile generated from 
different blastocyst derived stem cells showed that miRNAs from the miR-106/302 
family belonging to the miR-290 cluster are expressed in ESCs, trophoblast stem 
(TS) and extra-embryonic ectoderm stem (XEN) cells (Spruce, 2010). Accordingly, 
these miRNAs have been shown to play a key role in the regulatory network that 
controls ES cell pluripotency (Marson, 2008).  
 
Jouneau and colleagues showed that ESCs and EpiSCs have a different miRNA 
expression patterns and different sets of pluripotency associated miRNAs. They 
found that most miRNAs were transcribed from the miR290-295 and miR17-92 
clusters in ESCs, whereas in EpiSCs they mostly come from the miR302/367 
cluster (Jouneau, 2012). This data is comparable to what Card and collaborators 
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observed in vivo when they studied the expression patter of miR-302 at different 
embryonic stages. This miRNA was hardly detected at the blastocyst stage while its 
expression was strong at confined to the epiblast at 6.5dpc (Card, 2008). 
Interestingly, the seed region of the three different clusters is very similar, and 
consequently these miRNAs could potentially be targeting common genes. 
However, the clusters are differentially expressed at the blastocyst/ESCs (miR-
290-295 cluster) and at the epiblast/EpiSCs (miR-302/367 cluster) in vivo and in 
vitro (Pernaute, 2014; Card, 2008; Jouneau, 2012). Interestingly, the miR-302/367 
is sufficient to reprogram somatic cells to an induced programmed stem cell state 
without using Oct4, Sox2, Klf4 or Myc, the transcription factors that are normally 
used to generate iPSCs (Anokye-Danso, 2012). Additionally, a recent study showed 
how miR-290 cluster regulates the expression of the transcriptional repressor 
Mbd2. Repression of Mbd2 is required to stimulate glycolysis mediated by c-Myc, a 
process that enhances reprogramming efficiency (Cao, 2015). Further analysis is 
required to understand the biological meaning and different control of gene 
expression that miRNAs exert in ESCs and EpiSCs conferring them their metabolic, 




1.4 Cell death during early embryonic development 
Cell proliferation and cellular commitment are not the only characteristics 
required for correct embryonic development, cell death and its tight regulation are 
essential too. There are several examples of natural occurring cell death events 
during mammalian embryonic development that highlight the importance of the 
activation of cell intrinsic suicide pathways, commonly termed as programmed cell 
death  (Fuchs, 2015): 
- Elimination of primitive endoderm committed cells that do not reach the 
distal side of the epiblast (Plusa, 2008).  
- Elimination of less fit cells in the epiblast of the post-implantation embryo 
by cell competition (Sancho, 2013; Claveria, 2013).  
- Elimination of the inter-digital tissue for correct digit formation (Zakeri, 
1994) or cells in the anterior neural ridge for correct forebrain 
development (Nonomura, 2013). 
 
Programmed cell death has also been observed and studied in great detail in other 
organisms such as C. elegans or D. melanogaster. The proteins involved in the 
process of cellular elimination are evolutionary conserved, strengthening the 
importance of these events for correct embryonic development. Until very recently, 
apoptosis was the main pathway associated with the term “programmed cell 
death”. However, recent findings have shown that there are other cell death 
programmes such as autophagy or necroptosis (regulated necrosis). These three 
types of cell death share some components of the pathway and fine regulation of 
these factors will lead to a specific kind of death outcome (Elmore, 2007; Fuchs, 
2015).   
 
1.4.1 Apoptosis 
The term apoptosis was first used in 1972 to describe an active mechanism of 
controlled cell deletion. This processed was characterized by cytoplasmic 
condensation and membrane blebbing followed by engulfment of neighbouring 
cells (Kerr, 1972).  Apoptosis can be triggered by external factors such as 
activation of death receptors or by intrinsic mechanisms like DNA damage or 
increased reactive oxygen species. Either stimulus will trigger a cascade of events 
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that will converge in the activation of caspases. Caspases are cysteine-aspartic 
proteases that will cleave proteins required for cell viability leading to cell death 
(Elmore, 2007). Eleven caspases have been identified in mice and they have been 
categorizes into two groups according to their biological roles (McIlwain, 2013; Li, 
2008; Shalini, 2015):  
1. Inflammation: CASP1, CASP11, CASP12. They are involved in the 
maturation of cytokines by cleaving precursor proteins.  
2. Apoptosis: 
- Initiator caspases: CASP2, CASP8, and CASP9. These enzymes cleave 
the inactive forms of executioner caspases termed zymogens. 
- Effector caspases: CASP3, CASP6 and CASP7. These caspases cleave 
several cellular proteins essential for cell survival leading to cell 
death. 
Interestingly, some caspases have other functions that are non-apoptotic related 
such as in cell migration, differentiation or proliferation (reviewed in Miura, 2012 
and Shalini, 2015).  
 
1.4.1.1 Extrinsic apoptotic pathway 
Binding of a ligand to a cell death receptor, mainly from the TNF family, triggers 
the extrinsic apoptotic pathway.  This cascade has been well characterized 
following the events upon activation by Fas ligand (FasL) or TNF-α to their 
receptors, FasR and TNFR1 respectively (Elmore, 2007). FasL causes the 
oligomerization of its receptor forming a complex with Fas-Associated Death 
Domain (FADD) that will recruit the initiator CASP8 forming the death-inducing 
signalling complex (DISC) for its activation. CASP8 will then activate the effector 
caspases leading to death. (McIlwain, 2013; Elmore, 2007). CASP8 also has the 
ability to cleave the pro-apoptotic protein BID activating the intrinsic apoptotic 
pathway. This will amplify the caspase signalling and consequently cell death  (Li, 
1998).  
 
1.4.1.2 Mitochondrial apoptotic pathway 
Conversely to the extrinsic pathway, the intrinsic apoptotic pathway is triggered 
from an intracellular signal such as DNA damage, increased reactive oxygen 
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species or increased levels of cytoplasmic calcium. It is also known that the release 
to the cytosol of proteins that are normally restricted to mitochondrial 
intermembrane space will activate the effector caspases leading to cell death 
through this pathway (Elmore, 2007). 
 
Proteins that belong to the Bcl-2 family tightly regulate the mitochondrial 
apoptotic pathway. Most members of the BCL2 protein family have a 
transmembrane domain that allows them to anchor to cellular organelles. This 
characteristic is important, as it is determinant to locate them to the mitochondrial 
membrane (Czabotar, 2014). The main characteristic of this protein family is the 
presence of BH (blocks of sequence homology) domains that allow the interaction 
between members of the Bcl2 protein family These proteins can be classified into 
three groups according to their structural and sequence homology, as well as their 
functionality (Czabotar, 2014) (Figure 1.4): 
- Anti-apoptotic: BCL2, BCL-xL, BCL-W, MCL-1, A1 and BCL-B. These proteins 
contain four BH domains (BH1-BH4) 
- Effector apoptotic proteins: contain BAX, BAK and BOK. These proteins 
contain three BH domains (BH1-BH3) 
- Initiators of apoptosis: these proteins contain one BH domain only (BH3). 
They can be subdivided in two groups (Stamelos, 2012):  
1. Activators: BIM and tBID.  These proteins directly activate BAX/BAK 
to cause mitochondrial membrane permeabilization and also inhibit 
antiapoptotic factors.  
2. Sensitizers: PUMA, NOXA, BIK, HRK, BMF and BNIP3. These proteins 
neutralize anti-apoptotic factors preventing them to inhibit 
BAX/BAK and therefore promoting apoptosis. It has been shown that 
some of the sensitizers can act as direct activators such as PUMA or 
BMF (Du, 2011).  
The apoptotic threshold of the cell is determined by the relative balance of pro- 
and anti-apoptotic factors and when this balance is broken apoptosis is triggered 
by activation of BAX/BAK.  
In healthy cells BAK is mainly found in the mitochondria whereas BAX is in a 
dynamic equilibrium between the mitochondria and the cytosol (Schellenberg, 
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2013). It appears that the C-terminal domain of BAX and BAK determines the 
subcellular localization of these proteins based on the hydrophobicity of their 
sequence (Todt, 2015).  BAX/BAK activation involves a conformational change in 
these proteins that allows their oligomerization and the formation of pores in the 
outer membrane of the mitochondria. This process of mitochondrial outer 
membrane permeabilization (MOMP) will cause a loss of mitochondrial membrane 
potential and the release of proteins that are normally in the mitochondrial 
intermembrane space such as cytochrome-C (CytC) and SMAC  (second 
mitochondria derived activator, also known as DIABLO) (Czabotar, 2014) (Figure 
1.4). BAX and BAK also localize to the endoplasmic reticulum. The subcellular 
localization to this cellular organelle has been proposed as a parallel mechanism to 
increase the cell death response by altering the intracellular levels of Ca2+ and the 
activation of CASP12 (Zong, 2003). CytC is required for the formation of the 
apoptosome, a protein complex formed together with Apaf-1 and procaspase-9. 
This complex facilitates cleavage of caspase 9 which will then cleave the effector 
caspases 3 and 7. These caspases propagate the proteolytic cascade that will 
ultimately lead to an apoptotic cell death. However, there are intracellular proteins 
that inhibit caspases to control cell death, termed inhibitors of apoptosis (IAPs). 
IAPs can inhibit apoptosis through two different mechanisms: 1) by interacting 
with pro-caspases through a BIR (Baculovirus IAP repeat) domain; 2) by 
promoting ubiquitination of caspases or its own degradation once the cell is 
undergoing apoptosis (Fuchs, 2015).  
 
IAPs should be inactivated for a cell to undergo apoptosis. Upon MOMP, proteins 
such as SMAC or the mitochondrial serine protease HTRA2 (also known as OMI or 
PARK13) are released and displace caspases from IAPs or degrade them 
respectively. Other proteins that are released from the mitochondria upon MOMP 
promote apoptosis in a caspase independent manner such as apoptosis inducing 
factorM1 (AIFM1) or mitochondrial endonuclease G (EndoG), proteins then induce 
chromatin condensation and DNA fragmentation (Daugas, 2000; Li, 2001; Fuchs, 
2015). The activity of all these proteins reflect some morphological changes that 
indicate that a cell is undergoing apoptosis, such as cell shrinkage, nuclear 
condensation, plasma blebbing and formation of apoptotic bodies – cellular 
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fragments with tightly packed organelles with or without nuclear fragments 
(Elmore, 2007; Ziegler, 2004).  
 
There are other modulators of the mitochondrial apoptotic pathway such as the 
tumour suppressor gene p53. This gene is mutated in many human cancers and 
p53 null mice develop tumours shortly after birth (Chipuk, 2003). p53 increased 
expression and stabilization upon DNA damage leads to transcription of the target 
genes which has two main outcomes. First, to stop the cell cycle by inducing the 
expression of p21, an inhibitor of CDKs, allowing DNA repair. Second, to promote 
apoptosis by activating the transcription of the pro-apoptotic factors BAX, PUMA 
and NOXA (Vogelstein, 2000).  It can also induce apoptosis in a transcription-
independent manner by directly activating BAX (Chipuk, 2003; Chipuk 2004).  
 
1.4.2 Necroptosis and Autophagy 
There are other programmed cell death pathways other than apoptosis: autophagy 
and necroptosis. It has been difficult to understand, classify and differentiate these 
pathways from apoptosis as there are some proteins that are involved in the three 
death pathways. 
 
Autophagy is a type of programmed cell death that involves the degradation of 
cellular components (proteins, organelles…) through the formation of lysosomes 
allowing the recycling of the  resulting catabolized molecules (Feng, 2014).  It 
contributes to maintain cellular homeostasis and can act as a protective 
mechanism against cancer or aging.  It occurs normally at basal levels; however it 
can be induced upon a physiological stimulus like glucose or serum deprivation 









Figure 1.4 Schematic overview of the apoptotic pathways.  
Extrinsic apoptosis is triggered upon the binding of a ligand to a cell death receptor. This triggers 
the activation of Caspase 8 after the formation of the  DISC complex. Caspase 8 will then activate the 
effector caspases 3/7 leading to cell death. The mitochondrial apoptotic pathway is triggered by 
internal stimuli such as DNA damage, increase cytosolic calcium or ATP depletion.  This leads to an 
imbalance of pro- and anti-apoptotic factors that will cause the activation of BAX/BAK, formation of 
the mitochondrial membrane permeabilization, loss of mitochondrial membrane potential and 
release of CytC, Apaf1 and SMAC/Diablo. This allows the formation of the apoptotosme and 
activation of the effector caspase leading to cell death. Caspase 8 can also cleave BID, leading to the 
activation of the mitochondrial apoptotic pathway. Note that all the anti-apoptotic shown can also 
inhibit BAX whereas BAK is inhibited by Bcl-xL, Mcl1 and A1. (not shown in the diagram). Based on 
Czabotar, 2014. 
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There is still some debate regarding the classification of autophagy as a cell death 
mechanism or as an attempt to survive (Fuchs, 2015). In a normal scenario, the 
mTORC1, a protein complex involved in the regulation of metabolism, promotes 
anabolic pathways to favour cell growth. However, upon an autophagic signal such 
as energy depletion or starvation, mTORC1 is inactivated allowing the formation of 
the ULK1 complex. BECN1 phosphorylation by ULK1 recruits VPS34 and ATG14L, 
proteins that are required to start the synthesis of the phospholipid PI3P to form 
the nascent autophagosome (Mizushima, 2009; Russell, 2013).    The late 
autophagosome will fuse to a lysosome degrading the components to recyclable 
metabolites.   
 
The link between apoptosis and autophagy resides in BECN1 as it has a BH3 
domain. BCL2 and BCL-xL can interact with BECN1 to avoid autophagy (Maiuri, 
2007). Some publications have shown that BECN1 is also a caspase substrate and 
that autophagy precedes apoptosis. These suggest that autophagy might be one of 
the first responses for survival. However, if the response is sustained and severe, 
cells will overcome the survival mechanism by cleaving key components of the 
autophagic machinery such as BECN1  (Zhu, 2010; Wirawan, 2010).  
 
Necrosis has been described as a type of cell death consequence of a severe 
pathological damage or physicochemical stress such as heat/osmotic shock or 
mechanical stress. This will cause a loss of the membrane integrity and the release 
of intracellular content to the surrounding environment that will induce an 
inflammatory response. Nuclei conversely, generally remain intact during necrosis 
(Kaczmarek, 2013; Ziegler, 2004).  Necroptosis is a form of regulated necrosis 
mediated by receptor-interacting serine/threonine protein kinase 1 and 3 
(RIPK1/3) in a caspase independent manner. The necroptotic pathway is triggered 
by the activation of several cell death receptors, including TNFR1. After TNF 
binding, several proteins are recruited to form a protein complex (complex1) that 
can promote either cell survival or cell death (Fuchs, 2015): 
- Promotion of cell survival: IAPs in complex1 mediate the ubiquitination of 
RIPK1 in Lys63. This allows the translocation of NF-kB to the nucleus where 
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it will activate the transcription of pro-survival targets that will favour the 
degradation of RIPK1 through the proteasome.  
- Promotion of cell death: CYLD (cylindromatosis) can deubiquitinate RIPK1 
leading to its dissociation from complex1 and the formation of the DISC 
with RIPK3 and CASP8 among other proteins.  This complex favours a 
second checkpoint where RIPK1/3 or CYLD can be degraded by FLIP. 
Conversely CASP8 can be activated leading to apoptosis. In the absence of 
CASP8, RIPK1 and RIPK3 will form a heterodimer (necrosome) that will 
drive the formation of pores in the cell membrane mediated by MLKL. This 
will cause an osmotic imbalance that will cause cell membrane disruption 
and cell death (Fuchs, 2015). 
In order to better understand the molecular basis of necroptosis, several functional 
knock-outs have been analysed targeting principal components of this pathway. 
CASP8 null mice are embryonic lethal (Varfolomeev, 1998). However, the main 
role of CASP8 during embryonic development is to inhibit RIPK3 and consequently 
preventing necroptosis. This is shown by the fact that CASP8/RIPK3 mutant are 
viable as the formation of the necrosome is not possible (Kaiser, 2011). RIPK3 
mutant embryos are viable but they fail to control viral replication upon infection 
highlighting the importance of necroptosis to eliminate infected cells and enhance 
the immune response (Cho, 2009). 
 
 
1.5 Metabolism, a general overview of signalling and metabolic 
pathways 
Metabolism can be defined as the sum of the biochemical processes that take place 
in a living organism to produce or consume energy (DeBerardinis, 2012). 
Metabolic pathways are important to maintain intracellular homeostasis, to 
produce energy by breaking down macromolecules into smaller units (catabolism), 
but also to synthesize molecules to sustain cell viability (anabolism) (Leese, 2012; 
DeBerardinis, 2012).  
 
Energy production, normally translated as synthesis of ATP, depends on several 
factors such as nutrient availability and uptake ability, oxygen concentration or 
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temperature. However there are mechanisms to control proliferation when the 
amount of nutrients exceeds the minimum requirements (Vander Heiden, 2009). 
Extracellular growth factors are necessary to activate nutrient uptake and specific 
anabolic pathways that will produce the required biomass for cell division 
(nucleotides, lipids and amino acids) from different carbon (glucose, fatty acids), 
nitrogen (amino acids) and energy sources (ATP). Intracellular metabolic sensing 
mechanisms such as AMPK and post-translational modifications of signal 
transducers such as glycosylation or acetylation, are required to regulate the 
balance between anabolism and catabolism and progress through the cell cycle 
(Ward, 2012; DeBerardinis, 2012).  
 
One of the most important fuels that most organisms use to support their growth is 
glucose. Glycolysis is an important metabolic pathway that converts one molecule 
of glucose into pyruvate rendering 2 molecules of ATP and 2 of NADH. Pyruvate is 
a key cellular metabolite synthesised by this pathway and is a substrate for other 
metabolic routes (Berg, 2002). Pyruvate can be used to complete glucose oxidation 
in the tricarboxylic acid cycle (TCA), a metabolic pathway that occurs in the 
mitochondria under aerobic conditions. Metabolites derived from the TCA will be 
used to: 1) generate ATP in a processed called oxidative phosphorylation 
(OXPHOS) using NADH and FADH2 in the mitochondrial electron transport chain 
(ETC); 2) synthesize fatty acids or sterols from citrate in the cytoplasm; 3) 
Synthesize amino acids from oxaloacetate or α-ketoglutarate; 4) synthesize 
porphyrins from Succinyl-CoA. Pyruvate is also used to produce oxaloacetate to 
generate glucose or to regenerate the NAD+ used during glycolysis to produce 
lactate by the enzyme lactate dehydrogenase in low oxygen concentrations 
(anaerobic glycolysis). (Ward, 2012; Berg, 2002). Interestingly, Otto Warburg 
observed that cancer cells obtained energy by metabolizing glucose into lactate 
independently of the oxygen concentration rather than using the pyruvate in the 
TCA (Warburg, 1956).  
 
The first step of glucose metabolism is glucose uptake. This process is mostly 
regulated by the evolutionary conserved PI3K/AKT signalling pathway (Ward, 
2012), that is activated by receptor tyrosine kinases (RTKs) and G-protein-coupled 
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receptors (GPCRs). Activation of these receptors by a growth factor such as insulin 
leads to the activation of PI3K, a kinase required for the synthesis of PIP3, a 
membrane phospholipid required for signal transduction.  This will allow the 
phosphorylation and activation of AKT by PDPK1 in cell membrane. AKT 
phosphorylates mTOR inhibitors TSC2 and PRAS40 allowing protein synthesis and 
cell proliferation (Vander Haar, 2007; Hemmings, 2012). AKT can also 
phosphorylate FOXO transcription factors that are involved in the regulation of cell 
cycle, apoptosis or autophagy (Calnan, 2008). But an important role of AKT is to 
promote glucose uptake from the extracellular environment by   1) enhancing the 
expression of the glucose transporter GLUT1 in the plasma membrane (Von der 
Crone, 2000; Rathmell, 2003); 2) Enhancing the activity of several glycolytic 
enzymes such as hexokinases  (they catalyse the first step of glycolysis converting 
glucose into glucose-6-phospate) or phosphofructokinase (converts fructose-6-
phosphate into fructose 1-6 biphosphate (Ward, 2012). These two enzymes 
together with pyruvate kinase (enzyme required for the synthesis of pyruvate) 
tightly regulate the glycolytic flux (Berg, 2002). 
 
There are intracellular mechanisms that regulate the activity of AKT and mTOR. 
The lipid phosphatase PTEN prevents AKT activation by dephosphorylating PI3P 
(Ross, 2009) whereas the ATP/ADP sensor AMPK inactivates mTOR directly 
inducing cell cycle arrest (Gwinn, 2008).   
 
However, this is not the only pathway that is involved in the regulation of 
metabolism. Low oxygen concentrations lead to the stabilization of hypoxia 
inducible factor 1 α (HIF1α). This transcription factor reduces mitochondrial 
oxygen consumption by promoting the activity of PDK1, an inhibitor of pyruvate 
dehydrogenase. Pyruvate dehydrogenase is the enzyme that allows the conversion 
of pyruvate into acetyl-CoA, which will then enter the TCA cycle (Papandreou, 
2006; Kim, 2006).  HIF1α also promotes the expression of lactate dehydrogenase 
(LDHA) (Firth, 1994). LDHA catalyses the reaction to produce lactate and to 
regenerate NAD+ for glycolysis. However, in normal oxygen conditions, prolyl-
hydroxylases target HIFs for recognition by an ubiquitin ligase (Von Hippel Lindau 
– VHL) for subsequent proteasomal degradation (Ward, 2012).  
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1.5.1 Metabolism during early embryonic development 
Analysing the metabolic status of the early mammalian embryo is a hard task 
because results might be altered depending on factors such as the composition of 
the media used to culture the embryos in or the inaccessibility of the embryo in the 
need to perform the assays in situ. Nevertheless, the current evidence suggests that 
oxidative phosphorylation is the major source of energy production in the early 
embryo being low during cleavage stages but significantly increase at the 
blastocyst stage and at 6.5-7.5dpc (Houghton, 1996). Interestingly only 30% of the 
total oxygen consumed is used by the mitochondria during cleavage stages but this 
ratio increases up to 70% in the blastocyst (Trimarchi, 2000).  Wakefield and 
colleagues analysed the contribution of mitochondrial function to correct 
embryonic development and lineage specification.  Culturing embryos in the 
absence of pyruvate increased glycolysis to support ATP production.  Conversely, 
inhibition of mitochondrial function blocked glycolysis and TCA cycle activity 
affecting embryonic development (Wakefield, 2011). Around implantation, there is 
a dramatic increase in glucose uptake and a reduction in oxygen consumption, 
suggesting a switch in energy metabolism (Brison, 1991). The increase in glucose 
uptake enhances the activation of the pentose phosphate pathway, which 
provides ribose-5-phophate (required for nucleotide synthesis) and generation of 
NAPDH that has an important role to protect against reactive oxygen species (ROS) 
(Patra, 2014). Mutations in glucose-6-phosphate dehydrogenase (G6PD) in mouse 
embryos increase the susceptibility to cell death upon oxidative stress (Nicol, 
2000). This protective role suggests the possibility of a relation between 
metabolism and cell death. This hypothesis is strengthened as it has been reported 
that hexokinases, that are upstream G6PD, also have a protective role in the 
mitochondria, preventing BAX/BAX mitochondrial permbeabilization (Majewski, 
2004). Homozygous mutants for HKII are embryonic lethal and die around 7.5dpc , 
indicating how important is glucose metabolism at implantation and post 
implantation stages of mouse embryonic development (Heikkinen, 1999).  
 
1.5.2 Metabolism in the naïve and primed pluripotent states 
Previous studies have shown that hypoxic conditions prevent the differentiation of 
human ESCs (Forristal, 2010). It has also been shown that low oxygen tensions 
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enhances the reprogramming efficiency of human and mouse somatic cells 
(Yoshida, 2009). As previously discussed, at low oxygen conditions, HIFs will 
activate the transcription of different glycolytic associated genes such as PDK1 or 
LDHA.  
 
However, little is known about the metabolic status of mouse embryonic and 
epiblast stem cells. Zhou and colleagues did an extensive comparison of the 
metabolic status of mouse ESCs, EpiSCs and hESCs. In their analysis they measured 
oxygen consumption rates as well as extracellular media acidification, ATP levels 
and mitochondrial content and observed that whilst EpiSCs and hESCs rely on a 
glycolytic metabolism, mESCs depend both on oxidative phosphorylation and 
glycolysis as their energy sources (Zhou, 2012).  These studies suggested that an 
important event explaining the metabolic differences between mouse ESCs and 
EpiSCs is the reduction in expression of cytochrome-oxidase related genes and 
activity of complex IV of the ETC in EpiSCs. Consequently EpiSCs and hESCs have 
lower mitochondrial membrane potential than ESCs, and lower levels of basal ATP 
(Zhou, 2012). In addition to this, they also observed that mitochondria of EpiSCs 
and hESCs are elongated, narrow and present higher number of cristae and levels 
of mitochondrial DNA compared to ESCs, which have rounded mitochondria with 
just few cristae  (Zhou, 2012; Choi, 2015).  The degree of mitochondrial maturity 
correlates with the slightly advanced developmental stage of EpiSCs. Interestingly, 
the role of pluripotency factors such as Rex1 has been associated to the metabolic 
status of human ESCs, promoting glycolysis (Son, 2013). This could be explained 
by the expression of UCP2 (uncoupling protein 2) that in these cells promotes 
glycolysis by exporting pyruvate out from the mitochondria. Upon hESCs 
differentiation, the expression of this protein is repressed favouring oxidative 
phosphorylation (Zhang, 2011). In addition, a hypoxic environment enhances the 
expression of pluripotency genes and growth rates of human ESCs caused by 
activation of hypoxia inducible factors (HIFs) and their downstream targets  
(Forristal, 2010). It has also been reported that increasing glycolysis enhances the 
reprogramming efficiency of somatic cells (Yoshida, 2009) and that blocking this 
pathways has the opposite effect (Folmes, 2011). This data indicates that there is a 
direct link between pluripotency and metabolism in stem cells. However, it would 
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be interesting to study if the metabolic status of the recently generated naïve 
human ESCs (Takashima, 2014) differs from the primed human ESCs which have 
been used for these studies.    
 
1.5.3 Mitochondrial dynamics: a link between metabolism, pluripotency and 
cell death  
Mitochondria are very dynamic organelles. They are able to fuse or fragment upon 
different stimuli: cell division, apoptosis, starvation, and energy demand. 
Mitochondrial fission or fragmentation is important for degradation of 
damaged/less functional mitochondria through autophagy (Twig, 2008) and to 
segregate mitochondria to daughter cells during mitotic cell division (Taguchi, 
2007). The GTP-ase dynamin-related-protein 1 (DRP1) is recruited from the 
cytosol to the mitochondria where it will assemble to constrict mitochondria, in 
this way dividing the organelle (Mishra, 2014). Mitochondrial fission protein 1 
(FIS1), mitochondrial fission factor (MFF) or mitochondrial dynamics protein of 49 
kDa (MID49) and MID51 recruit DRP1 to the mitochondria (Loson, 2013). Drp1 
knockout mice are embryonic lethal and die around 10.5dpc (Ishihara, 2009). In 
contrast to this, mitochondrial fusion is mediated by mitofusins (MFN1 and MFN2), 
which are required for the fusion of the outer membrane of the mitochondria, and 
by optic atrophy 1 (OPA1), that mediates fusion in the inner mitochondrial 
membrane to form cristae (Westernmann, 2010).  MFN1, MFN2 and OPA1 null 
embryos die around 10.5dpc, which indicates the essential role of these proteins 
for correct embryonic development (Chen, 2003; Alavi, 2007). Mitochondria play a 
central role in metabolism as they are required to carry out two main metabolic 
pathways: TCA /OXPHOS and b-oxidation of fatty acids. They change their 
morphology and content to adapt to the cellular metabolic requirements or to cell 
cycle conditions. As an example, during starvation there is an increase in the 
expression of MFN1  and  a down-regulation of DRP1 which causes mitochondria 
elongation. This prevents mitochondrial degradation through autophagy (Rambold, 
2011) and enhances mitochondrial uptake of fatty acids to overcome the deficit in 
energy supply (Rambold, 2015).  
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It has also been shown that there is a direct correlation between mitochondrial 
dynamics and pluripotency. REX1 is a pluripotency transcription factor that in 
human ESCs induces mitochondrial fragmentation through the activation CDK1 
that in turn activates DRP1 (Son, 2013). Conversely, MFN2 and OPA1 are required 
for the correct differentiation of mouse ESCs into cardiomyocytes (Kasahara, 
2013). This suggests that mitochondrial fragmentation is favoured in a 
pluripotency state but fusion is required for differentiation, possibly to cope with 
the higher ATP demand of this process. Analysis of mitochondrial morphology by 
electron microscopy during the development of human embryos, from, the oocyte 
to implantation, has shown that a transition from fragmented to elongated 
mitochondria occurs (Sathananthan, 2000), similar to that found in the mouse ESC 
to EpiSC transition. 
 
The pro-apoptotic proteins BAX and BAK can interact with DRP1, MFN1 and MFN2 
during apoptosis modulating mitochondrial dynamics during the cell death 
response (Karbowski, 2002; Brooks, 2007).  Mitochondrial fragmentation occurs 
after CytC release.  This process is mediated by the translocation of the 
mitochondrial protein OPA1 to the cytoplasm during mitochondrial apoptosis 
favouring cytochrome C release from cristae (Arnoult, 2005; Frezza, 2006).  
 
These few examples show how interlinked pluripotency, metabolism, 
mitochondrial dynamics and cell death are. In this thesis we will study the intrinsic 
relation of these parameters in the naïve and primed states of pluripotency.  
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1.6 Aim of this thesis 
During pre-implantation development, prior to the segregation between epiblast 
and primitive endoderm, apoptosis serves as a selective mechanism to ensure 
proper segregation of lineage progenitors (Plusa, 2008; Xenopoulus, 2015). 
Additionally, apoptosis in the post-implantation mouse embryo peaks at 6.5dpc, 
when cells become hypersensitive to DNA damage (Heyer, 2000) and serves to 
eliminate defective cells (Sancho, 2013; Claveria, 2013). Previous work to this 
thesis in the Rodriguez laboratory and others showed an essential role of miRNAs 
in regulating cell survival during post-implantation but not pre-implantation 
development (Kanellopoulou, 2005; Suh, 2010; Spruce, 2010). These observations 
pointed either to a different apoptotic threshold between the epiblast of the pre-
implantation and post-implantation embryo or a different requirement for miRNAs 
between these stages. The main aim of this thesis is to unravel the mechanism by 
which miRNAs regulate apoptosis in the early mouse embryo and to study the 
contribution of Bcl2 protein family, mitochondrial dynamics and metabolism in 
establishing a differential apoptotic threshold between the naïve and primed 






2. Material and methods 
 
All materials were obtained from Sigma‐Aldrich unless otherwise stated. 
 
2.1 Mouse procedures and embryology methods 
 
2.1.1 Mice lines 
Two transgenic mouse lines were used in this thesis.  The Dicer line has loxP sites 
flanking the RNAseIII domain of Dicer, coded in exons 20 and 21 of this gene (Cobb, 
2005). Deletion of this region is mediated by the action of the Cre recombinase, 
causing the transcription and translation of a catalytically inactive protein. In 
order to delete Dicer specifically in the epiblast we used a mouse line in which the 
Cre recombinase gene is under the upstream regulatory sequence of the Sox2 gene, 
Sox2Cre (Hayashi, 2002). DicerFx/+ male mice, were crossed to Dicer+/- female mice 
carrying the Sox2Cre transgene to generate Dicer+/‐ offspring. Dicer+/‐ male mice 
carrying the Sox2Cre transgene (Dicer+/‐Sox2Cre) were crossed to DicerFx/Fx female 
mice to generate embryos with epiblast specific Dicer deletion.  
Bim+/- mice were obtained from Bouillet, 1999. Bim-/- were crossed to Dicer+/-
Sox2Cre males and to DicerFx/Fx females to generate offsrpings heterozygous for 
Bim. Dicer+/-Sox2Cre, Bim+/- males were crossed do Dicer Fx/Fx Bim +/- females to 
generate knock out embryos for Bim in which Dicer is specifically deleted in the 
epiblast.  
All of these strains were maintained and studied on a mixed genetic background. 
 
Mice were maintained on a 12-hour light, 12-hour dark cycle. Mattings were set up 
in the evening and plugs checked on the following morning. Pregnant females were 
sacrificed at the embryonic stage required and the uterus was removed. Embryos 
were then dissected from the uterus in M2 media and fixed, dehydrated and stored 
at -20°C to be used for the according protocol (see Whole Mount in situ 
hybridization for detail procedure of fixation and dehydration). All mice used in 
this investigation were maintained and treated under the Home Office’s ‘Animals 
(Scientific Procedures) Act 1986’ in the Clinical Biological Services Unit at Imperial 
College London – Hammersmith Campus, UK.  
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2.1.2 Mice and embryo genotyping 
Tail biopsies of transgenic mice were lysed in 600 μL of NaOH solution (1 pellet 
dissolved in 45mL of ddH2O). Samples were incubated at 100°C for 10 min. After 
cooling down, 100 μL of 1M Tris-HCl (pH 8.5) was added. Samples were gently 
homogenized, spun down and stored at 4°C.  
 
Yolk sacs from dissected embryos were digested in 25L embryo lysis buffer 
(50mM Tris‐HCl pH 8.5, 1 mM EDTA, 0.5% Tween‐20 in dH2O) overnight at 55°C 
with 1 μL of Proteinase K (20mg/mL).  Following this digestion, Proteinase K was 
inactivated by incubation of lysates at 95°C for 10 min and samples stored at 4°C.  
 
5 μL (tails) or 4 μL (embryos) of DNA lysate were used per reaction in a final 
volume of 50 μL containing 1 unit of Amplitaq DNA polymerase (Invitrogen), 1 μM 
of each primer, 0.2mM of each dNTP (Roche) and PCR buffer (1x) in ddH2O. Primer 
sequences and annealing temperatures can be found in Table 2.1.  The PCR was 
performed on a PTC-100 thermal cycler (Peltier) using the following program: an 
initial denaturation step at 95°C for 5 minutes followed by 35 amplification cycles 
(94°C for 30s, annealing temperature for 30 and 72°C elongation for 45s). A final 
elongation step of 72°C for 10 minutes followed the last amplification cycle. PCR 
products were analysed under UV light after size fractionation by electrophoresis 
in 2% agarose gels containing ethidium bromide. For embryos, 40 amplification 













Table 2.1 Primers used for embryos and cells genotyping 
 










259 - wt 











F: CATTCTCGTAAGTCCGAG TCT  
58 400 
R: GTGCTAACTGAAACCAGATTA  
Bim 
F: CATTCTCGTAAGTCCGAG TCT  
58 540 
R: CTC AGT CCA TTC ATC AAC AG  
 
 
2.1.3 Riboprobe synthesis for whole mount in situ hybridisation 
Plasmids (1.5g) containing the appropriate cDNAs were first linearized using 
restriction enzymes (New England Biolabs) as listed in table 2.2. DNA was then 
purified by phenol-chloroform (Invitrogen). DNA was precipitated using 1/10 of 
total volume of 3 M Sodium acetate (pH 5.2) and 2 times total volumes of 100% 
Ethanol (Fisher Scientific, UK) at ‐80 °C for 30 min, separated by centrifugation (14, 
000 rpm, 4 °C, 15 min) and washed in cold 70% ethanol. Precipitated linearized 
DNA was re‐suspended in 10 μL of dH2O, and stored at ‐20 °C until transcription of 
the riboprobe. Linearization was checked by running a 1% agarose gel.  
 
In vitro transcription of riboprobes was carried out using the RNA Polymerase 
shown in table 2.2. Reactions contained 1 g of linearized plasmid DNA, 100 units 
of RNA polymerase, 1x transcription buffer, 25 units of RNAse Inhibitor and 5μL 
DIG‐labeled nucleotide mix and were conducted in total volume made up to 50μL 
with dH2O (all reagents from Roche). Transcription was carried out at 37 °C for 2h 
after which 30 units of RNAse‐free DNAse I (Roche) was added prior to incubation 
at 37 °C for a further 15 min. Riboprobes were then purified using ChromoSpin 
columns (BD Biosciences, UK) after which 1μL of each probe was fractionated on a 
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1% agarose gel to assess the quality and approximate concentration of the probe 
in order to determine its working dilution. Riboprobes were kept at -20°.  
 
 












Nkx2.5 EcoRI T3 
Mesoderm / Heart 
progenitor cells and 
myogenic descendants 
1600 Lints, 1993 
Tbx18 HindIII T7 Pro-epicardium 2000 Kraus, 2001 
Fgf8 HindIII T3 
anterior neural ridge, 
midbrain and 
hindbrain junction, the 






Tbx18 was kindly provided by Andreas Kispert. 
 
2.1.4  Whole mount in situ hybridisation (WISH) 
WISH was adapted from the standard procedures (Thomas and Beddington, 1996) 
as follows. 
 
After dissection, embryos were fixed on 4% filtered PFA (paraformaldehyde) in 
PBS at 4°C overnight. On the following day embryos were dehydrated in serial 
dilutions of methanol in PBS (25, 50, 75 and twice in 100% methanol) 5 minutes in 
each dilution at room temperature (RT). Dehydrated embryos were kept at -20°C.  
 
Stored embryos were placed in 15 mm net wells (Corning). Depending on the 
embryonic stage we will use either a 500μm or 74μm mesh positioned on 12 well 
plates (VWR). 2mL of each solution is used per well. Embryos were rehydrated in 
serial dilutions of methanol in PBS/0.1% Tween (PBT) (75, 50, and 25% 5 min per 
wash) and twice in PBT. Embryos are bleached in 6% hydrogen peroxide in PBT 
for 1 hour to stop the activity of endogenous peroxidases at RT and then wash 
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three times in PBT (5 min per wash). Embryos were digested in Proteinase K 
(10μg/ml, in PBT) and incubated at RT for different periods depending on their 
developmental stage (7.5 min for 8.5 dpc and 10 min for 9.5 dpc). After digestion 
embryos were placed in Glycine (2mg/ml, in PBT) for 5 min to stop proteinase 
activity and then washed twice in PBT (5 min per wash). Following this, embryos 
were re‐fixed in a solution of 0.2% glutaraldehyde/ 4% PFA in PBT at RT for 20 
min. This is followed by two 5 min washes in PBT. 
 
Embryos were incubated in pre‐hybridisation buffer (50% Formamide, 5x SSC, 50 
μg/ml Heparin sulphate and 0.1% Tween‐20 in dH2O) at 70°C for 1‐2h and then 
transferred to the pre‐warmed hybridisation buffer (1 mg/ml torula RNA and 
1mg/ml Herring sperm DNA in Pre‐hyb buffer) containing the denatured 
riboprobe. Embryos were incubated O/N at 70°C.  Probes were used at a dilution 
between 1:50 and 1:200 depending on their approximate concentration. 
 
After hybridisation, embryos were washed two times for 30 min at 70°C in solution 
1, then two times in solution 1:2 for 10 min at 70°C and finally 3 times in solution 2 
for 5 min at RT. These washes are followed by a treatment with RNAse A 
(100μg/ml in Solution II, Roche Diagnostics) diluted in solution 2 and incubated 
for 30 min at 37°C (2 washes) to remove unbound probe. Embryos were washed 
once in Solution II and once in Solution III, 5 min per wash at RT after the RNAse A 
treatment. They were then washed twice in pre‐warmed Solution III at 65°C (30 
min per wash) and three times in TBST, 5 min per wash, at RT before being 
blocked at RT in sheep serum (10% in TBST) for 1‐2.5 hrs. After blocking, embryos 
were incubated with anti‐dioxigenin FAB antibody (1:2000, Roche Diagnostics) in 
Sheep serum (1% in TBST) O/N at 4°C with rocking and washed six times in TBST 
(1 hour per wash at RT except for the final wash O/N at 4°C) to remove unbound 
antibody. Embryos were then washed three times in NTMT (100 Mm NaCl, 100 
mM Tris‐HCl pH 9.5, 50 mM MgCl2 and 0.1% Tween‐20 made up in dH2O, 10 min 
per wash) at RT. 
 
For signal detection embryos were placed into Repelcote (BDH, UK) treated glass 
embryo dishes (RA Lamb, UK). The staining reaction was then performed with 
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NBT/BCIP solution (20μL per 1 ml of NTMT, Roche Diagnostics) at RT in the dark 
until a clean specific signal is observed. The solution is filtered using a 20 m pore 
membrane prior to incubation with the embryos. Once staining has reached the 
appropriate signal levels the embryos were washed with PBT (3 washes, 5 min per 
wash) to stop the reaction. Embryos were stored at 4°C until they are 
photographed, genotyped or used for cryosectioning. 
 
Solutions used:  1-. 50% Formamide, 4x SSC pH 4.5, 10% SDS in dH2O. 2-. 500 mM 
NaCl, 10mM Tris‐HCl pH7.5 and 0.1% Tween‐20 in dH2O. 3-. 50% Formamide, 2x 
SSC pH 4.5 in dH2O. TBST-. 137 mM NaCl, 1.34 mM KCl, 12.5mM Tris‐HCl pH 7.5 
and 0.1% Tween‐20 in dH2O. NTMT-. 100 Mm NaCl, 100 mM Tris‐HCl pH 9.5, 50 
mM MgCl2 and 0.1% Tween‐20 in dH2O. 
 
2.1.5 Cryosectioning 
Embryos were transferred to an eppendorf tube and added a 15% sucrose in PBS 
solution. This solution was replaced by a 30% one when embryos reached the 
bottom of the tube. Embryos were kept at 4°C until making the blocks. 
 
After removing the 30% sucrose in PBS solution, embryos were soaked for 30 min 
at 37°C in a solution of  7.5% gelatine/15%sucrose in PBS. Wells of a 12 well  filled 
to a half with that solution.. Once it got solidified each embryo was pipetted into a 
well and orientated. Once each well was completely solidified, the mould was 
extracted from the plate, cut, stuck to a piece of cardboard with OCT avoiding 
bubbles and placed in 2-methylbutane kept in dry ice for 1 min. Blocks were stored 
at -80°C until sectioned. A Leica cryostat was used to cut the blocks in 10m 
sections. Sections were placed on SuperFrost Plus slides (VWR) and kept at -20°C.  
 
2.1.6 Haematoxylin and Eosin staining 
Sections were fixed in formalin for 15 min at RT, rinsed with water and stained 
with Haematoxylin solution for 30 seconds to stain the nuclei. Slides were rinsed 
with water and de-stained with 1% acid alcohol for 5 seconds. After rising with 
water, slides were stained with eosin for 45 seconds. Slides were rinsed in water, 
drained and mounted in glycerol.  
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2.1.7 Whole mount TUNEL staining 
Whole mount TUNEL staining was performed with the ApopTag® Plus Peroxidase 
In Situ Apoptosis Kit (MerckMillipore). Briefly, dehydrated embryos were 
rehydrated through methanol gradients, washed in PBT (0.1% Tween‐20 in PBS) 
and treated with proteinase K as for the regular WISH protocol previously 
described. Following this they were re‐fixed in 4% paraformaldehyde in PBT at RT 
for 20 minutes. They were then washed 5 times in PBT at RT and fixed in 
Ethanol/Acetic Acid (2:1) at –20°C for 20 minutes. A further set of five PBT washes 
(5 minutes, 0.1% Tween‐20) was done at RT before embryos were moved to 1.5 ml 
Eppendorf tubes, treated twice with equilibration buffer (5 minutes for the first 
treatment and 1 hour for the second) at 25°C and incubated overnight at 37°C in 
reaction buffer:TdT enzyme (70:30, 0.1% Tween‐20). Following incubation 
embryos were washed 4 times with H2O:stop buffer (34:1, for 45 minutes) at RT, 
then transferred back to Netwells and washed 3 times in PBT (20 min per wash). 
Following this immunohistochemistry using an anti-dioxigenin‐AP conjugated 
antibody and signal detection were performed as previously outlined in the WISH 
protocol. 
 
2.2 Tissue culture methods 
 
2.2.1 Cell lines maintenance 
All cells were cultured at 37°C in an atmosphere with 5% CO2. Reagents used for 
tissue culture were obtained from Invitrogen unless otherwise stated.  
 
Two different ESCs lines were used in this thesis: DicerFx/Fx (Cobb, 2005) and 46C 
(Ying, 2003a). DicerFx/Fx were used for miRNA related experiments and 46C ESCs 
for all other assays. ESCs were maintained in an undifferentiated state on 0.1% 
gelatin-coated flasks (Nunc, Thermo Fisher) GMEM (supplemented with 10% (v/v) 
foetal calf serum (FCS; Seralab), 1X non-essential amino acids, 2 mM L-glutamine, 
0.1 mM β-mercaptoethanol and leukaemia inhibitory factor (1:500, LIF). ES cells 




Oligomycin ESC (OM ESCs): 46C ESCs were grown as specified above adding 
Oligomycin A (20nM). Cells were maintained under these conditions for at least 
three passages before performing any experiment. 
 
2i+LIF. 46C ESCs were seeded on 0.2% gelatin coated plates. Once attached, media 
was changed to N2B27 with 1 µM of the MEK inhibitor PD0325901 and 3 µM of the 
GSK3 inhibitor CHIR99021 with LIF. Cells were kept under these conditions for at 
least three passages before performing any experiment. For N2B27 formulation 
see EpiSCs 
 
Dicerfx/fx and 46C EpiSCs were differentiated from Dicerfx/fx and 46C ESCs as 
described in (Guo, 2009) by Dr. Barbara Pernaute. Briefly, ESCs were plated on 
dishes coated with human fibronectin (Millipore) in N2B27 (100mL DMEM F12, 
100mL Neurobasal, 1mL N2, 1mL B27 without retinoic acid) media containing 
20ug/ml Activin A (R&D Systems) and 12ng/ml bFGF (R&D Systems). Cells were 
passaged by mechanical disruption as previously described (Brons, 2007) until 
passage 12, where a stable EpiSCs line could be maintained. EpiSCs were grown on 
FCS coated dishes in N2B27 media containing 20ug/ml Activin A and 12ng/ml 
bFGF.  
 
2.2.2  Induction of Dicer deletion 
To induce Dicer deletion Dicerfx/fx ESCs and EpiSCs were cultured in the presence of 
0.3 mM 4-OH-Tamoxifen for three days and left untreated from the third day 
onwards. Dicer deletion was evaluated by PCR following the protocol described in 
section 2.1.2 for embryo genotyping. Dicer levels were also evaluated by qPCR.  
Addition of 4-OH-Tamoxifen allows the traslocation of the CRE recombinase to the 
nucleus and excision of the genomic region flanked by LoxP sequences. 
 
2.2.3 Inhibition of caspases after miRNA depletion in EpiSCs 
For inhibition of caspases EpiSCs were treated with 100mM Z-VAD-FMK (R&D 




2.2.4 Embryoid body differentiation 
For Embryoid bodies formation (EBs) EpiSCs cells were scrapped and diluted 1:25, 
then seeded in ultra-low adherent 6 well plates (Costar), 2 mL per well in ESC 
media without LIF. After differentiation, EBs were collected, spun down and kept 
at -80°C for RNA extraction. 
 
2.2.5 siRNA transfection 
Hiperfect transfection reagent (Qiagen) was used according to manufacturers’ 
instructions to transfect Bim siRNA (Mm_Bcl2l11_2 FlexiTube siRNA, Qiagen) at a 
final concentration of 50nM or Mcl1 siRNA (Mm_LOC632101_2 FlexiTube siRNA, 
Qiagen) at 25nM. Briefly, siRNAs were diluted in Optimem and incubated with 
Hiperfect for 30min. Cells were plated on top of the siRNA-Hiperfect mix. Media 
was replaced after 16 or 24 hours. Three other Bim siRNAs (Mm_Bcl2l11_1, 
Mm_Bcl2l11_3 and Mm_Bcl2l11_4 FlexiTube siRNAs) and Mcl1 siRNAs 
(Mm_LOC632101_3, Mm_Mcl1_5 and Mm_Mcl1_6 FlexiTube) were tested and 
showed lower level of Bim and Mcl1 inhibition respectively. Transfection efficiency 
was measured by q-RT PCR and western blotting. 
 
2.2.6 Crystal violet staining 
Cells were seeded on 12-well plates. Cells were fixed in 4% paraformaldehyde for 
5 min, rinsed twice with PBS and stained with 0.05% crystal violet for 30 min at RT.  
Plates were gently washed with tap water and let to get dried before acquiring 
images.   
 
 
2.3 Methods for Gene Expression Analysis 
 
2.3.1 mRNA isolation and quantitative PCR 
Cells were dissociated, spun down and pellets kept at -80oC until the moment of 
the analysis. mRNAs were extracted using  the RNeasy Mini Kit (Qiagen) following 
the manufacturer’s instructions. Genomic DNA was eliminated using the RNase‐
free DNase set (Qiagen) in accordance with the protocol outlined in the RNeasy 
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handbook entitled Optional On‐Column. After extraction, RNA was quantified using 
a Nanodrop spectrophotometer (Thermo Scientific).  
 
cDNA was synthesized from 1.5μg of total RNA using the SuperScript III Reverse 
Transcriptase system (Invitrogen). Briefly: 0.5 μL of nonamer primers (Sigma), 
1.5μg of total RNA and RNase free water were mixed to a final volume of 10 μL, 
incubated at 65°C for 5 minutes and then kept at 4°C. A mix containing 2 μL of 10 
mM dNTP mix (Roche), 2 μL of 0.1M DTT, 4 μL of 5X first strand buffer, 1 μL of 
RNase inhibitor (Roche) and 1 μL of 200 U/μL Superscript III was then added. A 
reaction mixture without the superscript enzyme was also added to a further 
reaction as a negative control. The cDNA synthesis reactions were then incubated 
at 25°C for 5 min, 50°C for 1 h 30 min and at 70°C for 15 min. The resulting cDNA 
was diluted 1:10 in dH2O and kept at ‐20°C until qPCR analysis.  
 
qPCR analysis was carried out using a ABI 7900HT Fast Real Time PCR System 
(Applied Biosystems). PCR reactions included 1 x SYBR‐Green PCR Mastermix 
(Qiagen), 300nM primers (Table 1) and 1μL of diluted cDNA template in a 15μL 
reaction volume using 384 well plates (Applied Biosystems). Negative controls 
were run for each sample and primer pair to monitor for genomic contamination. 
The following program was used for amplification by qPCR: 1) 95°C for 15min; 2) 
94°C for 15s; 3) 59°C for 30s; 4) 72°C for 30s; 5) Read; 6) 75°C for 1s; 6) Plate 
read; 7) 78°C for 1s; 8) Plate read; 9) Repeat from line two 39 times; 10) Melting 
curve was designed reading the plate every 0.2°C from 70 to 95°C holding for 1s 
between reads. Each measurement was performed in triplicate. Gene expression 
data were normalized according to the expression of the housekeeping gene -
actin. The expression levels of mRNA were calculated using the ΔΔCT method 








Table 2.3 Primers used for gene expression analysis 
 
Gene Forward Reverse 
b-Actin 5' CTAAGGCCAACCGTGAAAAG 3' 5' ACCAGAGGCATACAGGGACA 3' 
Bcl2 5' GTCGCTACCGTCGTGACTTC 3' 5' CAGACATGCACCTACCCAGC 3' 
Bim 5’ CCCGGAGATACGGATTGCAC 3’ 5’ GCCTCGCGGTAATCATTTGC 3’ 
Dicer 5' TATCGCCTTCACTGCCTTCT 3' 5' GCAACCTTTTGCAGTTCACA 3' 
DnmT3 5' AGGGGCTGCACCTGGCCTT 3' 5' TCCCCCACACCAGCTCTCC 3'  
Fgf5 5’ AAAGTCAATGGCTCCCACGAA 3’ 5’ CTTCAGTCTGTACTTCACTGG 3’ 
Gata4 5’ TCAACCGGCCCCTCATTAAG 3’ 5’ CACCCTCGGCATTACGACG 3’ 
Hmbs 5' ACTGGTGGAGTCTGGAGTCTAGATGGC 3' 5' GCCAGGCTGATGCCCAGGTT 3'  
Klf4 5’ ACCTATACCAAGAGTTCTCATC 3’ 5’ TCTGGCACTGAAAGGGCCGG 3’ 
Mcl1 5' AAAGGCGGCTGCATAAGTC3' 5' TGGCGGTATAGGTCGTCCTC3'  
Nanog 5’ CTTACAAGGGTCTGCTACTGAGATGC 3’ 5’ TGCTTCCTGGCAAGGACCTT 3’ 
Pou5f1 5’ CGTGGAGACTTTGCAGCCTG 3’ 5’ GCTTGGCAAACTGTTCTAGCTCCT 3’ 
Rbl2 5’ CCCGGAGCCAGGTGTACA 3’ 5’ CCTCATCACTGGGCTGGAAT 3’ 
Rex1 5’ CGAGTGGCAGTTTCTTCTTGG 3’ 5’ GACTCACTTCCAGGGGGCAC 3’ 
Sox1 5' GCGAGATGATCAGCATGTACC 3' 5' TAGTGCTGTGGCAGCGAGT 3'  
Sox2 5’ GAGTGGAAACTTTTGTCCGAG 3’ 5’ GAAGCGTGTACTTATCCTTCTT 3’ 
T 5' TTGAACTTTCCTCGATGTGCTGA 3' 5' TCCCAAGAGCCTGCCACTTT 3' 
 
 
2.3.2 Microarray analysis  
For the microarray analysis, RNA from three independent experiments was 
extracted as previously described. Labeling and hybridization to Affimetrix Mouse 
Gene 1.0ST microarrays were performed at UCL Genomics at the Institute of Child 
Health. Normalization and statistical analysis were performed using GeneSpring 
software. The Babelomics data analysis platform (Medina, 2010) was used to 
analyse the enrichment for miRNA targets amongst those genes significantly up or 
down-regulated upon Dicer deletion compared to all genes expressed in Dicerfx/fx 
ESCs and EpiSCs. A two-tailed Fisher exact test was used to determine significance 
(adjusted p<0.05). The bioinformatics platform DAVID (Huang da, 2009) was used 
to obtained gene ontology terms from those genes found significantly up-regulated 
by 1.2 fold change (p<0.05).  
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2.3.3 miRNA extraction and expression analysis 
For qPCR analysis of miRNA expression total RNA was extracted using the 
miRVana™miRNA Isolation Kit (Ambion) in accordance with the manufacturer’s 
instructions. TaqMan miRNA probes (Applied Biosystems) were used to perform 
miRNA qPCRs in stem cells. cDNA was synthetized with the TaqMan miRNA 
reverse transcription kit (Applied Biosystems) from 10ng of miRNAs. qRT-PCR for 
individual miRNAs was performed using TaqMan universal PCR master mix 
(Applied Biosystems). sno202 were used to normalize miRNA expression in ESCs 
and EpiSCs. 
 
2.4 Methods for protein analysis 
 
2.4.1 Western Blotting 
Cells were directly lysed in pre-warmed (95°C) Laemlli Sample buffer (50mM Tris-
HCl (pH 6.8), 2% SDS,  10% Glycerol in ddH2O). Proteins were denatured at 95°C 
for 10 min. Proteins were then quantified using the BCA protein quantification 
method (Pierce – ThermoScientific) according to the manufacturer’s instructions.  
To study mitochondrial localization of proteins from the Bcl2 family, mitochondrial 
fractionation was performed following the “Mitochondrial purification protocol” 
from Abcam.  
 
20 μg of protein were loaded into a Criterion XT Pre-casted 10% Bis-Tris gel (Bio-
Rad) adding b-mercatoehanol (0.025%) to the loading buffer and resolved (1.5 
hours at 150V). Proteins were then transferred onto a nitrocellulose membrane 
(G&E Healthcare) using vertical wet transfer (Criterion Blotter, Bio-Rad; 1 hour, 
100V). Membranes were blocked in 5% milk in TBS / 0.1% Tween (TBST) for 1 
hour before incubation with primary antibodies O/N at 4°C. The primary 
antibodies used were: α-Tubulin (1:2000, Cell Signalling), Bim/Bod (1:1000, Enzo) 
Phospho-Stat3 (1:1000, Cell Signalling), Phospho-p38 (1:1000, Cell Signalling), β-
Actin (Cell Signalling, 1:1000), PCNA (1:2000, Santa Cruz), Puma (1:1000, Cell 
Signalling), Bid (1:1000, Cell Signalling), Bcl2 (1:500, BioLegend), Mcl1 (1:10,000, 
Rockland), A1 (1:500, R&D Systems), Bcl-xL (1:1000, Santa Cruz), pDRP1 (S616) 
(1:1000, Cell Signalling), ATPb (1:1000, Abcam), TOM20 (1:1000, Santa Cruz), 
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phospho-AMPK (1:1000, Cell Signalling), cleaved PARP (1:1000, Cell Signalling), 
cleaved caspase 3 (1:1000, Cell Signalling), hexokinase II (1:1000, Cell Signalling), 
Nanog (1:1000; eBiosciences).  
 
On the following day, membranes were washed in TBST and subsequently 
incubated with the appropriate secondary antibody conjugated with horseradish 
peroxidase (Southern Biotech) diluted 1:5000 in 5% Milk/TBST for 1 hour at room 
temperature and then washed in TBST. Amersham ECL Western blotting detection 
system (GE Healthcare) and Amersham Hyperfilm ECL films (GE Healhcare) were 




2.4.2.1 General protocol for immunofluorescence  
Cells or cryosections were washed with PBS and fixed with 4% paraformaldehyde 
for 10 minutes five days after the starting point of tamoxifen treatment. After 
washing again with PBS, cells were permeabilized in 10% BSA + 0.4% Triton-X100 
diluted in PBS for 5 min, then washed once with PBS. They were blocked in 10% 
BSA, 0.1 % Triton-X100 in PBS (blocking solution) for 30 min. Antibodies were 
diluted in the blocking solution and incubated O/N at 4°C. Cells were washed with 
PBS two times and then the secondary antibodies (diluted in the blocking solution) 
were incubated in the dark for 45 minutes.  Cells were washed two times with PBS 
and mounted in a slide with Vectashield with DAPI (Vector Laboratories).  
 
2.4.2.2 Mitochondrial Staining 
Cells were washed with PBS and fixed with 3.7% formaldehyde diluted in serum 
free media for 15 min at 37°C, 5% CO2.  Cell were washed two times with PBS and 
incubated with pre-cooled acetone for 5 min at -20°C. Cells were washed two times 
with PBS and incubated with blocking/permeabilization (5% BSA, 0.4% Triton-X 
in PBS) solution for 30 min at RT before incubating with the primary antibody O/N 
at 4°C.  Excess antibody was removed and cells washed three times in PBS, then 
incubated with the secondary antibody for 45 min at RT. Before mounting with 
Vectashield with DAPI, secondary antibody was removed and cell washed again 
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three times in PBS. For Mitotracker staining: Cells were incubated with 
MitoTracker CMXRos (Invitrogen) 200nM for 20 minutes before fixation.  
 
Images were acquired in a LSM Z800 Confocal microscope and processed with FIJI. 
Images for deconvolution were acquired with the same microscope and further 
processed with the software Huygens. Deconvolution analysis was performed with 
the support and advice from Mr. Stephen Rothery from the Facility for Imaging by 
Light Microscopy (FILM) at Imperial College London.   
 
Primary antibodies used for immunofluorescence: Tom20 (1/100, Santa Cruz), 
ATPb (1:100, Abcam), Nanog (1:100, eBioscience), Gata4 (1:100, Santa Cruz), Sox2 
(1:100, R&D). AlexaFluor (Invitrogen) were used as secondary antibodies (1:600).  
 
 
2.5 Flow cytometry 
All flow cytometry experiments were performed using a LSRII Flow Cytometer 
System (BD Biosciences). All samples were transferred into strainer-cap flow 
cytometer tubes (BD Biosciences) before running the analysis. Compensation was 
calculated based on single stained samples using the FACS DIVA software. Data 
was processed using the single cell analysis software FlowJo. 
 
2.5.1 Annexin V staining 
Annexin V (AnnV) is a protein that has high affinity for phosphatidylserine, a 
phospholipid that is predominantly located in the inner side of the cell membrane. 
Upon apoptosis, it gets translocated to the extracellular leaflet of the cell 
membrane.  To assess the percentage of AnnexinV positive cells the AnnV-APC kit 
(eBiosiences) was used.  Cells were tripsinized and counted. 2x105 cells were 
resuspended in 100 μL of 1x AnnV binding buffer with 3 μL of APC-conjugated 
AnnexinV. Cells were incubated at RT for 15 min, then spun down and 





2.5.2 Mitochondrial Membrane Potential 
Mitochondrial membrane potential is another method to assess intrinsic or 
mitochondrial associated apoptosis.  Loss of mitochondrial membrane potential 
was measured by using DiOC6 (Sigma) and TMRM (Invitrogen), lipophilic cationic 
dyes that accumulate in the mitochondrial matrix when there is there is a 
differential membrane potential. Cells were harvested and counted. 2x105 cells 
were incubated with DiOC6 (40nM) or TMRM (100nM) for 15 min at 37°C.  Cells 
were spun down and resuspended in 400 μL of media.  
 
 
2.5.3 Caspase-3/7 substrate 
After mitochondrial membrane permeabilization, the release of proteins from the 
mitochondrial matrix favour the apoptososme formation and cleavage of the 
effector proteases caspase 3 and 7, which will degrade proteins required for 
correct cell viability. To measure activation of cleaved caspase 3/7 the reagent 
NucView-488 (Biotium) was used.  This molecule has a caspase cleaved 
recognition site (DEVD) linked to a fluorogenic DNA dye. After cleavage of this 
molecule, the fluorogenic part becomes florescent and translocates to the nucleus. 
For this assay 2x105 cells were incubated in 100 μL with 1 μL of NucView-488 for 
15 min at 37°C.  Cells were spun down and resuspended in in 400μL of media. Data 
is shown as median fluorescence intensity.  
 
2.6 Metabolic profiling 
The metabolic profile was obtained using the Metabolon Platform (Metabolon). 
Each sample consisted of 5 biological replicates. For each replicate, 1x107 cells 
were spun down and snap frozen in liquid nitrogen. Samples were analysed by 
liquid chromatography/mass spectrometry and gas chromatography/mass 
spectrometry. Compounds were identified by comparison to library entries of 
purified standards based on the retention time/index (RI), mass to charge ratio 
(m/z), and chromatographic data (including MS/MS spectral data) on all molecules 
present in the library.  Samples were normalized to protein content measured by 
Bradford assay. Statistical significant cut-off: p ≤0.05. 
 
 66 
2.7 BH3 profiling 
This assay is used to functionally test the sensitivity of mitochondria to a direct 
pro-apoptotic stimuli induced by incubation with BH3-only peptides. Is based on 
measuring loss of mitochondrial potential over time using the membrane potential 
dependent marker JC-1 (Enzo, Life Sciences).  The assay was performed following 
the protocol described by Anthony Letai’s laboratory (Ryan, 2013). Briefly, 15μL of 
2x peptides diluted in DTEB buffer (135mM threalose, 10mM HEPES KOH pH 7.5, 
50mM KCl, 20μM EGTA, 20μM EDTA, 0.10% BSA, 5mM succinic acid) were added 
to each well of a dark 384 well plate (Nunc).  Cells were dissociated with trypsin, 
counted and resuspended at 2.67x106 cells/mL.  Equal volume of cells and dying 
mix (4x digitonin (0.01%), 4x JC-1 (4mM) and Oligomycin (40μg/mL)) were 
incubated for 10 minutes. 15μL of this mix was added per well of the 384 well 
plate. DMSO and CCCP (Sigma) were used as no-depolarization and full 
depolarization controls. BID, BIM, BMF and a peptide control were tested in this 
profile.  Each sample was loaded by triplicate and a total of three biological 
replicates were analysed. Fluorescence was measured every 5 minutes for a period 
of 70 minutes, with a 544/590 filter in a FluoStar Omega plate reader (BMG 
Omega). Percentage of depolarization was calculated by normalizing the data to 
the membrane potential of cells that have not been exposed to peptides but have 
been treated with DMSO (vehicle) or CCCP, a protonophore that causes complete 


















The correct development of the mammalian embryo after fertilization requires the 
progression of several events in an orchestrated and controlled manner. These 
steps are accompanied by coordinated changes in cell signalling, metabolism, 
epigenetics and gene expression. 
 
MicroRNAs are key regulator molecules of gene expression. They mediate mRNA 
degradation or inhibition of protein translation by mainly targeting the 3’UTR 
region of the target mRNA (Ha, 2014). In the genome miRNA are usually found in 
clusters that are groups of miRNAs that are transcribed from the same locus. 
Functionally, miRNAs can be grouped into families, which are formed of miRNAs 
that have the same seed region, a conserved sequence on the 5’ end of the miRNA, 
and therefore share the same targets (Greve, 2013). Several studies have shown 
the importance of microRNAs during early mouse embryo development where 
they play relevant roles regulating the expression of genes involved in cell 
proliferation, pluripotency and cell survival (reviewed in Greve, 2013). However, 
very little is known regarding the roles of microRNAs in the first steps of 
differentiation. 
 
Several general genetic approaches have been taken to target the biogenesis of 
miRNAs to study their function in early embryonic development. Maternal zygotic 
deletion of Dicer (Tang, 2007) or Ago2 (Lykke-Andersen, 2008) cause 
developmental arrest and embryos are not able to complete the first mitotic 
division caused by defects in spindle formation or are not able to develop further 
than the two-cell stage respectively. Conversely, maternal zygotic deletion of Dcgr8 
does not impair pre-implantation development (Suh, 2010). Dgcr8 is required for 
processing of miRNAs immediately after transcription in the nucleus whereas 
Dicer or Ago2 are able to process other kind of small RNAs called endogenous-
small interfering RNAs (endo-siRNAs) besides miRNAs. Endo-siRNAs are 
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expressed in the oocyte but their expression decreases during embryonic 
development and they are not expressed by late pre-implantation stages (Suh, 
2011). This difference in the types of small RNAs regulated is likely to explain the 
discrepancy of the Dicer, Ago2 and Dgcr8 phenotypes. Zygotic deletion of Dicer is 
embryonic lethal at around 7.5dpc (Bernstein, 2003). Further characterization of 
these embryos showed that miRNAs are required to maintain the trophoblast stem 
cell population of the trophectoderm but are not required to initiate gastrulation. 
Additionally, Dicer null embryos have severe defects in visceral endoderm 
specification and are developmentally delayed respect to control embryos (Spruce, 
2010). Other approaches to study the roles of miRNAs consist in deleting single 
miRNAs or miRNA clusters to analyse their role in a specific context.  Deletion of 
specific miRNAs such as miR-205 or miRNAs clusters (i.e. miR-17 cluster) causes 
post-natal lethality. However, due to their functional redundancy, other mutations, 
such as miR-133, do not have any apparent phenotype (Farmer, 2013; Ventura, 
2008, Liu, 2008).  
 
Several studies have analysed the expression profile of miRNAs in human and 
mouse ESCs and mouse EpiSCs. miR-290/295 cluster is differentially highly 
expressed in ESCs compared to EpiSCs (Jouneau, 2012). miRNAs that belong to this 
cluster are also expressed to a similar level in the ICM of the pre-implantation 
embryo (Tang, 2010). Conversely, the expression of miR-302/367 cluster is higher 
in EpiSCs compared to ESCs (Jouneau, 2012) and the expression of miRNAs that 
belong to this cluster increases at post-implantation stages in the embryo 
(Pernaute, 2014; Parchem, 2014). This data indicates that there is a clear and 
sequential difference in the expression pattern of miRNAs between the naïve and 
the primed pluripotent states in vivo and in vitro that transits from the miR-
290/295 to the miR-302 cluster.  However, during cellular reprogramming using 
the transcription factors Oct4, Sox2 and Klf4 (OSK) miRNA expression occurs in a 
stochastic manner. Interestingly, adding Sall4 to the gene cocktail used to induce 
pluripotency leads to the activation of the miR-302/367 cluster first followed by 
the miR-290/295 cluster. This enhances the reprogramming efficiency by 
sequentially reverting the expression of these clusters compared to what happens 
in a normal differentiation scenario  (Parchem, 2014).  In human ESCs these 
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clusters are miR-302 and miR-372, which are orthologous of the mouse miR-302 
and miR-290 clusters respectively (Subramanyam, 2011).  miRNAs from these 
clusters are involved in the maintaining the pluripotency, avoiding differentiation 
and regulating cell cycle in pluripotent stem cells (reviewed in Greve, 2013).  
 
The aim of this chapter is to gain further knowledge about the role of miRNAs 
during the onset of differentiation. We will study how depletion of miRNAs may 
impact the transition from naïve to primed pluripotency as well as and exit from 




3.2.1 Characterization of ESCs and EpiSCs after miRNAs depletion 
During embryonic development there is a transition from a naïve to a primed state 
of pluripotency. ESCs and EpiSCs are used as in vitro models to capture these 
pluripotency states respectively. Therefore, they represent a valuable in vitro 
model to study the onset of differentiation. The pluripotent stems cells used for 
experiments performed in this chapter were kindly donated by Tatiana Nesterova 
(Cobb, 2005). These cells carry loxP sequences flanking exons 20 and 21 of the 
Dicer locus. These exons code for the catalytic RNAse IIIa domain of Dicer. ESCs 
were generated from the ICM of 3.5dpc mouse embryos derived from the Dicer flox 
homozygous mice crossed with either homozygous or heterozygous animals for a 
4-hydroxy-tamoxifen (hereafter tamoxifen) inducible Cre-recombinase targeted to 
the Rosa26 locus. Dr. Barbara Pernaute derived the EpiSCsFx/Fx from ESCsFx/Fx by 
culturing the cells in N2B27 with FGF and Activin A for several passages.  
 
In order to induce Dicer deletion, cells were treated with tamoxifen for three days 
and then the drug was removed. Deletion of Dicer was confirmed either at a 
genomic level by PCR (Figure 3.1A) or at a transcriptional level by qPCR (as 
shown in figures 3.3, 3.4 and 3.7). Depletion of miRNAs was also confirmed after 
Dicer deletion to validate this system. By day 5 after tamoxifen administration 







Figure 3.1 Depletion of miRNAs levels in pluripotent stem cells after Dicer deletion.  
A) Dicer deletion strategy and confirmation of its deletion by PCR.  B) miRNA levels that are highly 
expressed in ESCs and EpiSCs were analysed five days after Dicer deletion. A significant reduction 
of 5 fold in ESCs and 10 fold in EpiSCs was achieved compared to the endogenous control sno-202. 
Data from three independent experiments. Paired TTEST * p<0.05; **p<0.01. Error bars: SEM.  Dr. 
Barbara Pernaute measured levels of miRNAs in EpiSCs. 
 
 
In order to understand how depletion of miRNAs could alter the identity of ESCs 
and EpiSCs, microarray analysis was performed in these cells after having induced 
miRNA depletion for 5 days. 1000 genes were significantly up-regulated (p<0.05) 
after miRNA depletion in ESCs by 1.2 fold or more whereas only 249 where found 
up-regulated in EpiSCs. 91 of these genes were up-regulated in both cell lines. 
Conversely, 1033 and 249 genes were down-regulated by 1.2 fold change in ESCs 
and EpiSCs respectively. In silico analysis showed that the four miRNAs families 
significantly expressed in the embryo (Pernaute, 2014), were also predicted to 
regulate the up-regulated genes in Dicer deleted ESCs and EpiSCs. Of these miRNAs, 








Figure 3.2 Predicted enriched miRNAs in ESCs and EpiSCs.  
1000 genes were found up-regulated in ESCs and 249 in EpiSCs after Dicer deletion.  These up-
regulated genes are predicted to be regulated by the miRNAs listed above. Interestingly, most of 
them correlate with the miRNA families that are more expressed during early embryonic 
development (Pernaute 2014).  Indicated in the same colour are the miRNAs belonging to the same 




It has been previously described that Dicer deleted ESCs display a slower 
proliferation rate compared to control cells due to a lengthening of G1 (Wang, 
2008). “G1/S transition of mitotic cells”, “negative regulators of cell cycle” or “cell 
cycle arrest” are some of the  gene ontology (GO) terms that appeared in the 
functional analysis of the microarrays using the bioinformatics analysis platform 
DAVID (Huang da, 2009) supporting the involvement of miRNAs in regulating the 
cell cycle of ESCs. Analysis of specific genes in the array data revealed that the 
expression of the inhibitor of the G1 to S transition Lats2 and Rb1 were found 
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significantly up-regulated by a 1.7 fold change. Lats2 has been shown to be 
regulated by miR-290, a miRNA belongs to the miR-302 family (Wang, 2008). 
 
Conversely, analysis of this microarray data did not show significant differences in 
the expression of genes involved in maintaining the core pluripotency network or 
in the expression of epiblast specific or differentiation markers. This observation 
was validated by analysing the expression of an array of pluripotency and 
differentiation by qPCR five days after Dicer deletion. Our data showed that there 
were no significant differences in the expression of the pluripotency markers Oct4, 
Klf4, Sox2 or Rex1 nor in the epiblast marker Fgf5 between Dicer deleted and 
control ESCs or EpiSCs (Figure 3.3 A and B). The expression of the mesoderm 
marker T (brachyury) was similar to controls in ESCs but not in EpiSCs, where it 
was found to be up-regulated. However, this increase was not statistically 
significant (p=0.39). The neural marker Sox1 did not change upon miRNA 
depletion. Therefore, these data indicates that transient deletion of Dicer and 
reduction in miRNAs levels do not significantly alter the pluripotency network of 






Figure 3.3 mRNA levels in Dicer deleted ESCs and EpiSCs.  
mRNAs were quantified by qPCR after three or five days of Dicer deletion in A) ESCs and B) EpiSCs 
respectively. Gene expression was normalized to the endogenous control β-Actin. No significant 
differences in pluripotent or differentiation marker mRNA levels were observed after miRNA 
depletion respect to control cells. Data from three independent experiments. Paired TTEST *p<0.05. 
Error bars: SEM. Dr. Barbara Pernaute performed the expression analysis in EpiSCs  (panel B). 
 
 
3.2.2 Analysis of the differentiation potential of Dicer deleted 
EpiSCs 
It has been reported that ESCs depleted for miRNAs fail to down-regulate the 
pluripotency marker Pou5f1 (also known as Oct4) and to initiate differentiation 
(Kanellopoulou, 2005).  However, to our knowledge, there are no studies analysing 
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the differentiation potential of EpiSCs after miRNA depletion. EBs are multicellular 
aggregates formed from single ESCs in suspension in the absence of factors that 
allow maintenance of pluripotency. This method has been widely used to study 
differentiation processes as EB formation recapitulates several aspects of 
embryogenesis in vitro (Kurosawa, 2007).  EpiSCs also form EBs and differentiate 
primarily into ectodermal lineages, although they can also form mesoderm and 
endoderm derivatives (Tesar, 2007).  The experimental approach taken here to 
generate EBs from EpiSCs was adapted from Tesar (2007).  EpiSCs were cultured 
with or without tamoxifen to delete Dicer for three days and then transferred to 
extra low adherent plates to favour cell aggregation and EBs formation in 
suspension (Figure 3.4A). The main observation from these studies was that EBs 
could only be analysed at day 2 of differentiation as after this there was increased 
cell death and hardly any cells were present in miRNAs depleted cultures (Figure 
3.4B). Analysis of a small array of pluripotency and differentiation markers 
performed at day 0 and 2 of EBs formation indicated that in control cells both 
Pou5f1 and Fgf5 are down-regulated upon differentiation. In contrast to this the 
ectoderm maker Sox1 was up-regulated upon EpiSCs differentiation consistent 
with previous published observations (Tesar, 2007). No significant difference was 
found in the expression of these markers when Dicer deleted cells were compared 
to control cells (Figure 3.4B). This indicated that reduction in the levels of miRNAs 
does not impair exit of the primed state of pluripotency but could affect cell 
proliferation or survival, as smaller and fewer number of EBs were observed in 







Figure 3.4 EpiSCs-/- derived embryoid bodies showed differentiation signs but cannot be 
propagated in culture.  
A) Strategy followed to generate EBs from EpiSCs. B) EBs of control and deleted EpiSCs after two 
days in suspension and differentiation conditions. C) mRNA expression of epiblast and 
differentiation markers at days 0 and 2 of EBs formation. Gene expression was normalised to the 







3.2.3 miRNAs are required to regulate cell survival in EpiSCs  
Even though Dicer deletion does not appear to have a dramatic effect in 
maintaining the cellular identity of ESCs and EpiSCs it induces cell death in the 
epiblast at around 6.5dpc in the embryo (Spruce, 2010). In order to study the role 
of miRNAs in regulating the apoptotic response in vitro, the expression of caspase 
3 (CASP3) was monitored at days 3, 5 and 7 after tamoxifen treatment. When this 
was done an increase in the expression of activation of CASP3 was observed in 
Dicer deleted EpiSCs but not in ESCs. By day 7 after tamoxifen treatment, most 
EpiSCs have undergone apoptosis and hardly any cells were left in culture (Figure 
3.5A). This apoptotic response was quantified by flow cytometry measuring 
Annexin V (AnnV) and propidium iodide (PI). AnnV binds phosphatidyl serine, a 
phospholipid that normally faces the cytoplasmic side of the cell membrane but 
that is exposed to the extracellular environment upon apoptosis. PI is a membrane 
impermeable DNA intercalating agent used to stain dead cells. Again, a significant 
increase in AnnV positive cells from day 5 of tamoxifen treatment was observed in 
EpiSCs but not in ESCs.  At day 5, there was a significant 4.8 fold increase in AnnV 
positive cells (6±1.2% in control cells and 21.8±3.7% in Dicer deleted cells; Figure 
3.5B). 
Another indication of mitochondrial apoptosis is loss of mitochondrial membrane 
potential caused by the formation of pores in the mitochondria upon activation of 
the pro-apoptotic proteins BAX and BAK. To monitor loss of membrane potential 
we used DiOC6, a lipophilic cationic fluorescent dye used to stain mitochondria 
when used at low concentrations. Loss of mitochondrial membrane can be 
measured as a loss DiOC6 fluorescent intensity. This experiment showed that at 
day 5 after miRNAs depletion there was a significant increase (2.2 fold change) in 
the proportion of depolarized mitochondria in Dicer deleted EpiSCs compared to 
control cells. This was not observed in miRNA depleted ESCs. Dicer deleted EpiSCs 
were then cultured in the presence of the pan-caspase inhibitor Z-VAD-FMK to 
confirm that these cells were dying by apoptosis. Interestingly, this was sufficient 
to rescue the percentage of apoptotic EpiSCs after Dicer deletion – from a 5±1-fold 
increase in AnnV positive cells in  Dicer deleted EpiSCs compared to control cells 
(from 7±3 to 28.6±9 % of apoptotic cells)to a  2.5±0.8% fold increase in those cells 
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treated with the inhibitor (8.8±2.3% of apoptotic cells) (Figure 3.5D). This 
indicates that indeed miRNA depletion caused apoptosis in EpiSCs and that an 





Figure 3.5 Apoptotic response after Dicer deletion in ESCs and EpiSCs. 
 A) Dicer deletion causes cell death in EpiSCs but not in ESCs. Three days after tamoxifen treatment 
higher levels of cleaved Caspase 3 were detected in EpiSCs. These levels increased over time in 
EpiSCs but no significant changes were observed in ESCs. After seven days, hardly any EpiSCs 
remained in culture. Representative images of three independent experiments. B) Increase in cell 
death was quantified using the apoptotic marker Annexin V by flow cytometry. Apoptosis is 
triggered in EpiSCs but not in ESCs. C) Analysis of loss of mitochondrial potential using DiOC6. A 
significant loss of mitochondrial potential was observed in Dicer deleted EpiSCs but not in ESCs. D) 
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The pan-caspase inhibitor Z-VAD-FMK rescues the apoptotic phenotype observed upon miRNAs 
depletion in EpiSCs. Paired TTEST analysis: *p<0.05, **p<0.01, ***<p0.001. Error bars: SEM. Data 
for at least three independent experiments.  These experiments were performed in collaboration 
with Dr. Barbara Pernaute. 
 
 
3.2.4 Dicer deleted ESCs are able to transit to the primed state of 
pluripotency 
It has been reported that ESCs depleted for miRNAs are unable to differentiate as 
they fail to down-regulate the pluripotency marker Pou5f1 (Kanellopoulou, 2005).  
In these experiments differentiation was induced using the EBs formation assay. 
Further studies identified that during exit of pluripotency Dicer deleted ESCs do 
not methylate the Pou5f1 promoter. Correlating with this an up-regulation of Rbl2, 
an inhibitor or the DNA methyltransferase Dnmt3, could be observed (Sinkkonen, 
2008). In contrast with this published data by Sinkkonen (2008), previous data 
generated in the lab by Christian Schoen showed that the mRNA levels of Dnmt3 
were significantly up-regulated upon transient miRNAs depletion. This indication 
suggested the possibility that Dicer depleted ESCs are be able to initiate 













Figure 3.6 Dicer deleted ESCs show an up-regulation of Dnmt3a and Rbl2.  
Relative gene expression, as measured by qPCR, of Dicer deleted (Tx+) to control cells of Rbl2 and 
Dnmt3a seven days after tamoxifen administration. Data from three different biological replicates. 
Paired TTEST * p<0.05. Error bars: SEM.   
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Taking into account this information we decided to study if miRNA depleted ESCs 
were able to exit the naïve state of pluripotency. To test this hypothesis control 
Dicer conditional ESCs were cultured with tamoxifen for three days (to delete Dicer 
in the conditional cells) and then cultured in N2B27 with FGF and Activin A to 
drive the differentiation towards a primed pluripotency state. When this was done 
it could be observed that in both cell types the expression of the transcription 
factor Pou5f1 (Oct4) was slightly down-regulated after three days of differentiation, 
reaching similar levels to those found in EpiSCs. Similarly, levels of Klf4 
dramatically dropped after one day of differentiation whereas Sox2 and Rex1 were 
down-regulated gradually over time in both control and in Dicer deleted cells. 
Analysis of differentiation markers revealed that both the epiblast marker Fgf5 and 
the mesodermal marker brachyury (T) are both up-regulated upon differentiation 
in control and Dicer deleted cells. Interestingly, the EpiSCs line used as a control 
did not show high levels of T expression, a finding in line with the reported 
variability of T expression between EpiSCs lines (Bernemann, 2011). Therefore, 
three days of differentiation might be indicative on an “epiblast-like” state that 
differs from this specific EpiSCs line.   
 
Next, expression of members of the Bcl2 family were analysed to establish if 
differences in the expression levels of these factors could explain the differences in 
cell death previously observed between ESCs and EpiSCs. Expression of the anti-
apoptotic Bcl2 was found to be up-regulated upon differentiation in control 
conditions, whereas levels of this gene were slightly reduced in deleted cells (none 
statistically significant). In contrast to this, levels of the pro-apoptotic Bcl2l11 
(Bim) remained stable upon differentiation in control cells but increased in deleted 
cells from day 2, being statistically significant at day 3 (p<0.01) (Figure 3.7). 
 
These data suggests that naïve pluripotent cells are able to exit the naïve state of 
pluripotency upon miRNA depletion and reach an epiblast like state after three 









Figure 3.7 Characterization of Dicer null ESCs upon epiblast directed differentiation.  
mRNA levels were analysed by qPCR and gene expression was normalized to the one of EpiSC 
(EpiSC=1) using the ΔΔCt method, except for Dicer (expression normalized to b-Actin to analyse the 
efficiency of the deletion).  Down-regulation of the pluripotency markers Oct4, Klf4, Sox2 and Rex1 
is observed in control and mutant cells. Epiblast marker Fgf5 and the mesoderm marker T are up-
regulated upon differentiation, whereas there is a reduction in the levels of Sox1, reaching similar 
expression to EpiSCs. Bim expression does not vary in control conditions and is significantly higher 
at day 3 in Dicer deleted cells compared to controls. Bcl2 increases to similar levels to EpiSCs.  Data 
from three independent experiments. Paired t-test *<0.05, **<0.01.Error bars: SEM.   
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3.2.5 miRNAs regulate cell survival in the primed state of 
pluripotency in vitro  
Previous work in the lab indicated that miRNAs are regulating apoptosis in the 
epiblast of the post-implantation embryo (Spruce, 2010). Another recent 
publication of the Rodriguez lab showed that three miRNA families (miR-20, miR-
92 and miR-302) regulate cell survival at this stage by controlling the expression of 
the pro-apoptotic protein BIM (Pernaute, 2014). Also, previous experiments in this 
chapter showed that EpiSCs die after miRNAs depletion due to increased levels of 
cleaved-caspase 3 (Figure 3.5). We therefore hypothesized that when cells reach 
an epiblast like state during the differentiation from a naïve pluripotent state they 
will become sensitive to cell death. In order to test this hypothesis cell death was 
monitored using propidium iodide (PI) and Annexin V (AnnV) during three days of 
differentiation. During ESCs differentiation there are increased levels of cell death 
(Duval, 2006).  This can be easily observed by bright-field microscopy (Figure 
3.8A). Interestingly, upon Dicer deletion the effects of ESCs differentiation were 
exacerbated as after 3 days hardly any cells remained in culture (Figure 3.8A). A 
significant 1.9 fold decrease (p=0.03) in the proportion of alive Dicer deleted cells 
(PI/AnnV negative) could be observed when compared to controls (Figure 3.8B), 
from 45.4±5% in control cells to 22.7±2% in Dicer deleted cells.  
 
Together these data suggest a primary requirement for miRNAs in regulating cell 
survival in the prime state of pluripotency. Although this requirement prevented a 
proper analysis of the roles of miRNAs in differentiation, the results obtained here 
suggest that they are not required for exit of the naïve or primed pluripotent states. 








Figure 3.8  miRNAs regulate cell survival at the onset of differentiation.  
A) Morphological differences observed at day three of differentiation of Dicer Fx/Fx and Dicer -/- ESCs. 
Note that cell death occurs normally during differentiation. B) Alive cells (AnnV and PI negative 
cells) time-course during ESCs differentiation. 1.9 fold change decrease observed at day three in 
miRNAs depleted cells compared to control cells. Data from three independent experiments. Paired 










3.2.6 Characterization of Dicer Fx/-; Sox2Cre mice 
Dicer null embryos die around 7.5dpc (Bernstein, 2003) due to a requirement for 
miRNAs in the epiblast for cell survival and in extra-embryonic tissues for the 
maintenance of multi-potent stem cell populations (Spruce, 2010; Pernaute 2014). 
Analysis of an epiblast specific deletion of Dicer using the Sox2-Cre deletor line 
identified that in spite of the death, a significant amount of epiblast cells in Dicer 
Fx/-; Sox2Cre embryos are able to undergo germ-layer specification and to survive 
until 9.5-10 dpc (Spruce, 2010).  Further characterization of these embryos by 
studying apoptosis using TUNEL and analysing the expression of the neural 
marker SOX2 in cryosections showed that most of apoptotic cell death in Dicer Fx/-; 
Sox2Cre embryos occurs in the neural tube and adjacent areas. In addition, Fgf8 – 
which is normally expressed in the anterior neural ridge, in the junction between 
the midbrain and hindbrain, in the limbs, the somites and the tail bud -  was also 
found to be severely down-regulated in the forebrain of Dicer Fx/-; Sox2Cre mutant 
embryos (Figure 3.9).  
 
As part of the Spruce et al, 2010 study, the authors also made the intriguing 
observation that the hearts of Dicer Fx/-; Sox2Cre embryos lacked apoptosis, 
suggesting at the early stages of development this structure may not be severely 
affected by the absence of miRNAs (Spruce, 2010). In contrast to this, previous 
studies had reported a loss of contractile proteins in the heart and thus a severe 
decrease in cardiac contractility when miRNAs are depleted at later developmental 
stages in MHCCre/+ ; Dicerflox/+ embryos (Chen, 2008). For these reasons here we 
undertook to carry out an analysis of the first stages of heart development in the 

























































Figure 3.9 Characterization of cell death in Dicer Fx/-; Sox2Cre embryos. 
 A) Haematoxylin/Eosin and TUNEL staining of control and mutant embryos. (B) TUNEL positive 
cells appear to be concentrated in the neural tube region and adjacent areas by comparative 
analysis of the expression of the neural marker SOX2. C) Expression of Fgf8 by whole mount in situ 
hybridization is severely down-regulated in the forebrain of mutant embryos (n=3). Scale bars: 
100µm (A,B) and 1mm (C).  
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As a first step to analyse the hearts of Dicer Fx/-; Sox2Cre embryos their ability to 
beat directly after being dissected was studied. Hearts of 9.5 dpc mutant embryos 
showed contractile movements suggesting a correct beating behaviour was 
occurring and indicating that at least initial patterning of myocardial cells had 
taken place. In order to further study the structure of the heart in these embryos 
the expression of Nkx2.5, a gene that codes a transcription factor involved in the 
commitment and differentiation of the myocardial lineage (Reecy, 1999) was 
analyzed. At early stages of heart development this marker is expressed 
throughout the heart tube and allows to visualise the looping of this organ that 
occurs in the mouse embryo between the 11 and 12 somite stages (Moorman, 
2003). These studies revealed that although the hearts of mutant embryos showed 
expression of Nkx2.5, no obvious looping of this organ could be observed (Figure 
3.10 A and B’). Furthermore, a histological analysis of Dicer Fx/-; Sox2Cre embryos 
stained with Nkx2.5 revealed that adjacent to the Nkx2.5 expressing chambers 
there was an overgrowth of an abnormal tissue that surrounded the heart. This 
tissue does not appear in the wild type embryos and seems to be extended 
ventrally from the foregut in those sections containing Nkx2.5 positive cells 
(Figure 3.10 C-D’).   
 
To study the origin of this abnormal tissue we analysed the expression of the 
proepicardial marker Tbx18 by whole mount in situ hybridization. The 
proepicardium gives rise to the epicardium, a single cell layer covering the 
myocardium of the heart and that has been suggested to contain a stem cell 
population that can contribute to regeneration of the heart (Smart, 2012). The 
epicardium will give rise to the smooth muscle and the endothelial cells of the 
coronary vessels (Kraus, 2001). As these cells will surround the myocardium we 
hypothesized they could be the origin of the abnormal tissue. However, we 
observed that Tbx18 was expressed normally in the proepicardium suggesting this 
tissue is correctly formed in mutant embryos and therefore is unlikely to be the 






Figure 3.10 Phenotypical analysis of heart structures in Heart in Dicer Fx/-; Sox2Cre embryos. 
Whole mount in situ hybridization for Nkx2.5 at 9.5dpc shows little difference between control and 
mutants. A) Lateral view of control and A’) Dicer Fx/-; Sox2Cre mutant embryos. B) Ventral view of 
control and B’) Dicer Fx/-; Sox2Cre mutant embryos. C) Cryosections of 9.5dpc control and C’) Dicer 
Fx/-; Sox2Cre embryos stained with Nkx2.5. D) Cryosections of 9.5dpc control and D’) Dicer Fx/-; 
Sox2Cre embryos stained with haematoxylin and eosin. In the cryosections of control embryos the 
different chambers of the mouse heart can be easily distinguished. In contrast to this, in mutant 
embryos these chambers could not be easily determined suggesting heart defects. In mutant 
embryos an abnormal tissue around the heart could be observed (black arrow). At: abnormal 
tissue; Da: dorsal aorta; Fg: foregut; La: left atria; Lv: left ventricle; Nkx2.5+: Nkx2.5 expressing cells 










Figure 3.11 Proepicardium is correctly expressed in Dicer Fx/-; Sox2Cre embryos.  
Whole mount in situ hybridization for Tbx18 showing similar expression pattern in A) control  and 
B) Dicer Fx/-; Sox2Cre embryos indicating that is not the origin of the abnormal tissue observed in 
figure 3.10. Scale bars: 1mm. 
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The visceral yolk sac is connected to the embryo directly ventral to endoderm and 
to the developing heart. It envelops the embryo from gastrulation stages onwards 
(Madabhushi, 2011). To investigate if the abnormal tissue could be yolk-sac 
derived, sections of 9.5dpc embryos were stained with Gata4, that marks the 
definitive and extra-embryonic endoderm. When this was done it was observed 
that the abnormal tissue surrounding the heart expressed Gata4, suggesting that 
indeed it was of an extra-embryonic endodermal origin. Co-staining GATA4 with 
TUNEL also confirmed that there was not increased cell death in the heart or 
surrounding abnormal tissue in Dicer Fx/-; Sox2Cre embryos compared to controls 
(Figure 3.12).  Interestingly, Sox2 is also expressed in the developing foregut (Que, 
2007).  When we analysed the expression of this marker (Figure 3.9) we observed 
that the organization of the foregut was impaired in mutant embryos. This data 
suggests that this abnormal tissue could be originated as a consequence of 
























Figure 3.12 Expression analysis of GATA4 and TUNEL in Dicer Fx/-;Sox2Cre embryos. 
Expression analysis of GATA4 showed that the abnormal tissue has an endodermal origin. Most of 
TUNEL positive cells were found in the neural tube and adjacent areas but not in the cardiac region. 
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3.3 Discussion  
MiRNAs have been shown to be critical regulators of development and 
differentiation in mammals and to control key cellular processes, such as the cell 
cycle and apoptotic machinery among other processes (reviewed by Hudder and 
Novak, 2008).  
 
Analysis of Dicer mutants has revealed important insight into the roles of mRNAs. 
Full knock-out Dicer embryos die by day 7.5dpc due to an increase of apoptosis 
and defects in the extra-embryonic tissues (Bernstein, 2003; Spruce, 2010). To 
understand the precise cell types that require miRNAs for their survival during the 
early steps of differentiation and to overcome the problem of the requirements of 
miRNAs in extra-embryonic tissues, in this thesis I have used an in vitro approach 
relying on pluripotent stem cell lines. Previously published work (Kanellopoulou, 
2005) and this thesis have shown that Dicer deleted ESCs are viable, can form ESC 
like colonies and express pluripotency markers. Functional analysis of the 
microarrays performed in Dicer deleted ESCs did not show any GO terms 
associated with stem cell maintenance or differentiation. Expression analysis by 
qPCR confirmed these results and supported the hypothesis that miRNAs are not 
required for the expression of pluripotency or differentiation markers.    Dicer 
deleted ESCs display a slower proliferation rate compared to control cells due to a 
lengthening of G1 (Wang, 2008). We also found up-regulation of genes involved in 
this process such as Lats2 or Rb1 grouped in GO terms such as “negative regulators 
of cell cycle” which supported the involvement of miRNAs in regulating the cell 
cycle of ESCs. Interestingly, analysis of the genes that were found to be up-
regulated after Dicer deletion showed that miRNAs from the 302, 20 and 19 
families are predicted to regulate gene expression in ESCs and EpiSCs. These and 
the miR-92 families account for more than 60% of the total miRNA relative 
expression during early embryonic development (Pernaute, 2014). A recent 
publication analysed the impact of miRNAs on gene expression heterogeneity in 
pluripotent cells by comparing ESCs grown in Serum+LIF, that allows 
heterogeneity, to ESCs grown in 2i+LIF, which promotes self-renewal and prevents 
differentiation.  Interestingly, Dicer null and Dgcr8 null ESCs gene profile is closer 
to the cells grown in 2i+LIF (Kumar, 2014).  These results and the fact that Dicer 
 89 
null embryos survive pre-implantation stages, clearly indicate that miRNAs are not 
required to maintain the naïve pluripotent state.  
 
In contrast to these findings, miRNAs play essential roles in the exit of the naïve 
pluripotent state. Stable lines of Dicer mutant ESCs are able to form EB-like 
structures, however, these do not show clear molecular or histological evidences of 
differentiation (Kanellopoulu, 2005) and this has been attributed to a failure to 
silence the pluripotency gene Oct4 (Sinkkonen, 2008). However, we found that 
transient deletion of Dicer in ESCs allows exit of the naïve state of pluripotency and 
the initiation of cellular differentiation.  Furthermore, our studies also pinpoint a 
key role for miRNAs to ensure cell survival as cells transit from the naïve to the 
primed pluripotent state. This is indicated by the high levels of cell death observed 
when ESCs were forced to initiate differentiation and acquire and “epiblast”-like 
state or when miRNAs are deleted from EpiSCs. These observations led to the 
question of how miRNAs regulate cell survival in the epiblast. Previously, a 
correlation between the deletion of miR-17-92 cluster in the mouse and increased 
levels of the pro-apoptotic protein BIM has been shown (Ventura, 2008) and BIM 
protein expression was also found to be elevated in DicerFx/-; Sox2Cre embryos 
(Spruce, 2010). These results suggest that the main target of miRNAs in the 
epiblast is the pro-apoptotic protein Bim. Here, at three days of differentiation 
from ESCs to EpiSCs, a significant increase in the levels of Bim expression was also 
observed. This suggests not only that Bim up-regulation may be the cause of the 
death we observe, but also that the miRNAs of the 17-92 clusters are strong 
candidates for regulating cell survival in the early embryo. This hypothesis was 
recently confirmed in a publication of the Rodriguez laboratory. It showed that 
three miRNA families, miR-20, miR-92 and miR-302, regulate Bim expression and 
consequently contribute to the regulation of the mitochondrial apoptotic 
machinery in primed pluripotent stem cells (Pernaute, 2014).  
 
In order to understand why there are differences in the differentiation potential of 
the Dicer deleted ESCs used in this study compared to those used in other 
publications it is necessary to take into account the substantial differences in the 
experimental procedures used between our previously published studies. In our 
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experiments, Dicer was deleted transiently and levels of miRNAs were depleted. 
Conversely, in Kanellopoulu (2005) and Sinkkonen (2008) Dicer is deletion is 
stable and therefore ESCs do not show levels of mature miRNAs. Consequently, the 
residual levels of miRNAs that remained in our cells after Dicer deletion, might 
account for the up-regulation of lineage specific markers upon differentiation. 
Alternatively, as all other studies were performed in lines that are maintained for 
multiple passages in the absence of miRNAs, it is possible that the epigenetic 
changes observed represent an adaptation to culture conditions rather than reflect 
a specific requirement for miRNAs during differentiation.   
 
To address the in vivo requirements of miRNAs in the epiblast, here I have 
employed an epiblast specific deletion of Dicer (DicerFx/-; Sox2Cre). The extra-
embryonic regions, which are essential for correct embryonic development, 
remain wild type in these embryos, and therefore unlike Dicer full knock-outs that 
die around 7.5dpc, these embryos develop until 9.5-10.5dpc. However, one 
similarity of the Dicer null and DicerFx/-; Sox2Cre is that they both display increased 
apoptosis in the epiblast, an event that is likely to contribute to the death of both 
type of mutants (Spruce, 2010).   
 
When analysing if any tissues were preferentially affected by Dicer deletion I 
observed that the apoptosis was most prevalent in neural tissues. This observation 
was confirmed by the finding that DicerFx/-;Sox2Cre embryos  show truncation of 
the forebrain and down-regulation of Fgf8 expression in the anterior brain. These 
results suggest that a likely explanation for the forebrain truncations is the 
increased death observed in neural tissues. In contrast to this, the heart appeared 
to be correctly specified in DicerFx/-;Sox2Cre embryos, correlating with the lack of 
apoptosis observed in this tissue. Additionally, the low expression of the miRNA 
families that control survival of the epiblast, miR-20, 92 and 302 miRNA (Pernaute, 
2014) in the heart, suggest that a miRNA-independent mechanism regulates cell 
survival in the heart during early embryonic development. It is worth noting that 
although the heart is specified correctly in DicerFx/-; Sox2Cre embryos, this tissue 
failed to loop correctly suggesting a role for miRNAs in heart morphogenesis. 
Furthermore, DicerFx/-;Sox2Cre embryos also develop an abnormal tissue, of likely 
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extra-embryonic endoderm origin, that surrounds the heart at 9.5dpc. Both 
abnormal heart looping and misplaced yolk-sac tissue are characteristics of 
embryos that have failed to turn correctly. This could be due to defects on 
morphogenetic gradients such as gradients of fibroblast growth factors (Spruce, 
2010, Serls, 2005). Further experiments including sectioning embryos with the 
yolk sac and staining for other endoderm markers such as Foxa2 or Sox17 are 
required to confirm if this is indeed the case and establish what roles miRNAs play 
in controlling embryonic turning. 
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4. Intrinsic apoptotic machinery in the naïve and primed 
estates of pluripotency 
 
4.1 Introduction 
Mitochondrial apoptosis is an essential pathway that is required for correct 
embryonic development. During normal embryogenesis the first apoptotic events 
are observed during the segregation of the primitive endoderm and the epiblast 
(Plusa, 2008; Xenopoulos, 2015).  Studies of cell death during early embryonic 
development have shown that the epiblast of the post-implantation embryo is 
highly sensitive to apoptotic stimuli. For example stimulation of DNA damage by 
low dose ionising radiation leads to a significant increase in TUNEL positive cells at 
5.5dpc, reaching a maximum at 6.5dpc, but does not cause an apoptotic response 
at pre-implantation stages (Heyer, 2000). Additionally, at post-implantation stages, 
defective cells are eliminated through a mechanism known as cell competition. In 
this process, less fit cells or looser cells, down-regulate levels of the protein c-Myc, 
an important regulator of cell proliferation, energy balance and metabolism, and 
subsequently die by apoptosis and are engulfed by neighbouring cells (Sancho, 
2013; Claveria, 2013).  There are many other apoptotic events that occur naturally 
during later stages of embryonic development such as in the formation of the 
outflow tract (Barbosky, 2006), cell elimination in the inter-digital areas during 
limbs development (Zakeri, 1994) or in the anterior neural ridge for the correct 
patterning of the forebrain (Nonomura, 2013).  
 
Caspases, cysteine-aspartic proteases, are essential enzymes to carry out the 
apoptotic response. Deletion of these proteins in vivo highlighted the importance of 
apoptosis for correct embryonic development and immune response. Deletion of 
caspase-8 is embryonic lethal (Varfolomeev, 1998). Embryos die because of a 
misregulation in the necroptotic pathway, inducing the formation of the 
necrosome, a complex formed by RIKP1 and RIKP3. Cell death is caused by an 
osmotic imbalance and membrane disruption (Fuchs, 2015). Deletion of Caspase-9, 
an initiator caspase required to form the apoptosome to activate CASP3 and CASP7, 
results in a lethal phenotype. Less than 3% of Casp9 mutant mice survived up to 3 
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weeks after birth (Kuida, 1998).  These mice have severe problems in brain 
development that has been associated with decreased apoptosis (Kuida, 1998; 
Hakem, 1998). Apaf1 knockout mice are also embryonic lethal. The protein APAF1 
is required for the formation of the apoptosome together with CytC and CASP9.  
Embryos lacking Apaf1 present abnormal brain development with different 
phenotypes: external protrusions originated from the forebrain in the frontal area 
and in the face as well as deformities of the thalamus and hypothalamus when 
compared to controls (Yoshida, 1998). This occurs by accumulation of non-
proliferative Fgf8 expressing cells that should have been eliminated (Nonomura, 
2013). Casp3/Casp7 double knockouts present a lethal phenotype just after birth 
with severe defects in cardiac development.  Single knockouts for each of these 
genes are viable, possibly due to the compensatory effects that CASP3 and CASP7 
have on each other (Lakhani, 2006).  
 
The results from the previous chapter showed that there is a differential 
requirement for miRNAs in ESCs and EpiSCs. Depletion of miRNAs led to apoptosis 
in EpiSCs but not in ESCs. Furthermore, the loss of mitochondrial membrane 
potential, activation of caspase 3 and increase in AnnV positive cells observed in 
EpiSCs suggested that the death of EpiSCs was due to the activation of the 
mitochondrial apoptotic pathway. The aim of this chapter is to understand why 




4.2.1 BIM up-regulation causes cell death in EpiSCs but not in ESCs 
Previous work in the lab has shown that miRNA depletion leads to the up-
regulation of the pro-apoptotic protein BIM in vivo (Spruce, 2010). For this reason 
Bim mRNA and protein levels were analysed in Dicer deleted EpiSCs. When this 
was done we observed an up-regulation of Bim expression upon miRNA depletion 
at both the mRNA (2.14±0.08 fold increase) and protein levels (Figure 4.1). To test 
the functional significance of this up-regulation, we next performed a knock-down 
of Bim expression using siRNAs. For this I first optimised Bim knock-down by 
testing four different siRNAs at 25, 50 and 100nM. Results from this experiment 
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showed that Bim siRNA#2 reduced Bim expression by a 60% compared to control-
siRNA transfected cells (Figure 4.2A). Further analysis using Bim siRNA #2 at 
25mM showed a significant 68±7% (p=0.01) reduction in the expression of Bim 
mRNA and protein levels (Figure 4.2B).  Therefore, this siRNA was chosen for 
further experiments.  
 
Figure 4.1 Bim controls the apoptotic 
response upon miRNA depletion in 
EpiSCs.  
A significant up-regulation of Bim 
expression occurs 5 days after Dicer 
deletion. This was measured by qPCR, 
where relative gene expression was 
normalized to the endogenous control β-
actin (left panel). Increased protein 
expression was analysed by western 
blot (right panel). PCNA was used as a 
loading control. Data from this figure 










Figure 4.2 Optimization of Bim 
knockdown.  
A) Expression analysis of Bim mRNA by 
qPCR where relative gene expression 
was normalized to the endogenous 
control β-Actin. Bim siRNA#2 induced 
the highest levels of silencing (60%) at 
the different concentrations tested 
compared to control siRNA transfected 
cells (n=1). B) Bim siRNA #2 showed 
consistent and significant silencing at 
the transcriptional (left panel) and at 
the protein level (right panel) (n=3). 
Loading control α-Tubulin. Paired t-
test: **p<0.01. Error bars: SEM.  
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We then inhibited Bim expression in Dicer deleted EpiSCs. We observed that Bim 
down-regulation rescues the cell death phenotype in miRNA depleted cells (Figure 
4.3). This data indicated that miRNAs regulate cell survival at least in part by 










Figure 4.3 Down-regulation of Bim recues cell death in Dicer deleted EpiSCs.  
Bim-siRNA partially rescues apoptotic cell death caused by BIM up-regulation in EpiSCs measured 
by AnnV. Data from five independent experiments. Paired TTEST *p<0.05 Error bars: SEM. Data 




In the previous chapter we showed that miRNAs depletion leads to cell death in 
EpiSCs but not in ESCs. We therefore next analysed if the differences in cell 
survival phenotypes observed between these two cell types were due to miRNAs 
regulating Bim in EpiSCs but not in ESCs. When we studied Bim expression in ESCs 
we unexpectedly found that these cells also showed an up-regulation at the 
transcriptional and the protein levels (Figure 4.4). This indicated that in ESCs a 
moderate increase in Bim expression does not induce apoptosis, and suggests that 




Figure 4.4 Bim is up-regulated in ESCs upon miRNA depletion.  
Bim expression was found up-regulated 5 days after Dicer deletion was analysed by qPCR (left 








4.2.2 Mitochondria of EpiSCs are more sensitive to direct BH3 
peptide activation  
During mitochondrial apoptosis, BAX and BAK get activated and form a pore in the 
mitochondrial membrane, a process known as mitochondrial outer membrane 
permeabilization (MOMP). Upon MOMP, proteins from the mitochondrial matrix 
are released to the cytosol and promote the inhibition of anti-apoptotic factors 
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(SMAC/Diablo) or the activation of caspases through the formation of the 
apoptosome (Tait, 2013).   
 
We observed that when miRNAs are depleted, Bim is up-regulated in both ESCs 
and EpiSCs. However, this only causes apoptotic cell death in EpiSCs.  In order to 
understand if this differential sensitivity to an apoptotic stimulus is independent of 
miRNA depletion, I performed a BH3 profile in both cell types. This assay is used to 
functionally test the sensitivity of mitochondria to a direct pro-apoptotic stimulus 
induced by incubation with BH3-only peptides. This technique was firstly 
described in Anthony Letai’s Laboratory and measures loss of mitochondrial 
membrane potential over time by using the mitochondrial marker JC-1. JC-1 
accumulates in the mitochondria in a membrane potential dependent manner. 
Changes in JC-1 accumulation can be measured by a shift in the fluorescence 
emission from green (525nm – low mitochondrial potential) to red (590nm – 
normal/high mitochondrial potential) (Ryan, 2013). 
 
In our assays, specific peptides containing the BH3 domain of pro-apoptotic BH3-
only proteins were used to target mitochondria of cells that have been previously 
slightly permeabilized with digitonin, to allow peptide access.  The BH3 only 
proteins tested here where BID, BIM and BMF. BID and BIM are direct activators of 
BAX and BAK and therefore these peptides should induce high membrane 
depolarization (Czabotar, 2014). BMF is normally considered as a sensitizer, a 
member of the BCL2 protein family that interacts with anti-apoptotic proteins 
causing the release of direct activators. However, it has been reported that can 
BMF act as a direct activator too (Du, 2011). An inert peptide generated by a 
random iteration of amino acids into the PUMA peptide was included as a control 
of no membrane depolarization during the assay. Mitochondrial potential was 
monitored every 5 minutes for a total period of 70 minutes by measuring JC-1 
fluorescence at 590nm. Percentage of depolarization was calculated by 
normalizing the data to the membrane potential of cells that have not been 
exposed to peptides but have been treated with DMSO (vehicle) or CCCP, a 
protonophore that causes complete mitochondrial depolarization (Ryan, 2013).  
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Peptides were tested at 1uM and 10uM.  At 1 uM there was a trend indicating that 
mitochondrial membrane depolarization occurred at higher rates in EpiSCs than 
ESCs using BID and BIM peptides. At this concentration BID peptide induced a 
significant difference in the percentage of membrane depolarization of EpiSCs 
(63±1.8 %) compared to the 35±1.4% observed in ESCs at the end of the assay. 
These measurements were not statistically significant when comparing the 
depolarization between both cell lines using the BIM peptide or BMF (Figure 
4.5A).  When the concentration of peptide used was increased to 10uM, the same 
trend was observed. The three peptides used induced MOMP in ESCs and EpiSCs. 
Mitochondrial membrane depolarization occurred faster and at higher rates in 
EpiSCs compared to ESCs with each of the three peptides (Figure 4.5B).  For 
example, 20 minutes after treatment with the BID peptide 52±2% of mitochondrial 
membrane depolarization could be observed in ESCs.  In contrast, at this time 
point the level of depolarization of EpiSCs reached 74±5% (p=0.02).  For the BIM 
peptide 52±1.3% of depolarization was reached after 30 minutes in ESCs while 
mitochondria of EpiSCs reached 82±3.3% of depolarization (p=0.02). For BMF, 
50±0.1% of depolarization was reached 60 minutes after the initiation of the 
experiment in ESCs. In EpiSCs, the percentage was 60±2% at the same time point 
(p=0.039). Two way ANOVA analysis showed statistical significance for BID 1uM 
(p=0.0352), BID 10uM (p=0.0017) and BIM 10uM (p=0.0038). Appendix 1 includes 
a detailed specification of statistical significance for each time-point, peptide and 
cell line. Therefore, this data indicated that mitochondria of EpiSCs are more 
sensitive to depolarization caused by direct exposure to BH3-domain peptides 











Figure 4.5 BH3 profiling in ESCs and EpiSCs.  
ESCs and EpiSCs were subjected incubation with BH3-only peptides. Mitochondrial membrane 
potential was measured every 5 minutes using JC-1. Percentage of depolarization was calculated at 
A) 1uM and B) 10uM of peptides concentration.  Data shows higher and faster depolarization in 
EpiSCs compared to ESCs. Paired T-test was used to calculate statistical significance for each time 
point and for the comparison ESCs/EpiSCs and for BH3-petide/Control-peptide for each cell line. 
Data from three biological replicates, including three technical replicates per condition. Error bars: 
SEM. Statistical analysis of these experiments can be found in the Appendix 1.   
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4.2.3 Characterization of expression of BCL2 protein family in 
ESCs and EpiSCs  
In order to understand if the differential sensitivity to cell death is caused by a 
differential expression of pro- and anti-apoptotic proteins, an expression profile of 
the BCL2 protein family members was performed in ESCs and EpiSCs. As 
previously discussed, these proteins have an anchoring membrane domain in their 
C-terminal region that allows their localization to intracellular organelles such us 
the endoplasmic reticulum or the mitochondria (Czabotar, 2014). Because of this 
reason, both whole cell lysate and mitochondrial fractions were analysed in order 
to understand the subcellular localization of these proteins under normal 
conditions.  
 
When the levels of anti-apoptotic proteins were compared between ESCs and 
EpiSCs the most striking observation was that EpiSCs have higher expression of 
anti-apoptotic factors than ESCs, even though they are more susceptible to 
apoptotic stimuli. Analysis of both whole cell lysate and mitochondrial extracts 
revealed that EpiSCs express higher levels of BCL2 and BCL-xL and similar levels of 
MCL1 when compared to ESCs. In contrast to this A1 could only be detected in the 
whole cell lysate, where they were expressed at similar levels (Figure 4.6A). The 
pro-apoptotic BIM, BAD and BAX could be found localized to the mitochondria 
whereas BID and PUMA could only be detected in whole cell lysates.  All these 
proteins were similarly expressed between ESCs and EpiSCs (Figure 4.6A, B).  α-
TUBULIN and β-ACTIN were used as cytoplasmic protein loading controls and as 
expected they were absent from our mitochondrial extracts, for which ATPb, beta 
subunit of the ATP synthase (Complex V or the ETC) was used as a loading control.  
These data suggest that the differential apoptotic sensitivity observed between 
ESCs and EpiSCs is not due to a differential expression of the pro- and anti-
apoptotic proteins analysed. Therefore, other factors such as differential 
sensitivity of the mitochondria to permeabilization by pro-apoptotic factors or 
differential levels of activation of BAX/BAK upon apoptotic stimuli could help 











Figure 4.6 Expression profile of BCL2 protein family members in ESCs and EpiSCs.  
A) This profile showed higher expression of anti-apoptotic factors in EpiSCs compared to ESCs. No 
differences observed in the levels of pro-apoptotic proteins in both cell lines. B) Expression of BAX 
in ESCs and EpiSCs shows mitochondrial localization and no differential expression levels between 
both cell lines. Representative images for at least three independent experiments. Data generated in 
collaboration with Dr. Barbara Pernaute. WCL: whole cell lysate. Mito: mitochondrial fraction. 
Loading control: ATPb.  
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4.2.4 Inhibition of BCL2 and BCL-xL sensitises EpiSCs to cell death 
In order to test if indeed ESCs and EpiSCs have different apoptotic requirements 
we analysed the effects of inhibiting anti-apoptotic factors. For this we used ABT-
737 that specifically targets BCL2, BCL-xL and BCL-w (Oltersdorf, 2005) and 
impairs the interaction of these anti-apoptotic proteins with their pro-apoptotic 
targets. For example, it has been shown that it binds to BCL2 and consequently 
inhibits the BCL2-BAX interaction triggering apoptosis in (Rooswinkel, 2012), and 
it also has been demonstrated to prevent the BIM-BCL2 interaction in leukemic 
cells (Del Gaizo Moore, 2007).  
 
A titration of ABT-737 was performed over a 24-hour period in both ESCs and 
EpiSCs using concentrations ranging from 5 to 40uM and apoptosis was measured 
by flow cytometry using AnnV.  When this was done we observed that EpiSCs were 
highly susceptible to ABT-737. These cells showed a significant 1.8±0.1 fold 
increase in the proportion of apoptotic cells at 5uM, (from 5.3 ±0.8 % of AnnV 
positive in control conditions compared to 9.5±0.8 % in the presence of the 
inhibitor).  This fold change increased to 2.3±0.26 at the 10uM concentration (from 
5.3±0.8 % to 11.5±2.4 %) and 3.5±0.36  (from 5.3±0.8 to 18 ±2.2% of apoptotic 
cells) at 20 and 40 uM concentrations. In contrast to this observation, we observed 
no apoptotic response in ABT-737 treated ESCs when compared to control cells. 
The percentage of apoptotic cells oscillated between 7±1% in control cells and 
7.8±0.3% at 20uM. Therefore there were no significant changes in the fold increase 
of apoptotic cells (Figure 4.7A).  To address the in vivo significance of this data we 
compared the effects of ABT-737 on 3.5dpc pre-implantation embryos, where 
naïve pluripotent cells can be found, and on 6.5dpc post-implantation embryos, 
that contain primed pluripotent cells. For this we, cultured 3.5dpc and 6.5dpc wild 
type CD1 embryos for 1.5h using 2uM of ABT-737 and monitored apoptosis 
analysing the expression of cleaved CASP3 by immunofluorescence. Similar to 
what occurrs in ESCs and EpiSCs, ABT-737 treatment did not induce apoptosis in 
the pre-implantation embryos whereas a clear increase in CASP3 activation could 
be observed in post-implantation embryos (Figure 4.7B).   These results 
demonstrate that EpiSCs are more susceptible than ESCs to apoptotic stimuli 





















































Figure 4.7 EpiSCs are sensitive to BCL2, BCL-xL and BCL-w inhibition.  
ESCs and EpiSCs where cultured in the presence of ABT-737 for 24 hours at the indicated 
concentrations. Significant increase in apoptotic cell death was observed in EpiSCs but not in ESCs. 
Data from three independent experiments. Paired TTEST: *p<0.05, **p<0.01. Error bars: SEM. B) 
ABT treatment in pre and post implantation embryos. Increased expression of cleaved CASP3 is 
observed in 6.5dpc embryos but not in 3.5 dpc ones. n=7 per stage and condition. Data in panel B 
was generated by Dr. Barbara Pernaute. 
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4.2.5 Inhibition of MCL1 sensitises ESCs to cell death 
The anti-apoptotic protein MCL1 (Myeloid Cell Leukaemia 1) has been shown to be 
up-regulated in several haematological human cancers and knockdown of Mcl1 
reduces cell viability in a number of solid tumours (Modugno, 2015).  Furthermore, 
some tumours with high levels of MCL1 expression are resistant to ABT-737 and 
become sensitive to this drug upon Mcl1 depletion (Chen, 2007).  This suggests 
that in some instances MCL1 can compensate for BCL2/xL. In Figure 4.6 we 
observed that MCL1 is expressed with similar levels in ESCs and EpiSCs and that 
this protein is localized to the mitochondria. In the early embryo, Mcl1deletion 
leads to pre-implantation lethality (Rinkenberger, 2000), which indicates that Mcl1 
has an important role at the early stages of embryonic development. Furthermore, 
functional analysis of different MCL1 isoforms in MEFs revealed the importance of 
this protein to maintain mitochondrial integrity and energy balance (Perciavalle, 
2012).  
 
To further test the anti-apoptotic requirements of ESCs we used the small molecule 
inhibitor AT-101 that targets BCL2, BCL-xL and MCL1. This drug has been used as 
a potential therapy to induce apoptosis in several cancer cells in vitro (Ren, 2015) 
and is in phase 1 clinical trials to treat solid tumours (Schelman, 2014).  AT-101 
causes degradation of MCL1 leading to apoptosis in both Chronic lymphocytic 
leukaemia B cells (Balakrishnan, 2009) and in VCaP prostate cancer cells (Loberg, 
2007). Liu and colleagues also showed that this drug causes the inactivation of 
AKT signalling driven by up-regulated PTEN, and as a consequence of this MCL1 is 
down-regulated (Li, 2014). Titration of this drug was performed in ESCs for a 24h 
period. To establish the form of cell death induced by AT101 we measured cleaved 
caspase 3 and cleaved PARP, which are pan-apoptotic markers, as well as loss of 
mitochondrial membrane potential. These markers are read-outs of activation of 
the mitochondrial apoptotic machinery. We observed that mitochondrial 
membrane potential was significantly lost after 24h treatment with AT101 and 
that this loss was more accentuated the higher the concentration of the drug 
(Figure 4.8A), with a complete loss of mitochondrial potential being observed at 
5-10 uM AT101 (Figure 4.8A). There was a significant 2.44± 0.4 fold increase in 
Annexin V positive cells (from 14.2±4.2 to 33.8±6%; p=0.003) after 24h treatment 
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with 10uM AT101 (Figure 4.8B). Western blot analysis revealed that AT101 
induced a concentration dependent increase in the expression of the apoptotic 
markers cleaved CASP3 and cleaved PARP (Figure 4.8C). Interestingly we 
observed that unlike what has been reported to occur in some cancer cells 
(Balakrishnan, 2009, Loberg, 2007) MCL1 was not degraded upon AT101 
treatment in ESCs (Figure 4.8C).  This suggests that the mechanism of action of 
this drug is not clear and that further experiments are required to detect if AT101 
is directly disrupting the MCL1-BIM interaction in these cells or is working 




Figure 4.8 Effect of AT-101 in ESCs.  
A) AT-101 causes a loss of mitochondrial potential in ESCs measured with TMRM by flow 
cytometry. Left panel indicates median fluorescence intensity of three independent experiments. 
Note the logarithmic scale.  Right panel is a diagrammatic representation of the loss of 
mitochondrial potential. B) A significant 2.4 fold increase from 14.2 to 33.8% of apoptotic cells was 
measured using Annexin V.  C) AT-101 induces apoptotic cell death in ESCs measured by cleaved 
PARP and CASP3.Loading control α-Tubulin. Data from three independent experiments.  Paired 
TTEST **p<0.01.Error bars: SEM.  
 106 
4.2.6 Mcl1 regulates cell survival in ESCs 
Given that I could not conclusively prove that AT-101 was targeting Mcl1 I used 
other methods to inhibit this protein in ESCs. For this I tested four different siRNAs 
at two different concentrations, 12.5 and 25nM. In this single experiment the 
siRNAs that most efficiently reduced Mcl1 expression was #3 (Figure 4.9A). This 
siRNA was further tested at 12.5, 25 and 50nM in order to optimize the assay. 
Results of these experiments showed that 12.5nM achieved a 45% reduction in the 
expression levels of Mcl1 whereas at 25nM and 50nM the percentage of 
knockdown was 60% (Figure 4.9B). Reduction of MCL1 at the protein level was 
also confirmed by western blot (Figure 4.9B). Therefore, 25nM of Mcl1-siRNA #3 









Figure 4.9 Optimization of Mcl1 knockdown in ESCs. 
A) Expression analysis of Mcl1 mRNA by qPCR relative to the endogenous control β-Actin. siRNA #3 
induced the highest levels of silencing out of the four siRNAs and two concentrations tested. B) 
Optimization of the concentration using Mcl1-siRNA#3. 25nM and 50nM achieved a 60% reduction 
in Mcl1 expression quantified by qPCR (left panel).  Down-regulation of Mcl1 was also observed at 
the protein level (right panel). α-Tubulin was used as a loading control for the western blot. 
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Viable cell numbers were quantified over time using a Vi-Cell cell counter that 
incorporates trypan blue to exclude non-viable cells. When the proportion of 
viable cells was analysed 24 hours post-transfection, a significant decrease in Mcl1 
knock-down cells was observed when compared to control ESCs (from 
558,930±76,000 to 288,084±60,000 cells. p=0.04, Figure 4.10A). This indicated 
that Mcl1is required for naïve pluripotent cell survival. Next we analysed if 
inhibition of BCL2/xL/w using ABT-737 enhances this phenotype. For this, cells 
were transfected with Mcl1siRNAs and after 16 hours they were cultured in the 
presence of ABT-737 or a vehicle (DMSO) for a further 8 or 24 hours.  This 
difference was decreased by a 3.32-fold by the presence of ABT-737 
(610,744±49,755 to 183,843±32,074 cells; p=0.002). However, the difference 
between Mcl1siRNA treated and Mcl1 siRNA plus ABT-737 treated was not 
statistically significant at this time-point (p=0.06). By 40 hours post transfection 
the decrease in viable cells induced by Mcl1 inhibition was 2.28 fold (from 
1,323,162±95,095 to 579,209±98,125 cells). At this time-point, the number of 
viable cells when treated with Mcl1-siRNA and ABT-737 was reduced by a 2.7 fold 
(from 1,182,528±20,015 to 439,203±95,856 cells). This difference was statistically 
significant (p=0.027). Crystal violet staining was used to monitor qualitatively cell 
viability. Similar to what was observed above, a clearly lower level of staining was 
observed in Mcl1-siRNA transfected cells compared to control-siRNA treated cells 
at 24 and 40 hours post transfection, and this difference was enhanced by ABT-
737 at 40 hours post transfection (Figure 4.10B). This data suggests that Mcl1 is 
required for the survival of ESCs and that it at least partially cooperates with 








Figure 4.10 Effect of Mcl1 deletion in ESCs. 
A) Time course of viable cell numbers of Mcl1-siRNA compared to control-siRNA transfected cells. 
The effect of ABT-737 was also assessed for 24hours starting 16 hours post-transfection. Data from 
three independent experiments. Error bars: SEM. Paired TTEST *p<0.05 **p<0.01.   B) Cell viability 
was also evaluated using the crystal violet staining. A clear reduction in this stain can be observed 
in Mcl1 knock-down cells at 24 and 40h post-transfection. ABT-737 induces a further decrease in 
viability at 40h post-transfection. Representative image of three independent experiments.  
 
 
4.2.7 BIM deletion rescues apoptosis in the absence of MCL1 
Our data indicates that BIM is a key regulator of the mitochondrial pathway at the 
onset of embryonic differentiation (Figures 4.1 and 4.3; Spruce, 2010). MCL1 
binds to BIM to avoid activation of BAX/BAK preventing apoptosis (Gomez-Bougie, 
2004; Sharma, 2013). Taking this into account, the next approach we took was to 
test if BIM depletion could rescue the cell death phenotype observed when levels 
of MCL1 are reduced. 
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In order to address this question, ESCs were transfected with different siRNAs: 
control (50nM), Bim (25nM), Mcl1 (25nM) and a combination of Bim-Mcl1 siRNAs 
(25nM each)*. Cell viability was quantified 24 hours post-transfection.  As found 
above, Mcl1 knock-down caused a significant 1.8 fold-decrease in cell numbers 24 
hours post-transfection (from 367,130±44,933 to 196,427±39,601 viable cells; p= 
0.029) whereas the Bim-siRNA did not cause any effect compared to the 
transfected control. However, when both Mcl1 and Bim siRNAs were co-
transfected, a significant rescue in cell number was observed (1.5 fold increase 
compared to Mcl1-siRNA transfected cells, reaching 306,065±46,506 viable cells; 
p=0.04) (Figure 4.11). This indicates that in ESCs an essential role of Mcl1 is to 





























Figure 4.11 Bim Knock-down rescues cell numbers in Mcl1 depleted ESCs.  
Inhibition of Mcl1 using siRNAs causes a significant reduction of viable cells 24 hours post-
transfection. Cell numbers are rescued when cells are also co-transfected with a Bim siRNA. Data 
from three independent experiments. Paired TTEST: *p<0.05. Error bars: SEM. 
* Co-transfection experiments should have been performed by transfecting each single target siRNA 
with the control siRNA. e.g. 25nM of siRNA control + 25nM of Mcl1 or Bim siRNA respectively, in 




We next set out to determine the mode of cell death regulated by Mcl1 and Bim. 
For this we analysed activation of CASP3/7, Annexin V staining and cleavage of 
PARP as apoptotic markers. Analysis of the proportion of cells showing CASP3/7 
activation by flow cytometry revealed a significant 2±0.09 fold increase (from 
24.5±1.55 to 49.4±3.04%, p=0.0013) in Mcl1 knock-down cells. Furthermore, this 
increase could be rescued Bim knock down, as we only observed a 1.41±0.05 fold 
increase in CASP3/7 activation when cells were transfected with both the Bim and 
Mcl1 siRNAs (from 24.5±1.55 to 34.7±2.4%, p=0.023)(Figure 4.12A).  Annexin V 
also showed a significant 2.2±0.16 fold increase (from 14.3±1to 31±0.8 % of AnnV 
positive cells; p=0.006) in Mcl1 knock-down cells and only a 1.4±0.8  fold increase 
(from 14.3±1to 19.66±0.9%, p=0.002) in double transfected cells (Figure 4.12B). 
Western blot analysis of cleaved PARP and CASP3 showed a similar pattern, with 
Mcl1 knock-down increasing PARP/CASP3 cleavage and inhibition of Bim and Mcl1 
reducing the levels of these proteins with respect to the Mcl1 inhibited cells 
(Figure 4.12C).  Analysis of levels of MCL1 and BIM 24 hours after siRNA 
transfection confirmed that these in these experiments a good level of knock-down 
of these proteins was being obtained (Figure 4.12C).  Together, these data 
suggests that MCL1 interacts with BIM in the mitochondria of ESCs to regulate cell 
survival. In the absence of MCL1, BIM is released and therefore able to activate 









Figure 4.12 Bim Knock-down rescues apoptotic cell death caused by inhibition of Mcl1 in 
ESCs.   
Apoptosis was monitored 24 hours post-transfection with different siRNAs. A significant increase of 
cell death was observed in Mcl1 knock-down cells.  Cell death was partially rescued when Bim-
siRNA was co-transfected with Mcl1-siRNA. A) Activity of CASPASE3/7 measured by flow 
cytometry in ESCs. B) Apoptotic cell death measured by AnnV by flow cytometry in ESCs C) 
Western blot to illustrate levels of BIM and MCL1 knock-down and apoptosis (cleaved-PARP, 
cleaved-CASP3) in ESCs. Data from three independent experiments. Image for a representative 




We next wanted to establish if the difference in apoptotic response between ESCs 
and EpiSCs is due to the former relying primarily on Mcl1 for their survival and the 
latter on Bcl2/xL/w.  For this reason we tested the effects of Mcl1 siRNA inhibition 
in EpiSCs. We observed that 24 hours after transfection with the Mcl1-siRNA, a 
2.35±0.26 fold change increase in AnnV positive cells (from 11.46±1.8% in control 
conditions to 27.8±7.7% after Mcl1 knock-down). Furthermore, co-transfection 
with Bim-siRNA was sufficient to rescue this apoptotic cell death – 14.3±2.5% of 
AnnV positive cells (Figure 4.13).  This data indicates that in EpiSCs not only BCL2 
and BCL-xL are required to inhibit Bim, but that also Mcl1 is required to perform 
this role. This suggests there are different apoptotic requirements in naïve and 









Figure 4.13 Bim knock-down rescues apoptotic cell death caused by inhibition of Mcl1 in 
EpiSCs.  
Down-regulation of Bim is sufficient to rescue the apoptotic response caused by Mcl1 inhibition.  
Apoptotic cell death measured by AnnV in EpiSCs. Data from three independent experiments. 
Paired TTEST *p<0.05, **p<0.01. Error bars: SEM.  Data for this figure was obtained in 
collaboration with Dr. Barbara Pernaute. 
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4.2.8 Bim knockout partially rescues cell death in vivo in a Dicer 
null background 
Mice lacking the pro-apoptotic protein BIM are viable, but have several defects that 
affect their immune system and consequently develop a severe autoimmune 
response with age - around 50% of full knockouts and 35% of heterozygous die 
one year after birth (Bouillet, 1999). Our data suggests that BIM plays an 
important role in regulating apoptosis in ESCs, EpiSCs and in the epiblast of the 
post-implantation embryo.  Our lab had previously shown that Dicer deletion 
specifically in the epiblast leads to increase apoptosis during the early stages of 
organogenesis (8.5-9.5dpc and (Spruce, 2010). In order to understand if deletion 
of Bim could rescue this cell death we generated embryos in which we delete Dicer 
in the epiblast using the Sox2-Cre deletor and that are also null for Bim (DicerFx/-; 
Sox2-Cre+/-; Bim-/-).  These embryos were generated by crossing DicerFx/Fx Bim+/- to 
Dicer+/-Sox2Cre Bim+/- and were analysed by TUNEL staining to assess the levels of 
cell death.  
 
During normal embryonic development there are high levels of apoptotic cells all 
along the brain midline, from the forebrain to the midbrain and the nasal placode 
at 9.5dpc. Some areas with high density of TUNEL positive cells are observed in the 
dorso-lateral posterior region of the embryo, behind the first and second brachial 
arches, as can be observed in DicerFx/- Bim +/+ embryos  (Figure 4.14A-B). DicerFx/-
;Sox2Cre embryos (wild type for Bim) have a dramatic increase in apoptotic cells, 
mostly in the forebrain, neural tube and in the tail bud (Figure 4.14C-E).  
Interestingly, when both Bim alleles are deleted in conjunction with an epiblast 
deletion of Dicer a partial rescue of the phenotype was observed. Analysis of 
DicerFx/- Bim -/- embryos revealed a decrease in TUNEL positive cells in the tail bud, 
in the neural tube and in the forebrain compared to DicerFx/-;Sox2Cre embryos 
(Figure 4.14F-H).  This result suggests that an up-regulation in BIM expression 
accounts for part of the cell death caused by Dicer deletion, but it is also likely that 
additional miRNA targets are controlling cell survival during early organogenesis. 
In the previous chapter we observed that the expression of Fgf8 was severely 
down-regulated in the forebrain of DicerFx/-;Sox2Cre embryos compared to controls. 
Apoptosis plays a key role in shaping ANR by regulating the Fgf8 morphogenetic 
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gradient (Nonomura, 2013).  Given the partial rescue of cell death observed in the 
forebrain of DicerFx/-; Sox2-Cre+/-; Bim -/- embryos, we next analysed how this 
affects Fgf8 expression. In DicerFx/-;Sox2Cre  embryos the expression of this marker 
is severely down-regulated in the forebrain compared to controls, but the 
expression in the tail bud appears to be normal (Figure 4.15A and B). When 
DicerFx/-; Sox2-Cre+/-; Bim -/- embryos were analysed we observed an increase in 
Fgf8 expression in the forebrain when compared to DicerFx/-; Sox2-Cre embryos, 
indicating a partial rescue of the forebrain truncations caused by Dicer deletion 
(Figure 4.15C) (Figure 4.14G). These results suggests that miRNA regulation of 
Bim plays an key role not only in regulating cell survival in the forebrain, but also 









Figure 4.14 Bim deletion partially rescues the apoptosis observed in a DicerFx/-:Sox2Cre 
embryos.  
Whole mount TUNEL staining in 9.5dpc  A-B) control embryos, C-E) DicerFx/-; Sox2Cre embryos and 
F-H) DicerFx/-; Sox2Cre Bim-/- embryos.  Arrows indicate areas with differential levels of TUNEL 
between Bim wild type of deficient embryos in a Dicer null background. n≥3 for each genotype. 





Figure 4.15 Bim deletion partially rescues the expression of Fgf8 in the forebrain in a 
DicerFx/-; Sox2Cre embryos. 
 Analysis of the expression of Fgf8 of 9.5 dpc by whole mount in situ hybridization in A) Control, B) 
DicerFx/-; Sox2Cre  and C) DicerFx/-; Sox2Cre Bim-/- embryos. Fgf8 expression is restored in double 
mutant embryos. n≥3 for each genotype. Scale bar: 1mm.  
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4.3 Discussion  
In the previous chapter a we observed that the naïve and primed pluripotent states 
present a different sensitivity to miRNA depletion. In the embryo Dicer deletion 
causes the up-regulation of the pro-apoptotic protein BIM (Spruce, 2010) and we 
found BIM expression was increased after miRNAs depletion in ESCs and EpiSCs. 
However, this up-regulation only triggered an apoptotic response in EpiSCs, 
suggesting that ESCs and EpiSCs have a different apoptotic threshold. This 
argument is supported by our BH3 profiling that show that EpiSCs have higher 
rates of mitochondrial depolarization over time after treatment with pro-apoptotic 
BIM, BID and BMF peptides. The main aim of this chapter was therefore to study 
the differences and similarities of the apoptotic machinery of ESCs and EpiSCs to 
be able to understand the causes for the different apoptotic threshold of these two 
cells types.  
 
An expression analysis of several members of the BCL2 protein family showed no 
difference in the expression and subcellular localization of pro-apoptotic proteins 
between ESCs and EpiSCs. However, unexpectedly we found higher levels of anti-
apoptotic factors in EpiSCs than in ESCs, specifically higher levels of BCL2 and 
BCL/xL. To functionally test the apoptotic requirements of these cells we altered 
the balance of pro and anti-apoptotic factors using two small molecule inhibitors, 
ABT-737 and AT-101, as well as siRNAs against Mcl1. Data from these experiments 
revealed that EpiSCs require Bcl2, Bcl-xL, Bcl-w and Mcl1 for their survival whereas 
ESCs rely only on Mcl1. Bim depletion was sufficient to rescue cell death caused by 
inhibition of these anti-apoptotic factors, indicating that this protein plays a 
central role in the induction of apoptosis during early development.  
 
In vivo, a precise role for anti-apoptotic proteins in the naïve and primed 
pluripotent states has not been completely defined due to functional redundancy 
of some of these factors Mcl1 is expressed in the trophectoderm and in the inner 
cell mass before implantation. Its deletion leads to embryonic lethality at 
implantation stages (Rinkemberger, 2000), that is in agreement with the 
requirement we find here for Mcl1 in ESCs. Deletion of Bcl-xL results in embryonic 
lethality at 13dpc with increased levels of apoptosis in neuronal and 
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haematopoietic cells (Motoyama, 1995). Bcl2 deficient mice complete embryonic 
development but display different features such as growth retardation, increased 
apoptosis in thymus and spleen or renal failure that lead to early post-natal 
mortality (Veis, 1993). Lastly, Bcl-w knock-out mice are viable showing only a 
phenotype in the testis where Bcl-w is required for spermatogenesis (Print, 1998).  
 
One caveat of our experiments is that we have not addressed the function of A1 or 
Bcl-b (also known as Bcl2l10/Diva) that belongs to the Bcl2 anti-apoptotic protein 
family. We observed no differences in A1 protein expression between ESCs and 
EpiSCs, but the existence of four A1 genes in the murine genome that are 
differentially expressed depending on the cell type, complicates the analysis of this 
factor in pluripotent stem cells or the generation of A1 deficient embryos (Vogler, 
2012). Nevertheless, deletion of A1-a, is not embryonic lethal and the only 
phenotype observed so far in these mice is that their haematopoietic cells are more 
susceptible to cell death, suggesting an important role of this protein in the 
regulation of apoptosis in the immune system (Hamasaki, 1998).  Bcl-b null mice 
are fertile and do not show any clear histological abnormalities and their lifespan 
is not different from wild type of heterozygous littermates. Although BCL-b protein 
expression was not analysed in this thesis in ESCs and EpiSCs, the deletion of this 
protein has been reported not alter embryonic development (Russell, 2002).  
However, further work should involve functional analysis of A1 and Bcl-b in ESCs 
and EpiSCs.    
 
With regard to pro-apoptotic proteins, this thesis has primarily focussed on Bim, as 
the deletion of this protein is sufficient to rescue Dicer deleted early post-
implantation and early organogenesis stage embryos (Pernaute, 2014 and this 
thesis). Interestingly we found that Bim inhibition is sufficient to rescue effects of 
Mcl1 inhibition in ESCs and as well as Mcl1 and Bcl2/xL/w inhibition in EpiSCs.  
This indicates that this protein plays a key role in regulating the apoptotic 
threshold during early embryogenesis. The experimental procedure chosen was to 
transfect the cells with different siRNAs: Bim (25nM), Mcl1 (25nM), a combination 
of Bim-Mcl1 siRNAs (25nM each) and a siRNA control (50nM), based on the results 
obtained when validating the efficiency of the knock-downs. Co-transfection 
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experiments should have been performed by transfecting each single target siRNA 
with the control siRNA (e.g. 25nM of siRNA control + 25nM of Mcl1 or Bim siRNA 
respectively) to maintain an equal final concentration (50nM) in all conditions. The 
experimental outcome of these experiments should not be affected by the 
experimental approach taken but future experiments should be planned taking 
observation into account. However, as indicated above naïve and primed 
pluripotent cells display a very different response to moderate levels of Bim over-
expression and this is not due to there being differences in the expression of pro-
apoptotic factors between these two cell types. This said, the expression analysis of 
the pro-apoptotic BMF, PUMA, HRK, BIK, BOK and BAK could not be fully assessed 
during this thesis and should be determined to exclude the involvement of these 
proteins in differences in apoptotic response of ESCs and EpiSCs.  
 
The key issue that remains is why do ESCs and EpiSCs have such different anti-
apoptotic requirements. The low levels of BCL2 expression found in ESCs may 
account for why these cells are not sensitive to ABT-737, but raise the question of 
why ESCs are more resistant to moderate levels of BIM over-expression induced by 
Dicer deletion or by the use of BH3-only peptides. Given that the levels of pro-
apoptotic factors analysed are similar between these two cell types it is possible 
that the difference may lie in how the mitochondria of naïve and primed 
pluripotent cells responds to the activation of pro-apoptotic factors. But to address 
this we need to do several experiments. First, it would be interesting to know if the 
ability of anti-apoptotic factors to bind to pro-apoptotic proteins is similar 
between these two cell types. Second, we would need to address how these 
interactions and the localization pro- and anti-apoptotic factors are affected by 
apoptotic stimuli. Third, it would also be important to know if there is a differential 
activation of BAX/BAK upon induction of apoptosis.  Together these experiments 
should provide an overview of how the mitochondrial apoptotic machinery differs 
in naïve and primed pluripotent cells. 
 
Previous work in the lab had described that deletion of Bim led to a rescue of 
apoptosis in Dicer-/- embryos at 6.5 dpc (Pernaute, 2014). In order to study the 
role of Bim in regulating apoptosis during organogenesis a similar approach was 
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taken. We observed that in contrast to what occurs during early post-implantation 
stages, at 8.5-9.5 dpc there was not an absolute requirement for Bim to trigger the 
apoptotic response in the embryo. Here we observed that when Dicer was 
specifically deleted from the epiblast, the deletion of Bim only led to a partial 
rescue of cell death. Interestingly, the partial rescue observed was enough to 
restore part of the forebrain truncation phenotype, that is one of the clearest 
characteristics of Dicer deficient embryo (Spruce, 2010).  
 
The formation of the nervous system and the forebrain require an exquisite 
regulation of gene expression from early stages of post-implantation embryonic 
development. miRNAs have been shown to play a critical role during this process 
(Parchem, 2015).  Specific deletion of miR-302 family impairs embryonic 
development with severe defects in the neural tube closure (Parchem, 2015). 
Interestingly, we have previously shown that miRNAs from the 290, 302, 25, 17 
and 106 clusters account for more than 70% of the total miRNAs expressed in the 
developing embryo (Pernaute, 2014).  More specifically, miR-92, 302 and 20 are 
directly involved in the regulation of the apoptotic machinery by controlling the 
expression of Bim (Pernaute, 2014). These miRNAs, as mentioned above, are also 
involved in regulating gene expression in the neural tube (Mukhopadhyay, 2011).  
Interestingly, the expression of these miRNAs gets restricted to the neural lineage 
upon embryonic development (Pernaute, 2014; Parchem, 2015). In contrast to 
what we observe upon Dicer mutation, deletion specifically of the miR-302 family 
reduced the number of TUNEL positive cells compared to control in the neural 
tube (Parchem, 2015). A possible explanation for this is that in our model, miRNAs 
from the 19 and 20 families are also eliminated and that these are the primary 
miRNAs regulating Bim in the embryo.  
 
During forebrain development Fgf8 expressing cells are quickly eliminated by 
apoptosis to control the morphogenetic gradients that pattern the forebrain 
(Nonomura, 2013) and blockage of the apoptotic response by deletion of Apaf1, 
leads to aberrant accumulation of non-proliferative Fgf8 expressing cells. Fgf8 is 
normally expressed in the anterior neural ridge, in the junction between the 
midbrain and hindbrain, in the limbs, the somites and the tail bud and was 
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severely down-regulated in the forebrain of Dicer mutant embryos (Figure 4.15A). 
However, in the absence of Bim, we observed a rescue in the expression of Fgf8. In 
addition, a qualitative decrease in TUNEL positive cells was observed in the tail 
bud and in the forebrain of these embryos. Therefore, all this data suggests that an 
exquisite control of the regulation of apoptosis is essential for correct embryonic 
neural development and that miRNAs play an essential role in shaping the 
signalling centres that will pattern the developing embryo by finely tuning the 
apoptotic response in the forebrain.  
 122 
5. Mitochondrial: regulation of pluripotency, metabolism 
and sensitivity to cell death 
 
5.1 Introduction 
Mitochondria are cellular organelles that are involved in many cellular functions 
such as the regulation of cellular metabolism or apoptosis. They carry out the 
oxidation of pyruvate to CO2 and H2O through the TCA cycle and the electron 
transport chain. During this process, a proton gradient is generated in the 
intermembrane space of the mitochondria through the electron transport chain. 
Oxidation of fatty acids also occurs in the mitochondria. During this process the 
reducing equivalents NADH and FADH2 that are generated during this process will 
deliver their electrons to the electron transport chain favouring the proton 
gradient. This proton gradient will then be used to generate ATP through the 
activity of the ATP-synthase. Intermediate metabolites that are generated in the 
TCA cycle such as citrate or α–ketoglutarate, are used as precursors for amino acid, 
fatty acid or glutathione synthesis respectively (Weinberg, 2015).   
 
Mitochondria are very dynamic organelles. The concept of mitochondrial dynamics 
could refer to mitochondrial movement along the cytoskeleton, re-structuring of 
mitochondrial cristae (remodelling of the inner mitochondrial membrane) or the 
process of fusion and fission of mitochondria (remodelling of the outer 
mitochondrial membrane). Mitochondrial dynamics directly impact processes such 
as mitochondrial biogenesis, mitophagy, mitochondrial DNA maintenance, 
apoptosis and metabolism (Detmer, 2007). In this thesis the term ‘mitochondrial 
dynamics’ is used to refer to changes in mitochondrial morphology.  
 
Mitochondrial dynamics is an important process to maintain cellular viability.  The 
GTPase DRP1 (Dynamin related protein 1) is required for mitochondrial 
fragmentation, not only during cellular division to evenly distribute mitochondria 
to the daughter cells (Taguchi, 2007), but also to reduced mitochondrial size 
during cell death to favour phagocytosis (Gomes,2011). Mitofusins, on the other 
hand, favour mitochondrial fusion, a process that occurs and is required during 
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mouse and human stem cell differentiation (Kasahara, 2013).  During the apoptotic 
response, BAX colocalizes with DRP1 and mitofusin 2 (MFN2) suggesting that the 
mitochondrial membrane permeabilization and consequential apoptosis are 
directly related to the mitochondrial dynamic machinery (Karbowski, 2002; 
Montessuit, 2010).    
 
Several studies have analysed the structure of mitochondria of ESCs and EpiSCs 
and during embryonic development. These publications observed several 
morphological differences between these cell types by transmission electron 
microscopy. They showed that mitochondria of ESCs are small with hardly any 
cristae whereas EpiSCs and human ESCs have more elongated mitochondria and 
more developed cristae (Zhou, 2012, Sathananthan, 2000). A very recent 
publication has reported that mitochondrial structure is very important to prevent 
or allow BAX activation and interaction with the mitochondria to initiate apoptosis. 
This study argued that fragmented mitochondria do not allow the conformational 
change of BAX alpha helix 9 and therefore this confers resistance to apoptosis 
(Renault, 2015).  This suggests that the mitochondrial shape of ESCs could play a 
role in their relative resistance to apoptotic stimuli. However, not only the 
morphology is different between this cell types, also the metabolism. ESCs 
combine oxidative phosphorylation and glycolysis to obtain energy whereas 
EpiSCs and human ESCs are mainly glycolytic (Zhou, 2012).  
 
The aim of this chapter is to analyse the mitochondrial morphology in ESCs and 
EpiSCs and study the relationship between mitochondrial dynamics, pluripotency, 





5.2.1 Changes in mitochondrial morphology between the naïve 
and primed pluripotent states  
In order to understand if the morphological structure of the mitochondria could be 
one of the causes contributing to the differential sensitivity to cell death of ESCs 
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and EpiSCs, images of these cells were taken with the following mitochondrial 
specific antibodies and probes: 
 ATPb, a subunit of the mitochondrial ATP Synthase, also known as Complex 
V of the electron transport chain or F1/FO ATP synthase. It is the enzyme 
responsible of generating ATP from ADP by pumping protons from the 
intermembrane space to the mitochondrial matrix, reducing oxygen to 
water at the last step of the electron transport chain. This enzyme is 
located in the inner membrane of the mitochondria (Alavian, 2014) 
(Figure 5.1A).  
 TOM20 is the receptor of the translocase of the outer mitochondrial 
membrane complex. It is responsible of recognising mitochondrial proteins 
that have been synthesised in the cytosol and allow their translocation 
through the TOM40 channel. It is a marker of the outer membrane of the 
mitochondria (Schmidt, 2010) (Figure 5.1B). 
 MitoTracker CMXRos is a fluorescent lipophilic and cationic dye that stains 
active mitochondria in live cells. Its accumulation is dependent on 
membrane potential. The molecule has a chloromethyl group that allows 
covalent reactions with proteins of the mitochondrial matrix permitting 
fluorescent analysis post aldehyde fixation (Pendergrass, 2004) (Figure 
5.1C). 
 
Data obtained from these different staining showed that the mitochondrial 
morphology of ESCs appeared to be more rounded and fragmented compared 
to EpiSCs, which were more elongated and interconnected. ATPb staining gave 
a clearer image with a stronger signal compared to TOM20 or MitoTracker. 








Figure 5.1 Optimization of mitochondrial staining in ESCs and EpiSCs.  
Cells were stained with A) ATPb, B) TOM20 and C) MitoTracker CMXRos. Mitochondria of ESCs 








Kasahara and colleagues showed that ESCs with the same genetic background to 
the ones used in this thesis (E14Tg2.A, derived from 129/Ola mice) appeared to 
have elongated mitochondria (Kasahara, 2013).  In contrast to this, as shown in 
Figure 5.1, the mitochondria of ESCs were found to be fragmented and rounded.  
Therefore I wanted to study if the analysed cells were truly pluripotent stem cells 
and not differentiated counterparts that could arise due to the heterogeneity that 
the Serum+LIF culture conditions allows. In order to address this question, ESCs 
and EpiSCs were stained with the pluripotency marker NANOG and ATPb. This 
analysis revealed that ESCs that express NANOG have rounded and fragmented 
mitochondria (Figure 5.2A). Interestingly, ESCs that have lost the expression of 
this naïve pluripotency marker have elongated, narrow and interconnected 
mitochondria (Figure 5.2A -white arrows). A more detailed image of this 
observation can be found in Figure 5.2A’. EpiSCs express NANOG in much lower 
levels than ESCs and their mitochondria are not fragmented as the ones of ESCs 
(Figure 5.2B and 5.7C).  
 
ESCs can be maintained under a variety of different culture conditions that provide 
different degrees of pluripotency (Nichols, 2009). For this reason we next 
investigated how these culture conditions affected the mitochondrial structure. 
ESCs grown in 2i+LIF, conditions are thought to be in a ground state of 
pluripotency (Wray, 2010) while those grown in Serum+LIF (as above) are 
thought to fluctuate between the naïve and primed states of pluripotency (Hackett, 
2014). When cells were grown in 2i (1 µM of the MEK inhibitor PD0325901 and 3 
µM of the GSK3 inhibitor CHIR99021) + LIF and stained with ATPb and NANOG the 
mitochondria also appeared fragmented and rounded, very similar to the 










Figure 5.2 Pluripotency and mitochondrial morphology.  
Expression analysis of NANOG (red), ATPB (green) and nuclei (DAPI-blue) in A-A’) ESCs 
(Serum+LIF), B) EpiSCs and C) ESCs (2i+LIF).  Mitochondria of ESCs grown in 2i+LIF conditions are 
rounded and fragmented, similar to the ESCs maintained in Serum+LIF, indicating that this 
morphology is characteristic to the naïve pluripotent state. On the contrary, pluripotent stem cells 
and cells that exit the naïve pluripotency (reduced levels or absence of NANOG expression), have 
elongated mitochondria (A- white arrow, A’ and B). Scale bars: 10μM. 
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Together, this indicated that mitochondria of ESCs are fragmented and rounded, 
independently of the conditions used to maintain the cell line. This morphology is 
referred in the literature as “donut” or toroid shaped mitochondria (Benard, 2007). 
It also showed a direct correlation between pluripotency and mitochondrial 
structure. Naïve pluripotent cells progress from rounded and fragmented 
mitochondria to narrow, elongated and interconnected during the process of 
cellular differentiation.   
 
In order to gain a better understanding of the mitochondrial structure and 
organization in pluripotent cells, image analysis with increased resolution was 
performed.  Z-stacks of these cell types where taken every 14nm and 
deconvolution, a computational imaging technique that is used to improve contrast 
and resolution of confocal microscopy images using Huygens software, was 
applied. Three-dimensional reconstruction of these images where generated using 
the image analysis software Fiji. These images provided information of the real 
mitochondrial structure, organization and distribution in naïve and primed 
pluripotent stem cells. These studies confirmed that mitochondria of ESCs have a 
donut-shaped morphology, are mostly fragmented, separated from each other, and 
rounded. However, mitochondria of EpiSCs were narrower than the ones of ESCs, 










Figure 5.3 Reconstruction of mitochondrial structures of pluripotent stem cells.  
ESCs (2i or Serum + LIF) and EpiSCs were stained with the mitochondrial marker ATPb. Z-stacks 
were taken every 14nm to allow deconvolution analysis. Deconvoluted images were used to 
generate a 3D reconstruction of mitochondria to analyse the morphological differences between 
these two cell types. Representative images from three independent experiments. Scale bar: 5μm. 
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5.2.2 Alteration of mitochondrial dynamics changes the 
sensitivity to cell death 
The next question I wanted to answer was if alteration of mitochondrial dynamics 
could modulate the cell death response of ESCs.  As we have discussed, ESCs are 
more resistant to cell death than EpiSCs. We have found that the mitochondria of 
ESCs are fragmented and rounded compared to EpiSCs, which have narrow, 
elongated and fused mitochondria. To address if these different mitochondrial 
shapes are due to different activity of DRP1 the expression of phosphorylated 
DRP1 in serine 616 in ESCs cultured in 2i+LIF, Serum+LIF and in EpiSCs was firstly 
analysed. This specific phosphorylation is associated with active mitochondrial 
fragmentation (Son, 2013; Xie, 2015). We observed that both 2i+LIF and 
Serum+LIF cultured ESCs expressed high levels of p-DRP1 (S616), which 
correlates with their phenotype of fragmented and rounded mitochondria. 
Interestingly, the levels of phosphorylated DRP1 are reduced in EpiSCs, reflecting 
the mitochondrial morphology of these cells (Figure 5.4A).  
 
mDIVI-1 is an inhibitor of DRP1 that blocks the GTPase domain (Cassidy-Stone, 
2008). Previous works have shown that this drug induces the formation of 
mitochondrial networks (Renault, 2015, Xie, 2015). The first performed assay was 
to check mitochondrial structure in ESCs after treatment for 24-hours with two 
different concentrations mDIVI-1, 10 and 50μM. No major differences in the 
mitochondrial morphology were observed at 10μM compared to control ESCs. 
However, at 50μM mDIVI-1 induced an increase in mitochondrial fusion events 
(Figure 5.4B). In order to analyse how mDIVI-1 affected the apoptotic threshold of 
ESCs, cells were cultured with 10 and 25μM mDIVI-1 for 24hours and then treated 
with sodium arsenite (NaAsO2) for a further 4 hours. NaAsO2 is a potent oxidative 
stress-inducing agent. Arsenite can react with thiol groups (-SH) of cellular 
proteins and enzymes inhibiting their activities or with glutathione, an important 
antioxidant and reducing agent that balances levels of reactive oxygen species 
(ROS) (Mari, 2009). As a result, it causes oxidative stress and mitochondrial 
damage that ultimately induces mitochondrial apoptosis (Ivanov, 2013). 
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We observed that 10μM mDIVI-1 had little effect on the response of ESCs to 
NaAsO2. Conversely, 25μM and 50μM mDIVI-1 led to increased apoptosis of ESCS 
(Figure 5.4C). Increased levels of the energy sensor AMPK where found when 
using the mitochondrial inhibitor at these two concentrations suggesting defects in 
ATP production. Additionally, this co-related with an increased expression of the 
apoptotic markers CASP3 and cleaved PARP. The apoptotic response was 
enhanced in the presence of NaAsO2. Interestingly, NaAsO2 not only activated the 
stress response, as indicated by increased levels of p-p38, but also reduced the 
levels of p-DRP1 and activated AMPK independently of mDIVI-1 (Figure 5.4C).  
These results suggest that high levels of mitochondrial fission of ESCs (as 
suggested by the high levels of p-DRP1 and fragmented mitochondria) are at least 





Figure 5.4 Alteration of mitochondrial dynamics affects sensitivity to cell death.  
A) Expression of p-DRP1 (S616) in 2i + LIF ESCs, Serum + LIF ESCs and EpiSCs. B) Mitochondrial 
structure after 24h incubation with the DRP1 inhibitor mDIVI-1 using in Serum+LIF ESCs. 
MitoTracker CMXRos (red) Nuclei were stained using DAPI (blue). C) Inhibition of mitochondrial 
fusion with mDIVI-1 increases the cell death response after in ESCs at 25μM and 50μM as shown by 
increased levels of apoptotic markers. Data from two independent experiments. 
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5.2.3 Modulation of the metabolic status of ESCs using oligomycin 
A 
The next we aimed to address was to understand what regulates the changes in 
mitochondrial dynamics and sensitivity to death signals occurring between the 
naïve and primed pluripotent states. During this transition there are important 
changes at the epigenetic and transcriptional levels (Tesar, 2007; Brons, 2007; 
Nichols, 2009). Here we have described that as cells make this transition they 
change their sensitivity to cell death stimuli. A further important change that 
occurs during this transition is in the metabolic status of the cells. Naive 
pluripotent cells rely in both oxidative phosphorylation and glycolysis for their 
energy production. In contrast to this, primed pluripotent stem cells are mainly 
glycolytic (Zhou, 2012).   
 
Given that direct relationship between metabolism and the mitochondrial 
apoptotic pathway I tested if changing the metabolic requirements of ESCs would 
make these cells more “epiblast-like” and increase their sensitivity to apoptotic 
stimuli. Oligomycin A is a selective inhibitor of the ATP synthase (or Complex V of 
the electron transport chain) and has been used to reduce mitochondrial ATP 
production. For example human lung carcinoma cells or T cells treated with this 
drug increase glucose consumption and lactate production – that are both 
indicative of an increased glycolytic rates (Hao, 2010; Gerriets, 2015).   After 
culturing ESCs for three passages in the presence of 20nM oligomycin A (termed 
OM ESCs hereafter), these cells displayed clear morphological changes. The ESC 
colonies were more compact and dome-shaped than those cells grown in 
Serum+LIF but did not reach the level of compaction of those cells grown in 2i+LIF. 
This morphology was different from that of EpiSCs that grow forming flat colonies 
(Figure 5.5A). This morphological change was accompanied by a slower growth 
rate of those cells grown with oligomycin A, as indicated by the decreased cell 









Figure 5.5 Morphology and growth rates of OM ESCs.   
A) Morphological differences observed between ESCs grown in 2i and Serum +LIF, OM (Serum+ 
LIF) and EpiSCs. Images were taken using an inverted light microscope. B) Cell count of ESCs and 










These observations indicated that oligomycin treatment changes the growth rate 
of ESCs. Given that changes in proliferation patterns are accompanied by a 
reprogramming of cellular metabolism, we performed a metabolic profile analysis 
to determine the metabolic status of OM ESCs. Principal component analysis 
performed was used to see which biological samples cluster together but are also 
metabolically diverse between groups. This analysis showed that the biological 
replicates from EpiSCs group together but differ from ESCs and OM ESCs, which 
are similar to each other (Figure 5.6A). In spite of the fact that ESCs and OM ESCs 
clustered together we detected 177 differentially expressed metabolites between 
these two cell types (50 up-regulated and 127 down-regulated). We also found 
that 78 metabolites were up-regulated and 216 down-regulated when EpiSCs were 
compared to ESCs.  
 
Given that the reported differences between ESCs and EpiSCs have been primarily 
in the glycolytic and OXPHOS pathways, we focussed on these in the first instance. 
Analysis of specific metabolites involved in glycolysis showed that glucose-6-
phophate, 3-phosphoglycerate or phosphoenolpyruvate are up-regulated in EpiSCs 
when compared to ESCs. Lower levels of pyruvate and increased lactate in these 
cells suggest that as previously reported (Zhou, 2012), EpiSCs are more glycolytic 
than ESCs.  In contrast to this, OM ESCs are not more glycolytic than ESCs. The only 
metabolite found to be significantly increased in OM ESCs when compared to ESCs 
was pyruvate (Figure 5.6B). Analysis of the metabolites involved in the TCA cycle 
showed lower levels of succinate, fumarate and malate suggesting overall lower 
activity of the TCA in OM ESCs and EpiSCs compared to ESCs. 
 
The endoplasmic reticulum and mitochondria contribute to synthesise most of the 
lipid in the cells.  Alteration of the overall levels of fatty acid could have an impact 
in the sensitivity to cell death by triggering a stress response (reviewed in Holthuis, 
2014). For this reason we compared fatty acids composition in EpiSCs with respect 
to control ESCs. When this was done we observed a significant amount of 
metabolites belonging to the fatty acid group to be down-regulated in EpiSCs 
compared to ESCs. Surprisingly, this was also found in OM ESCs (Figure 5.7A). 
This could be due to defects in the synthesis or to a higher utilization of these 
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molecules. Sphinganine and sphingosine, sphingolipids that are synthesised from 
long chain fatty acids, were also found significantly down- regulated in EpiSCs and 
OM ESCs compared to ESCs (Figure 5.7B). These sphingolipids can be used to 
synthesise ceramide, which is considered pro-apoptotic, or sphingosine-1-
phosphate, which protects against apoptosis (reviewed in Hannun, 2008). Neither 
ceramide or sphingosine-1-phosphate were analysed in this metabolic profile and 
it will be necessary to evaluate the levels of these molecules to understand if the 
differences in sphingolipid metabolism could be important for the differential 
sensitivity to cell death observed between ESCs and EpiSCs. Carnitine is a molecule 
synthesized by two essential amino acids: lysine and methionine. The main role of 
carnitine is to transport fatty acids from the cytosol to the mitochondrial matrix. 
Carnitine plays an important role preventing apoptosis in muscle cells (Vescovo, 
2002) and has an anti-oxidant effect reducing levels of ROS (Ye, 2010). We 
observed lower levels of carnitine and other related metabolites grouping OM ESCs 
and EpiSCs compared to control ESCs (Figure 5.7C). Further work is required in 
order to understand if lipid composition is a determinant factor contributing to the 
higher susceptibility to cell death observed in EpiSCs compared to ESCs and if OM 















Figure 5.6 Glycolysis and TCA metabolic pathways in OM ESCs and EpiSCs compared to ESCs. 
 A) Principal component analysis showed that EpiSCs metabolically differ from ESCs and OM ESCs, 
that cluster closer to each other. B) EpiSCs have increased levels glycolytic metabolites compared 
to ESCs. On the contrary, no major differences were observed in OM ESCs except for the 
accumulation of pyruvate. C) Analysis of the metabolites involved in the TCA cycle showed an 









Figure 5.7 Fatty acid metabolism overview in OM ESCs and EpiSCs compared to ESCs.  
The metabolic profile performed showed a significant down-regulation of A) fatty acid, B) 
sphingolipid and C) carnitine metabolic pathways in OM ESCs and EpiSCs compared to ESCs.   
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In order to test if the changes in ESC colony morphology, growth and metabolism 
were accompanied by a change in  cell identity, a number of pluripotency and 
differentiation markers were analysed by qPCR in ESCs, OM ESCs and EpiSCs 
(Figure 5.8A).  This analysis showed that the expression of the pluripotency 
markers Pou5f1, Sox2, Rex1, Nanog and Klf4 was comparable in OM and control 
ESCs. In contrast to this, EpiSCs did not express Rex1 or Klf4. Similarly, Fgf5, a 
specific marker of EpiSCs, showed a very low level of expression in OM ESCs and 
ESCs. The expression of Bcl2, which is highly expressed in EpiSCs and is low in 
control ESCs (Figure 3.7), was also found to be low in OM ESCs both at the 
transcriptional and at the translational level (Figures 5.8 A and C). In the third 
chapter of this thesis it was previously discussed that the ESCs used in these thesis 
express higher levels of T compared to EpiSCs. Interestingly, OM ESCs have lower 
levels of T compared to control ESCs (Figure 5.8A). This suggests that OM ESCs 
have lower levels of differentiation than our control ESCs, a hypothesis that is 
supported by the increased Nanog protein expression as well as more homogenous 
expression of Nanog in these cultures (Figure 5.8B-C).   p-STAT3 is required to 
maintain pluripotency and can act as a direct transcriptional activator of 
hexokinase II (HKII) (Jiang, 2012). Interestingly OM ESCS displayed slightly higher 
levels of hexokinase II (HKII) and p-STAT3 expression when compared to control 
ESCs, further strengthening the case for the lower levels of differentiation of OM 













Figure 5.8 Characterization of OM ESCs.   
A). The gene expression profile of OM ESCs showed more similarities to ESCs than to EpiSCs 
suggesting that OM ESCs are closer to the naïve pluripotent state. mRNA levels relative to the 
endogenous control Hmbs. Data from three independent experiments. Error bars: SEM. B) 
Immunofluorescence stain for the pluripotency marker NANOG (green) and nuclei (DAPI, blue) in 
ESCs maintained in three different culture conditions and EpiSCs. C) Comparative protein analysis 
between ESCs, OM ESCs and EpiSCs. Higher levels of NANOG, p-STAT3 and HKII in OM ESCs suggest 
lower levels of differentiation in these cells compared to ESCs. Representative western blot of five 
different experiments. Loading control α-Tubulin.   
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Overall, these data indicates that oligomycin A treatment does not significantly 
affect ESC cellular identity, as OM ESCs showed a naïve pluripotent identity 
equivalent to that found in control ESCs. As expected, we instead observed that 
oligomycin A is inducing a number of metabolic changes in ESCs as indicated by 
the significant changes in the level of expression of 177 metabolites that are likely 
to cause the lower growth rate of these cells.  
 
 
5.2.4 Oligomycin A changes the susceptibility of ESCs to cell death  
In order to study if oligomycin A could change the sensitivity to cell death of ESCs, 
OM ESCs and EpiSCs were cultured in the presence of sodium arsenite (NaAsO2). 
Different concentrations of NaAsO2 were tested in order to optimise the cell death 
assay over a period of 16 hours (Figure 5.9A). 6μM induced a 2-fold increase in 
cell death in ESCs and a 2.5-fold increase in EpiSCs measured by Annexin V.  At 
20μM the apoptotic cell death response of ESCs increased to 4-fold and in contrast 
to this, in EpiSCs it was 8-fold. Finally, 60μM NaAsO2 induced a 7-fold increase in 
cell death in ESCs and an 8.5-fold in EpiSCs. Given that the differences in sensitivity 
to cell death are most apparent at 20μM NaAsO2, this concentration was tested in 
OM ESCs.  When this was done a 7.4 fold increase (from 9.6±1 to 68.5±6% of 
apoptotic cells) induced by NaAsO2 was observed. This increase was equivalent to 
the one observed in EpiSCs in which the drug caused a 7.5 fold increase (from 
8.0±0.4 to 60±4.5 % of apoptotic cells). These levels were significantly higher than 
the ones observed in ESCs, where the drug induced a 3.2-fold increase (from 
14.5±2% to 51.2±6%) of apoptotic cells (Figure 5.9B). Levels of cleaved CASP3 
and PARP were also measured by western blot and also found to be higher in OM 
ESCs treated with NaAsO2 when compared to control ESCs treated with NaAsO2 
(Figure 5.9C). Therefore, this data suggests that metabolic changes caused by  
oligomycin A increased the sensitivity to cell death of ESCs without changing their 












Figure 5.9 OM ESCs are more sensitive to cell death compared to ESCs.   
A) Optimization of the assay. Several concentrations of NaAsO2 were tested in ESCs and EpiSCs to 
determine which could induce a differential response to cell death. Data represents the ratio of 
AnnV positive cells to each control cell line. B) Analysis of apoptotic cells after oxidative stress 
caused by 20μM NaAsO2. A 7.4±1.1 fold increase in AnnV positive cells in OM ESCs, an increase that 
was equivalent to the 7.5± 0.6 fold change observed in EpiSCs in this experiment and was 
significantly higher than the 3.6±0.3 seen in ESCs C) Samples plotted in B were subjected to 
Western blot to analyse the expression of the apoptotic markers cleaved CASP3 and PARP upon cell 
induced cell death by NaAsO2. Data from three independent experiments. Paired T-TEST: *<0.05; 




5.2.5 Oligomycin A changes the mitochondrial morphology of ESCs 
Finally, I wanted to address if this differential sensitivity to cell death could be due 
to a change in mitochondrial structure of OM ESCs. To answer this question, 
confocal images for deconvolution were taken as for Figures 5.3. Three-
dimensional reconstruction of these images revealed that OM ESCs have a 
combination of rounded/fragmented mitochondria and elongated/fused 
mitochondria (Figure 5.10A). This phenotype correlated with the expression p-
DRP1 (S616) in these cells, where it was found down-regulated compared to ESCs 
(Figure 5.10B). Therefore, this data supports the possibility that that an important 
factor that determines the different sensitivity of ESCs and EpiSCs is their different 
mitochondrial morphology, and that this may be regulated by the metabolic state 





Figure 5.10 3D mitochondrial structure in OM ESCs compared to ESCs and EpiSCs.  
A) Deconvoluted z-stack of ESCs, OM ESCs and EpiSCs. OM ESCs present a combination of 
rounded/fragmented with narrow/elongated and fused mitochondria. Representative images of 
three independent experiments. Scale bars: 10μM. B) Analysis of the expression of p-DRP1 (S616) 
in ESCs, OM ESCs and EpiSCs. Oligomycin A induces a reduction in this DRP1 phosphorylation site 
and co-relates with the mitochondrial morphology observed in A.  Representative western blot of at 
least 5 independent experiments. Loading control α-Tubulin. 
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5.3 Discussion  
In the previous chapter we discussed the similarities and differences between the 
apoptotic machinery of ESCs and EpiSCs.  We found that cell survival is mainly 
regulated by MCL1 in ESCs but that EpiSCs also require BCL2, BCL-xL and BCL-w. 
However, we found similar levels of pro-apoptotic and higher expression of anti-
apoptotic proteins in EpiSCs than in ESCs, indicating that the differential sensitivity 
to cell death does not only depend on the balance of expression of BCL2 family 
members.  A recent publication pointed that mitochondrial morphology is an 
important parameter to allow/prevent apoptosis. In this study they argued that 
the intrinsic resistance to apoptosis of rounded and fragmented mitochondria does 
not allow BAX conformational change to induce MOMP (Renault, 2015). To test if 
differences in mitochondrial shape could contribute to the different sensitivity to 
apoptosis of ESCs and EpiSCs we performed an exhaustive analysis of 
mitochondrial morphology. 
 
The data presented in this chapter showed that there are very significant 
differences in the mitochondrial morphology of ESCs, that are fragmented and 
rounded, and EpiSCs, that have narrower, more elongated and fused mitochondria.  
These observations are in agreement with the reported differences in the 
mitochondrial morphology observed between these cell types by electron 
microscopy (Sathananthan, 2000; Zhou, 2012). To our knowledge, this is the first 
study that presents an overview of the three-dimensional organization of these 
organelles in ESCs and EpiSCs. Our results therefore suggest that the differential 
morphology of ESCs and EpiSCs could contribute to the higher sensitivity to cell 
death that EpiSCs have. However, further work is required to prove this. It will be 
necessary to precisely determine mitochondrial size in ESCs and EpiSCs. The 
confocal analysis showed in Figure 3 could be used to measure the size of the 
mitochondria in ESCs, as most of them are individual and fragmented. Analysing 
the size of the mitochondria in EpiSCs would not be trivial as they are fused 
together forming a network. It will be interesting to size fractionate ESC and 
EpiSCs mitochondria and study if there is a correlation between size and 
susceptibility to permeabilization by BH3 peptides, as has been done by Renault 
and colleagues (Renault, 2015).  
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One alternative possibility as to why mitochondrial shape could affect response to 
death signals is that it could alter interaction with the endoplasmic reticulum (ER). 
It is possible that the narrower morphology observed in EpiSCs could lead to 
closer interactions with the ER and therefore a hypothetical higher susceptibility 
to Ca2+ induced apoptotic (Rowland, 2012, Filadi 2015). In order to address this 
possibility we would need to study the interaction of mitochondria and 
endoplasmic reticulum in ESCs and EpiSCs together with the levels of Ca2+ and the 
evaluation of the apoptotic response upon increasing the levels of cytosolic Ca2+. 
 
Our data on the morphology of mouse ESCs contrasts with what has been reported 
for human ESCs. Previous studies have shown that the mitochondria of human 
ESCs are elongated and have a similar morphology to those found in EpiSCs (Son, 
2013). One likely explanation for this is that in contrast to mouse ESCS, human 
ESCs and mouse EpiSCs are thought to be in a primed state of pluripotency. Naïve 
human ESCs have only just been isolated (Takashima, 2014; Theunissen, 2014) 
and it would be interesting to study the mitochondrial morphology of these cells.  
 
Mitochondrial dynamics is an important parameter that contributes to 
mitochondrial shape and apoptosis. Cellular proteins that favour mitochondrial 
fission such as DRP1 or fusion like mitofusins or OPA1, orchestrate the process of 
mitochondrial division or elongation and cristae remodelling respectively (Suen, 
2008). The activity of the mitochondrial fragmentation protein DRP1 is mainly 
regulated by its phosphorylation status. Phosphorylation at serine 616 is generally 
considered to promote fragmentation whereas phosphorylation at serine 637 to 
promote elongation (Suen, 2008). We found that naïve pluripotent cells have very 
high expression of p-DRP1 (S616) compared to primed pluripotent cells or OM 
ESCs. The expression of total DRP1, most appropriate control to compare the 
expression of p-DRP1, could not be assessed in these experiments. However, 
analysis of the expression of this protein posterior to the experimental results 
showed in this chapter, showed similar levels of total DRP1 between ESCs and 
EpiSCs (Appendix 3).  This specific phosphorylation is regulated by CDK1 or 
ERK1/2 and has been shown to promote mitochondrial fragmentation during 
mitosis of human ESCs (Son, 2013) or pancreatic tumour growth (Kashatus, 2015) 
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respectively. OM ESCs showed lower proliferation rates compared to control ESCs. 
In order understand if the lower levels of p-DPRP1 (S616) observed in these cells 
is due to differential expression CDKs, levels of these proteins should be measured 
in comparison to ESCs. Brain tumour initiating cells derived from glioma have 
more fragmented mitochondria than their non-tumorigenic counterparts (Xie, 
2015). This phenotype correlates with high level of expression of p-DRP1 (S616) 
that in this case is phosphorylated by CDK5. In this study shRNA mediated 
silencing of DRP1 was linked to the activation of the energy sensor AMPK and this 
led to cell death in brain tumour initiating cells (Xie, 2015). We observed that the 
use of the DRP1 inhibitor mDIVI-1 induced AMPK activation and cell death in ESCs, 
suggesting that altering mitochondrial dynamics could induce cell death. It would 
be interesting to analyse if this response is just due to an acute depletion on ATP 
levels, suggested by AMPK activation, or by alteration of mitochondrial dynamics. 
Sustained culture with mDIVI-1 to allow metabolic adaptation and treatment with 
an apoptosis inducing agent will allow to discern between these two possibilities. 
EpiSCs are viable and proliferative although they exhibit lower levels of p-DRP1 
(S616). Therefore, a different mechanism other than acute reduction of ATP levels 
should be regulating the differential sensitivity to cell death between ESC and 
EpiSCs.  
 
The second important phosphorylation site to regulate DRP1 function is serine 637. 
Use of rapamycin, an mTOR inhibitor, has been widely used to induce autophagy. 
Upon this treatment there is an increase in protein kinase A that specifically 
phosphorylates DRP1 in serine 637, which is located in the GED (GTPase effector) 
domain of this protein which is required for self-assembly and GTPase activity, 
favouring elongation (Gomes, 2011; Chang, 2007). Sustained phosphorylation of 
DRP1 at S637 delayed mitochondrial fragmentation and cell death after treatment 
with the protonophore CCCP (Cereghetti, 2010). Conversely, de-phosphorylation 
at this site by calcineurin or constitutive de-phosphorylation achieved by 
mutagenesis, promotes the translocation of DRP1 to the mitochondria and 
facilitation of apoptosis (Cribbs, 2007, Cereghetti, 2008; Cereghetti, 2010). 
However, brain tumour initiating cells have low expression levels of p-DRP1 
(S637) compared to their non-tumorigenic counterparts (Xie, 2015), which 
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indicates that reduction/absence of this phosphorylation does not always imply 
cell death.   For these reasons, further work is needed to analyse the expression of 
p-DRP1 S637 in ESCs and EpiSCs. Subcellular localization of DRP1 for each 
phosphorylation site will provide very useful information to understand how this 
protein could influence sensitivity to cell death in pluripotent stem cells. In order 
to avoid possible deleterious effects induced by mDIVI-1, DRP1 null ESCs (Ishihara, 
2009) and constitutively mutants for the phosphorylation sites (Cereghetti, 2008) 
could be used to address this question in the future.  
 
These studies should be complemented with expression analysis of proteins that 
favour mitochondrial fusion. Recent publications have shown that ablation of 
mitofusins (Mfn1 or Mfn2) enhances reprogramming efficiency of mouse 
embryonic fibroblasts by promoting glycolysis (Son, 2015). Additionally, mouse 
ESCs show low expression of MFN1 and MFN2 when compared to human ESCs 
(Son, 2015). Therefore, lower levels of mitofusins could explain the lower 
mitochondrial complexity of these cells compared to mouse EpiSCs and human 
ESCs (Zhou, 2012, Filadi, 2015).  Given the similarities between human ESCs and 
EpiSCs, it is tempting to speculate that there will be higher levels of mitofusins in 
EpiSCs and that this contributes to the more elongated mitochondria of these cells. 
In addition, ERK is able to phosphorylate MFN1 in T562 promoting apoptosis upon 
a cell death stimulus in mouse embryonic fibroblasts (Pyakurel, 2015). 
Mutagenesis of this amino acid preventing its phosphorylation was shown to 
reduce levels of cytochrome c release (Pyakurel, 2015). Taking into consideration 
that EpiSCs are maintained in the presence of FGF (that activates ERK1/2), it 
would be interesting to assess the impact of this signalling pathway and the role 
that mitofusins have on cell death in this cell type. First we would need to analyse 
the expression of mitofusins in EpiSCs. Second, assess if ERK phosphorylates this 
specific amino acid in these cells. Then, evaluate if EpiSCs expressing a constitutive 
dephosphorylated form of MFN1 are more resistant to apoptosis compared to 
controls. Analysis of the proteins involved in mitochondrial fusion in ESCs will 
provide a better understanding of the regulation of mitochondrial dynamics in 
pluripotent stem cells and the correlation observed with their pluripotent identity 
and relative sensitivity to cell death. 
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An important change that occurs during the transition from the naïve to the 
primed state of pluripotency is related to the metabolism. Naive pluripotent cells 
rely in both oxidative phosphorylation and glycolysis for their energy production. 
In contrast to this, primed pluripotent stem cells are mainly glycolytic (Zhou, 
2012).  Given the direct link between mitochondrial apoptosis and metabolism we 
tested if changing the metabolic requirements of ESCs would make these cells 
more “epiblast-like” and increase their sensitivity to apoptotic stimuli.  In order to 
achieve this we used oligomycin A that blocks the ATP synthase. Culturing ESCs 
with oligomycin A induced a change in the susceptibility to cell death that 
correlates with increased mitochondrial elongation. The down-regulation in 
pDRP1 (S616) observed in these cells further supported the hypothesis that 
mitochondrial dynamics are changed in OM ESCs and that this could be the reason 
for the changed apoptotic sensitivity of these cells. This possibility should be 
further tested by carrying out similar analysis of the mitochondria of OM ESCs to 
those described above in ESCs and EpiSCs (e.g. analysis of mitochondrial 
morphology and size, studying the expression of pro- and anti-apoptotic factors in 
these cells and performing a BH3 profiling). 
 
An alternative explanation for the increased sensitivity to apoptosis of OM ESCs is 
suggested by the metabolic profile performed that showed that there were 
significantly less lipid metabolites in OM ESCs and EpiSCs than in ESCs. Alteration 
in lipid metabolism could account for the differential sensitivity to cell death as 
lipid composition of the mitochondrial membranes is an important determinant of 
the apoptotic response (Scharwey, 2013). Isolation of mitochondria of each cell 
type and analysis by mass-spectrometry will be required to understand up to 
which extent the lipid composition of the mitochondria correlates with the 
differential sensitivity to cell death observed.  Then functional studies altering the 
lipid composition of the mitochondria of ESCs and EpiSCs would be required to 
validate this possibility. 
 
The results presented in this chapter indicate that there is a correlation between 
mitochondrial morphology and pluripotency and metabolism.  Exit of the naïve 
pluripotency state correlates with down-regulation of the mitochondrial 
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fragmentation marker p-DRP1 (S616). In addition, alteration of mitochondrial 
dynamics– reflected by down-regulation of p-DRP1 (616) - results in increased 
sensitivity to cell death. Therefore, analysing mitochondrial dynamics during early 
embryonic development would help to better understand if the differential 
sensitivity to cell death observed between the epiblast of the pre- and the post-
implantation embryo is also dependant on mitochondrial structure. 
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6. Final discussion 
 
The correct development of the mammalian embryo requires exquisitely 
controlled events of cell division, correct spatial and temporal control of gene 
expression at different levels – transcriptional, post-transcriptional and epigenetic, 
and adequate response to intracellular and extracellular signals. During the early 
sates of embryonic differentiation there is a transition from a naïve pluripotent 
state found in the epiblast of the pre-implantation embryo, to a primed state of 
pluripotency in the epiblast of the post implantation embryo. ESCs and EpiSCs are 
used as in vitro models to capture these pluripotent states respectively (Nichols, 
2009).  
 
During pre-implantation development, prior to the segregation between epiblast 
and primitive endoderm, apoptosis serves as a selective mechanism to ensure 
proper segregation of lineage progenitors (Plusa, 2008; Xenopoulus, 2015). 
Additionally apoptosis in the post-implantation mouse embryo peaks at 6.5dpc, 
when cells become hypersensitive to DNA damage (Heyer, 2000) and serves to 
eliminate defective cells (Sancho, 2013; Claveria, 2013). Previous work to this 
thesis in the Rodriguez laboratory and others showed an essential role of miRNAs 
in regulating cell survival during post-implantation but not pre-implantation 
development (Kanellopoulou, 2005; Suh, 2010; Spruce, 2010). These observations 
pointed either to a different apoptotic threshold between the epiblast of the pre-
implantation and post-implantation embryo or a different requirement for miRNAs 
between these stages. The main aim of this thesis was to resolve this question and 
unravel the mechanism by which miRNAs regulate apoptosis in the early mouse 
embryo. 
 
The third chapter of this thesis aimed to address the requirements of miRNAs at 
the onset of differentiation. ESCs and EpiSCs in which Dicer deletion is driven by a 
tamoxifen inducible Cre-recombinase were used as in vitro models to answer this 
question. The obtained results indicate that ESCs can transit to the prime 
pluripotent state and the EpiSCs can exit the primed pluripotent state upon 
reduction of miRNA levels. Conversely, other groups have shown that Dicer-/- ESCs 
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fail to differentiate (Kanellopoulou, 2005) and this has been attributed to the role 
of miRNAs regulating the methylation of pluripotency promoters upon 
differentiation through the down-regulation of Dnmt3a (Sinkkonen, 2008). A more 
recent study has shown that Dgcr8-/- and Dicer-/- ESCs are transcriptionally closer 
to ESCs grown in 2i+LIF (ground naïve pluripotency) than in Serum+LIF 
(metastable naïve pluripotency) (Kumar, 2014; Hackett, 2014). Together these 
results indicate that miRNAs are not required to regulate pluripotency but for 
modulating the transition to the primed pluripotent state (EpiSCs). Conversely, we 
found that transient Dicer deletion caused an up-regulation in the expression of 
Dnmt3a at the transcriptional level. This difference or residual levels of miRNAs 
could explain why in our system cells were able to exit the naïve and primed 
pluripotent states in contrast to stable Dicer deleted ESCs. 
 
One important impediment for analysing the role of miRNAs in regulating 
differentiation was their role in ensuring cell survival during the ESC to EpiSCs 
transition.  We found that Dicer deletion caused the activation of the mitochondrial 
apoptotic pathway in EpiSCs but not in ESCs. Furthermore, decreased cell viability 
was observed when Dicer deleted ESCs were forced to differentiate and reached an 
“epiblast-like” state. To be able to precisely determine the roles of miRNAs in 
differentiation it will be necessary to inhibit cell death upon miRNA depletion 
using a pan-caspase inhibitor or Bax-/-Bak-/- ESCs and test the differentiation 
potential of these cells.  
 
Regarding the mechanism by which miRNAs regulate cell survival during early 
development, this thesis identified that it was through the regulation of the pro-
apoptotic protein BIM (Spruce, 2010).  Support for this hypothesis has come from 
recent work where transfections with single miRNAs that target BIM (miR-92, 
miR-20 and miR-302) or with Bim siRNAs, are able to rescue levels of apoptosis in 
Dicer deleted EpiSCs. Furthermore, in vivo, the apoptosis observed in Dicer-/- 
embryos is rescued in a Bim-/- background (Pernaute, 2014). Interestingly, the 
expression of miR-92, miR-20 and miR-302 becomes mainly restricted to the 
ectoderm at 8.5dpc (Pernaute, 2014). Further characterization of cell death 
performed in this thesis in DicerFx/-;Sox2Cre embryos, which have an epiblast 
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specific deletion of   Dicer, survive till 9.5dpc and present neural defects, showed 
that ectodermal derived tissues were qualitatively more susceptible to cell death 
than for example the developing heart, where these miRNAs are not expressed. 
This suggests an important role of BIM regulating cell survival during the 
development of the nervous system and contributes to understand the forebrain 
truncation phenotype characteristic of DicerFx/-;Sox2Cre embryos.  
 
However, when comparing the roles of miRNAs in naïve and primed pluripotent 
cells an extremely interesting question arose: why BIM up-regulation, that is 
obvious in Dicer/- ESCS and EpiSCs, is able to induce cell death in EpiSCs and not in 
ESCs? This phenotype suggested that there was a differential apoptotic threshold 
between these two cell types. In order to discard the possibility that this difference 
was influenced by depletion of miRNAs levels, a BH3 profile was performed to 
assess if there could be differences in mitochondrial depolarization upon a direct 
BH3-only mediated pro-apoptotic stimulus (Ryan, 2013). Analysis of these 
experiments showed higher and faster mitochondrial depolarization of EpiSCs 
compared to ESCs. These results indicate that the lower apoptotic threshold 
observed between these cell types is intrinsic to EpiSCs and independent on 
miRNA depletion.  
 
The aim of the fourth chapter of this thesis was to contribute to develop our 
understanding on how the apoptotic machinery is regulated between the naïve and 
primed pluripotent states. Firstly we hypothesised that the different apoptotic 
threshold observed between ESCs and EpiSCs could be due to differential levels of 
expression of pro- and anti-apoptotic factors. A comparative analysis of various 
members of the Bcl2 protein family showed that EpiSCs express higher levels of 
BCL2 and BCL-xL than ESCs, whereas no differential expression of pro-apoptotic 
factors were found between these cell types. Given that BIM interacts with several 
anti-apoptotic proteins of the BCL2 protein family: BCL2, BCL-xL (Bcl2l1), BCL-w 
(Bcl2l2) and MCL1 (Figure 6.1) we decided to study how altering the balance 
between pro- and anti-apoptotic factors that interact with BIM could affect 






Figure 6.1 BIM protein interactome.  
Bim (Bcl2l11) interacts with the anti-apoptotic proteins Mcl1, Bcl2, Bcl-xL (Bcl2l1), Bcl-w (Bcl2l2); 
the pro-apoptotic proteins Bax and Bak and also with the LC8. Interactome was generated using 
STRING database (von Mering, 2003) with a confidence score >0.9 (max. value: 1).  
 
 
The BAD mimetic ABT-737 targets BCL2, BCL-xL and BCL-w and has been shown 
to induce apoptosis in cancer cells and reduce tumour size (Oltersdorf, 2005, Del 
Gaizo Moore, 2007). We found that ABT-737 induces a high apoptotic response in 
EpiSCs and the epiblast of the post-implantation embryo, presumably by releasing 
BIM from the anti-apoptotic factors, but not in ESCs or in pre-implantation 
embryos. To study the role MCL1, the fourth protein that directly interacts with 
BIM, in ESCs and EpiSCs two different approaches were used. First, by chemical 
inhibition using AT-101, an inhibitor that targets MCL1, BCL2 and BCL-xL; second, 
direct silencing through the use of siRNAs. We observed that reducing the levels of 
Mcl1 in ESCs and EpiSCs causes apoptosis in both cell lines and that this could be 
rescued by down-regulation of Bim. Results from these experiments showed that 
EpiSCs require more anti-apoptotic proteins than ESCs, which mainly rely on Mcl1 
to regulate their survival.   
 
The expression of the anti-apoptotic A1 and Bcl-b or the pro-apoptotic Bak, Bik, 
Bok, Bmf, Hrk, and Noxa could not be assessed in this thesis. Deletion of each of 
these genes in vivo does not impair embryonic development as occurs with Bcl-xL 
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or Mcl1  (Russell, 2002; Youle, 2008, Ke, 2012). The expression analysis of these 
proteins would be required to assess their significance establishing the apoptotic 
threshold in ESCs and EpiSCs. Another issue that needs to be addressed in the 
future is if BAX/BAK are differentially activated between ESCs and EpiSCs upon the 
same apoptotic stimulus.  If BAX/BAK are easier to activate in EpiSCs than in ESCS 
it will be necessary to determine the regulatory mechanisms behind this difference. 
 
Given that the different sensitivity to cell death in ESCs and EpiSCs was not caused 
by an intrinsic imbalance of pro- and anti-apoptotic factors, the next step taken 
was to study if the mitochondrial structure of these cells could alter the apoptotic 
threshold. Mitochondrial shape plays a key role in determining the cell’s apoptotic 
response.  (Wasilewski, 2009; Renault, 2015; Xie, 2015). Given the key roles that 
this organelle play in metabolism and the regulation of cell fate (Kasahara, 2014), 
the fifth chapter of this thesis focused on analysing mitochondria structure, 
dynamics and influence on sensitivity to cell death. This study provided a 
comprehensive analysis of the mitochondrial morphology of naïve and primed 
pluripotent stem cells. Three-dimensional reconstruction of the images taken 
showed dramatic differences in the mitochondrial structure of these cells types. 
ESCs have ‘donut’-shaped mitochondria (rounded and fragmented) compared to 
the ones of EpiSCs that more fused, elongated and narrower. These observations 
support previous investigations in which mitochondrial morphology was analysed 
by transmission electron microscopy in mouse ESCs, EpiSCs and human ESCs 
(Zhou, 2012). The expression of p-DRP1 (616), indicator of mitochondrial 
fragmentation, was found to be higher in ESCs compared to EpiSCs, correlating 
with the observed mitochondrial structure.  Even though other proteins related in 
mitochondrial fusion/fission could not be assessed in this thesis, this suggested a 
different regulation of mitochondrial dynamics in these cells. The DRP1 inhibitor 
mDIVI-1 was used to assess if alteration of mitochondrial morphology could 
directly impact on sensitivity to cell death. The use of this drug induced changes in 
mitochondrial morphology in ESCs but also the activation of the energy sensor 
AMPK. These results did not allow to discern if the cell death response upon 
mDIVI-1 treatment was caused by an acute depletion of energy levels or by 
alteration of mitochondrial dynamics. Given that DRP1 is not required for 
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pluripotency (Ishihara, 2009), future work will involve longer incubation periods 
with mDIVI-1 to analyse the effects of chronic rather than acute DRP1 inhibition, to 
test if this interferes with their naïve pluripotent identity and if this makes ESCs 
are more susceptible to apoptotic stimuli. Another approach will involve the use of 
Drp1-/- ESCs to induce mitochondrial elongation (Ishihara, 2009) or Mfn1-/- and 
Mfn2-/-EpiSCs to promote fragmentation in order to evaluate how these mutations 
affect the apoptotic response in ESCs and EpiSCs.  
 
In accordance with the data presented in this thesis we hypothesise that rounded 
and fragmented mitochondria are more resistant to cell death compared to 
narrower, elongated and fused mitochondria.  This hypothesis challenges the 
general opinion about mitochondrial dynamics and apoptosis. It is generally 
acknowledged that favouring mitochondrial elongation delays cytochrome C 
release and therefore apoptosis (Cereghetti, 2008) or to promote survival upon 
nutrient deprivation (Gomes, 2011; Rambold 2011). Conversely, promoting 
fragmentation has been associated with apoptosis (Cereghetti, 2008; Pyakurel, 
2015). However, several publications and this thesis presented data that question 
this general view (Shen, 2007; Xie, 2015; Renault, 2015, Pyakurel, 2015). Further 
functional assays will be required to conclusively distinguish between these views, 
but it is possible that the effects of mitochondrial shape and size on cell survival 
may vary depending on the cell type or the apoptotic-inducing agent used. As 
pointed by Filadi and colleagues, Mfn2-/- cells responded to ceramide (Ca2+ 
mediated apoptotic response) but not to etoposide (DNA damage) (Filadi, 2015). 
Ca2+ can modulate DRP1 favouring its translocation to the mitochondria and 
apoptosis (Cereghetti, 2008; Cereghetti, 2010). In addition, post-translational 
modifications controlling the activity of the proteins that regulate mitochondrial 
dynamics can modulate the apoptotic response independently of mitochondrial 
shape (Pyakurel, 2015). Evaluating the apoptotic response caused by BH3-only 
peptides will provide a more accurate analysis by eliminating the need to 
distinguish between Ca2+ dependent or independent response upon an apoptotic 
stimulus. Finally, different publications have reported interaction of DRP1 and 
Mitofusins with members of the BCL2 protein family (Karbowski, 2002; Li, 2008a). 
Study of the interactions of BCL2 protein family with proteins involved in 
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mitochondrial dynamics in basal and in an apoptotic conditions will provide 
valuable information to clarify the opposing results of these studies.  
 
The transition from the naïve to the primed state of pluripotency involves a 
metabolic switch from a bivalent metabolic profile, where cells rely on oxidative 
phosphorylation and glycolysis for their energy, to a primarily glycolytic 
metabolism (Zhou, 2012). A last part of the thesis was an evaluation of how 
changes in the metabolic status of ESCs could impact in sensitivity to cell death. 
The inhibitor of the ATP synthase oligomycin A was used in ESCs, with the 
expectation that it would drive a switch to a more glycolytic metabolism. However, 
the metabolic profiling carried out showed that the major differences between OM 
ESCs and ESCs were not in glycolysis or the TCA cycle, but rather in lipid 
metabolism, as a significant down-regulation in fatty acid, sphingolipid and 
carnitine metabolism was observed in OM ESCs. Interestingly, these pathways 
were also found to be down-regulated in EpiSCs. In addition, mitochondrial 
structure of OM ESCs showed narrow elongated and fused mitochondria, which 
also correlated with down-regulation in the expression of p-DRP1 (S616) and 
higher susceptibility to oxidative stress when compared to control ESCs. 
Interestingly, despite these changes in their metabolic profile and mitochondrial 
structure, OM ESCs cells remained naive pluripotent. These results suggest that 
mitochondrial morphology is highly dependent on cell metabolism rather than on 
the pluripotent state of the cell.  
 
It was previously described that the proliferative capacity of ESCs depends on 
glycolysis. Inhibition of this pathway using the glucose analogue 2-DG (2-
deoxyglucose) reduced ESCs proliferation (Kondoh, 2007). We found that 
oligomycin also decreased proliferation in ESCs suggesting that both pathways are 
required for the high growth rate of these cells. Unpublished data from the lab 
(Appendix 2) and a recent publication showed that glycolysis is necessary to 
maintain pluripotency in ESCs (Rodrigues, 2015). Interestingly, increased 
glycolysis is necessary and improves the efficiency of reprogramming (Folmes, 
2011). Additionally, metabolic reprogramming precedes the expression of 
pluripotency genes. Also, reprogrammed cells present less mature mitochondria 
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compared to the differentiated counterparts (Folmes, 2011).  This supports our 
view that the metabolic status is linked to the mitochondrial dynamics of the cell. 
Interestingly, inhibition of mitofusins – proteins involved in mitochondrial fusion – 
also enhances reprogramming efficiency by stabilizing HIF1a and therefore 
stimulating glycolysis (Son, 2015). This publication also showed low expression of 
MFN1/MFN2 in ESCs and higher expression in hESCs (Son, 2015) that correlates 
with the mitochondrial morphology of these cell types (Zhou, 2012 and this thesis). 
Further evaluation of other proteins involved in mitochondrial fusion proteins 
(MFN1, MFN2, OPA1) and their regulation would be required to understand how 
alteration of mitochondrial morphology and the metabolic status of the cell could 
modify the apoptotic threshold.  
 
Summarizing, in this thesis we have shown that miRNAs are essential to control 
cell survival in the epiblast of the post-implantation embryo, in vivo and in vitro. 
The pro-apoptotic protein BIM plays an important role triggering the apoptotic 
response in the naïve and primed pluripotent states but these two pluripotency 
types have a different sensitivity to Bim over-expression. In agreement with this, 
EpiSCs require more anti-apoptotic factors to regulate their survival and therefore 
show a lower apoptotic threshold. Finally, we discussed how the link between 
mitochondrial morphology/dynamics and cellular metabolism could contribute to 
different the apoptotic threshold observed in the naïve and primed pluripotent 
states. Further investigation in vitro and in vivo, is required to precisely establish 
how the synergy of metabolism, miRNA expression, pluripotency status and 
mitochondrial dynamics found in primed pluripotent cells determines the low 
apoptotic threshold of this cell type to ensure the elimination of defective cells that 
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Two way ANOVA analysis showed statistical significance for BID 1uM (p=0.0352), 


































Figure A.1 Inhibition of glycolysis promotes ESCs differentiation.  
ESCs culture in the presence of 2mM 2DG for 48h loss alkaline phosphatase staining – a marker of 
embryonic stem cells.  Lower number of cells was qualitatively noted supporting previous 
published data in which ESCs cultured in the presence of 2DG showed slower proliferation rates.  
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8.3 Levels of total DRP1 in ESCs and EpiSCs 
 
 
